




Analysis Type:	PANTHER Overrepresentation Test (Released 20200728)
Annotation Version and Release Date:	PANTHER version 16.0 Released 2020-12-01
Analyzed List:	upload_1 (Homo sapiens)
Reference List:	human_background.txt (Homo sapiens)
Test Type:	BINOMIAL
Correction:	NONE
PANTHER GO-Slim Biological Process	human_background.txt - REFLIST (16250)	upload_1 (830)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (raw P-value)
mammary gland development (GO:0030879)	1	1	.05	+	19.58	4.98E-02
regulation of circadian rhythm (GO:0042752)	7	5	.36	+	13.98	3.58E-05
circadian regulation of gene expression (GO:0032922)	16	9	.82	+	11.01	2.08E-07
regulation of mitotic spindle organization (GO:0060236)	4	2	.20	+	9.79	1.82E-02
circadian rhythm (GO:0007623)	22	11	1.12	+	9.79	3.07E-08
rhythmic process (GO:0048511)	24	11	1.23	+	8.97	7.29E-08
regulation of chromatin assembly or disassembly (GO:0001672)	5	2	.26	+	7.83	2.75E-02
regulation of autophagosome maturation (GO:1901096)	5	2	.26	+	7.83	2.75E-02
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	5	2	.26	+	7.83	2.75E-02
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	5	2	.26	+	7.83	2.75E-02
poly(A)+ mRNA export from nucleus (GO:0016973)	13	5	.66	+	7.53	6.16E-04
protein demethylation (GO:0006482)	11	4	.56	+	7.12	2.65E-03
regulation of stress fiber assembly (GO:0051492)	6	2	.31	+	6.53	3.84E-02
negative regulation of macroautophagy (GO:0016242)	6	2	.31	+	6.53	3.84E-02
lysosomal microautophagy (GO:0016237)	3	1	.15	+	6.53	1.42E-01
intracellular mRNA localization (GO:0008298)	3	1	.15	+	6.53	1.42E-01
centrosome localization (GO:0051642)	6	2	.31	+	6.53	3.84E-02
regulation of telomere maintenance via telomerase (GO:0032210)	3	1	.15	+	6.53	1.42E-01
piecemeal microautophagy of the nucleus (GO:0034727)	3	1	.15	+	6.53	1.42E-01
vacuolar protein processing (GO:0006624)	3	1	.15	+	6.53	1.42E-01
gland development (GO:0048732)	6	2	.31	+	6.53	3.84E-02
endosome to lysosome transport (GO:0008333)	7	2	.36	+	5.59	5.05E-02
response to heat (GO:0009408)	7	2	.36	+	5.59	5.05E-02
sterol biosynthetic process (GO:0016126)	14	4	.72	+	5.59	6.16E-03
cellular response to heat (GO:0034605)	7	2	.36	+	5.59	5.05E-02
mRNA cis splicing, via spliceosome (GO:0045292)	11	3	.56	+	5.34	1.95E-02
ribosomal subunit export from nucleus (GO:0000054)	11	3	.56	+	5.34	1.95E-02
intracellular pH reduction (GO:0051452)	8	2	.41	+	4.89	6.38E-02
histone deubiquitination (GO:0016578)	4	1	.20	+	4.89	1.85E-01
attachment of spindle microtubules to kinetochore (GO:0008608)	8	2	.41	+	4.89	6.38E-02
stress fiber assembly (GO:0043149)	8	2	.41	+	4.89	6.38E-02
regulation of telomere maintenance via telomere lengthening (GO:1904356)	4	1	.20	+	4.89	1.85E-01
contractile actin filament bundle assembly (GO:0030038)	8	2	.41	+	4.89	6.38E-02
cellular response to hypoxia (GO:0071456)	8	2	.41	+	4.89	6.38E-02
activation of innate immune response (GO:0002218)	4	1	.20	+	4.89	1.85E-01
regulation of autophagosome assembly (GO:2000785)	8	2	.41	+	4.89	6.38E-02
mitotic metaphase plate congression (GO:0007080)	8	2	.41	+	4.89	6.38E-02
plasma membrane phospholipid scrambling (GO:0017121)	8	2	.41	+	4.89	6.38E-02
pH reduction (GO:0045851)	8	2	.41	+	4.89	6.38E-02
vacuolar acidification (GO:0007035)	8	2	.41	+	4.89	6.38E-02
skeletal muscle organ development (GO:0060538)	4	1	.20	+	4.89	1.85E-01
mitochondrial RNA processing (GO:0000963)	4	1	.20	+	4.89	1.85E-01
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	9	2	.46	+	4.35	7.82E-02
regulation of macroautophagy (GO:0016241)	18	4	.92	+	4.35	1.44E-02
autophagosome maturation (GO:0097352)	9	2	.46	+	4.35	7.82E-02
metaphase plate congression (GO:0051310)	9	2	.46	+	4.35	7.82E-02
regulation of telomere maintenance (GO:0032204)	9	2	.46	+	4.35	7.82E-02
mitotic recombination (GO:0006312)	9	2	.46	+	4.35	7.82E-02
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	9	2	.46	+	4.35	7.82E-02
telomere-telomerase complex assembly (GO:1905324)	9	2	.46	+	4.35	7.82E-02
telomere maintenance via telomerase (GO:0007004)	9	2	.46	+	4.35	7.82E-02
response to light stimulus (GO:0009416)	23	5	1.17	+	4.26	7.06E-03
sterol metabolic process (GO:0016125)	28	6	1.43	+	4.20	3.51E-03
steroid biosynthetic process (GO:0006694)	24	5	1.23	+	4.08	8.38E-03
ribonucleoprotein complex localization (GO:0071166)	39	8	1.99	+	4.02	1.05E-03
ribonucleoprotein complex export from nucleus (GO:0071426)	39	8	1.99	+	4.02	1.05E-03
telomere capping (GO:0016233)	10	2	.51	+	3.92	9.34E-02
muscle organ development (GO:0007517)	5	1	.26	+	3.92	2.25E-01
mitochondrion distribution (GO:0048311)	5	1	.26	+	3.92	2.25E-01
phosphatidylcholine metabolic process (GO:0046470)	5	1	.26	+	3.92	2.25E-01
glycogen biosynthetic process (GO:0005978)	10	2	.51	+	3.92	9.34E-02
kinetochore assembly (GO:0051382)	5	1	.26	+	3.92	2.25E-01
type I interferon signaling pathway (GO:0060337)	5	1	.26	+	3.92	2.25E-01
transcription by RNA polymerase III (GO:0006383)	10	2	.51	+	3.92	9.34E-02
cholesterol biosynthetic process (GO:0006695)	5	1	.26	+	3.92	2.25E-01
cytoplasmic mRNA processing body assembly (GO:0033962)	10	2	.51	+	3.92	9.34E-02
glucan biosynthetic process (GO:0009250)	10	2	.51	+	3.92	9.34E-02
response to type I interferon (GO:0034340)	5	1	.26	+	3.92	2.25E-01
histone H3-K4 methylation (GO:0051568)	10	2	.51	+	3.92	9.34E-02
negative regulation of protein ubiquitination (GO:0031397)	5	1	.26	+	3.92	2.25E-01
mitochondrial RNA metabolic process (GO:0000959)	10	2	.51	+	3.92	9.34E-02
secondary alcohol biosynthetic process (GO:1902653)	5	1	.26	+	3.92	2.25E-01
regulation of epithelial cell differentiation (GO:0030856)	5	1	.26	+	3.92	2.25E-01
protein stabilization (GO:0050821)	15	3	.77	+	3.92	4.26E-02
glucose homeostasis (GO:0042593)	15	3	.77	+	3.92	4.26E-02
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	15	3	.77	+	3.92	4.26E-02
establishment or maintenance of bipolar cell polarity (GO:0061245)	16	3	.82	+	3.67	4.98E-02
'de novo' protein folding (GO:0006458)	16	3	.82	+	3.67	4.98E-02
mitotic spindle assembly (GO:0090307)	16	3	.82	+	3.67	4.98E-02
regulation of protein stability (GO:0031647)	16	3	.82	+	3.67	4.98E-02
establishment or maintenance of apical/basal cell polarity (GO:0035088)	16	3	.82	+	3.67	4.98E-02
mRNA export from nucleus (GO:0006406)	27	5	1.38	+	3.63	1.34E-02
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	27	5	1.38	+	3.63	1.34E-02
negative regulation of autophagy (GO:0010507)	11	2	.56	+	3.56	1.09E-01
telomere maintenance via telomere lengthening (GO:0010833)	11	2	.56	+	3.56	1.09E-01
mRNA transport (GO:0051028)	28	5	1.43	+	3.50	1.54E-02
phosphatidylinositol phosphorylation (GO:0046854)	34	6	1.74	+	3.45	8.74E-03
RNA export from nucleus (GO:0006405)	52	9	2.66	+	3.39	1.68E-03
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	29	5	1.48	+	3.38	1.76E-02
response to radiation (GO:0009314)	35	6	1.79	+	3.36	9.97E-03
RNA localization (GO:0006403)	59	10	3.01	+	3.32	1.11E-03
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	12	2	.61	+	3.26	1.26E-01
positive regulation of proteasomal protein catabolic process (GO:1901800)	24	4	1.23	+	3.26	3.59E-02
collagen fibril organization (GO:0030199)	6	1	.31	+	3.26	2.64E-01
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	6	1	.31	+	3.26	2.64E-01
C4-dicarboxylate transport (GO:0015740)	6	1	.31	+	3.26	2.64E-01
rRNA base methylation (GO:0070475)	6	1	.31	+	3.26	2.64E-01
kinetochore organization (GO:0051383)	6	1	.31	+	3.26	2.64E-01
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	6	1	.31	+	3.26	2.64E-01
bone development (GO:0060348)	6	1	.31	+	3.26	2.64E-01
regulation of centrosome duplication (GO:0010824)	6	1	.31	+	3.26	2.64E-01
positive regulation of cell-substrate adhesion (GO:0010811)	6	1	.31	+	3.26	2.64E-01
mitochondrial transcription (GO:0006390)	6	1	.31	+	3.26	2.64E-01
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	6	1	.31	+	3.26	2.64E-01
IMP metabolic process (GO:0046040)	6	1	.31	+	3.26	2.64E-01
AMP metabolic process (GO:0046033)	6	1	.31	+	3.26	2.64E-01
response to temperature stimulus (GO:0009266)	12	2	.61	+	3.26	1.26E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518)	6	1	.31	+	3.26	2.64E-01
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	6	1	.31	+	3.26	2.64E-01
actin filament depolymerization (GO:0030042)	18	3	.92	+	3.26	6.60E-02
regulation of RNA splicing (GO:0043484)	67	11	3.42	+	3.21	8.27E-04
RNA transport (GO:0050658)	55	9	2.81	+	3.20	2.44E-03
nucleic acid transport (GO:0050657)	55	9	2.81	+	3.20	2.44E-03
establishment of RNA localization (GO:0051236)	55	9	2.81	+	3.20	2.44E-03
protein export from nucleus (GO:0006611)	49	8	2.50	+	3.20	4.21E-03
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	25	4	1.28	+	3.13	4.07E-02
positive regulation of cellular protein catabolic process (GO:1903364)	25	4	1.28	+	3.13	4.07E-02
regulation of chromatin organization (GO:1902275)	25	4	1.28	+	3.13	4.07E-02
steroid metabolic process (GO:0008202)	44	7	2.25	+	3.11	8.23E-03
chromosome localization (GO:0050000)	13	2	.66	+	3.01	1.43E-01
establishment of chromosome localization (GO:0051303)	13	2	.66	+	3.01	1.43E-01
histone H2A ubiquitination (GO:0033522)	13	2	.66	+	3.01	1.43E-01
regulation of proteasomal protein catabolic process (GO:0061136)	33	5	1.69	+	2.97	2.86E-02
alternative mRNA splicing, via spliceosome (GO:0000380)	33	5	1.69	+	2.97	2.86E-02
chaperone-mediated protein folding (GO:0061077)	20	3	1.02	+	2.94	8.42E-02
negative regulation of actin filament polymerization (GO:0030837)	27	4	1.38	+	2.90	5.12E-02
regulation of mRNA processing (GO:0050684)	54	8	2.76	+	2.90	7.36E-03
establishment of protein localization to extracellular region (GO:0035592)	34	5	1.74	+	2.88	3.18E-02
protein secretion (GO:0009306)	34	5	1.74	+	2.88	3.18E-02
nuclear export (GO:0051168)	62	9	3.17	+	2.84	5.26E-03
proteasome assembly (GO:0043248)	7	1	.36	+	2.80	3.01E-01
negative regulation of blood pressure (GO:0045776)	7	1	.36	+	2.80	3.01E-01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	35	5	1.79	+	2.80	3.54E-02
response to hypoxia (GO:0001666)	21	3	1.07	+	2.80	9.40E-02
regulation of cellular protein catabolic process (GO:1903362)	35	5	1.79	+	2.80	3.54E-02
negative regulation of phosphatase activity (GO:0010923)	7	1	.36	+	2.80	3.01E-01
regulation of glucose metabolic process (GO:0010906)	7	1	.36	+	2.80	3.01E-01
energy reserve metabolic process (GO:0006112)	14	2	.72	+	2.80	1.61E-01
signal peptide processing (GO:0006465)	7	1	.36	+	2.80	3.01E-01
response to oxygen levels (GO:0070482)	21	3	1.07	+	2.80	9.40E-02
glycogen metabolic process (GO:0005977)	14	2	.72	+	2.80	1.61E-01
cellular glucan metabolic process (GO:0006073)	14	2	.72	+	2.80	1.61E-01
steroid hormone mediated signaling pathway (GO:0043401)	7	1	.36	+	2.80	3.01E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263)	21	3	1.07	+	2.80	9.40E-02
mRNA stabilization (GO:0048255)	7	1	.36	+	2.80	3.01E-01
epidermal cell differentiation (GO:0009913)	7	1	.36	+	2.80	3.01E-01
response to decreased oxygen levels (GO:0036293)	21	3	1.07	+	2.80	9.40E-02
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	7	1	.36	+	2.80	3.01E-01
mitotic sister chromatid cohesion (GO:0007064)	7	1	.36	+	2.80	3.01E-01
mismatch repair (GO:0006298)	14	2	.72	+	2.80	1.61E-01
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	28	4	1.43	+	2.80	5.70E-02
negative regulation of inflammatory response (GO:0050728)	14	2	.72	+	2.80	1.61E-01
Golgi to plasma membrane transport (GO:0006893)	21	3	1.07	+	2.80	9.40E-02
mitotic DNA replication (GO:1902969)	7	1	.36	+	2.80	3.01E-01
dicarboxylic acid transport (GO:0006835)	7	1	.36	+	2.80	3.01E-01
glucan metabolic process (GO:0044042)	14	2	.72	+	2.80	1.61E-01
protein localization to extracellular region (GO:0071692)	35	5	1.79	+	2.80	3.54E-02
organic hydroxy compound biosynthetic process (GO:1901617)	49	7	2.50	+	2.80	1.41E-02
nucleobase-containing compound transport (GO:0015931)	64	9	3.27	+	2.75	6.41E-03
hormone-mediated signaling pathway (GO:0009755)	36	5	1.84	+	2.72	3.91E-02
response to unfolded protein (GO:0006986)	36	5	1.84	+	2.72	3.91E-02
cellular response to unfolded protein (GO:0034620)	36	5	1.84	+	2.72	3.91E-02
neuron projection extension (GO:1990138)	29	4	1.48	+	2.70	6.31E-02
ribonucleoside diphosphate metabolic process (GO:0009185)	22	3	1.12	+	2.67	1.04E-01
purine ribonucleoside diphosphate metabolic process (GO:0009179)	22	3	1.12	+	2.67	1.04E-01
purine nucleoside diphosphate metabolic process (GO:0009135)	22	3	1.12	+	2.67	1.04E-01
ATP generation from ADP (GO:0006757)	22	3	1.12	+	2.67	1.04E-01
glycolytic process (GO:0006096)	22	3	1.12	+	2.67	1.04E-01
ADP metabolic process (GO:0046031)	22	3	1.12	+	2.67	1.04E-01
nucleus organization (GO:0006997)	22	3	1.12	+	2.67	1.04E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	22	3	1.12	+	2.67	1.04E-01
regulation of mRNA splicing, via spliceosome (GO:0048024)	45	6	2.30	+	2.61	2.97E-02
glucose 6-phosphate metabolic process (GO:0051156)	15	2	.77	+	2.61	1.79E-01
epithelial cell proliferation (GO:0050673)	15	2	.77	+	2.61	1.79E-01
regulation of translational initiation (GO:0006446)	15	2	.77	+	2.61	1.79E-01
insulin receptor signaling pathway (GO:0008286)	15	2	.77	+	2.61	1.79E-01
demethylation (GO:0070988)	30	4	1.53	+	2.61	6.96E-02
protein monoubiquitination (GO:0006513)	15	2	.77	+	2.61	1.79E-01
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	30	4	1.53	+	2.61	6.96E-02
peptide secretion (GO:0002790)	38	5	1.94	+	2.58	4.73E-02
nuclear transport (GO:0051169)	92	12	4.70	+	2.55	3.28E-03
nucleocytoplasmic transport (GO:0006913)	92	12	4.70	+	2.55	3.28E-03
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	23	3	1.17	+	2.55	1.15E-01
telomere maintenance (GO:0000723)	31	4	1.58	+	2.53	7.64E-02
telomere organization (GO:0032200)	31	4	1.58	+	2.53	7.64E-02
chromatin assembly or disassembly (GO:0006333)	31	4	1.58	+	2.53	7.64E-02
developmental cell growth (GO:0048588)	31	4	1.58	+	2.53	7.64E-02
mitotic spindle organization (GO:0007052)	31	4	1.58	+	2.53	7.64E-02
negative regulation of catabolic process (GO:0009895)	31	4	1.58	+	2.53	7.64E-02
response to abiotic stimulus (GO:0009628)	87	11	4.44	+	2.48	5.96E-03
cyclic nucleotide metabolic process (GO:0009187)	16	2	.82	+	2.45	1.97E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	16	2	.82	+	2.45	1.97E-01
vesicle-mediated transport to the plasma membrane (GO:0098876)	32	4	1.63	+	2.45	8.34E-02
tRNA processing (GO:0008033)	56	7	2.86	+	2.45	2.67E-02
regulation of meiotic cell cycle (GO:0051445)	8	1	.41	+	2.45	3.35E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	16	2	.82	+	2.45	1.97E-01
translational termination (GO:0006415)	8	1	.41	+	2.45	3.35E-01
ubiquinone biosynthetic process (GO:0006744)	8	1	.41	+	2.45	3.35E-01
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	8	1	.41	+	2.45	3.35E-01
retrograde transport, endosome to plasma membrane (GO:1990126)	8	1	.41	+	2.45	3.35E-01
cholesterol metabolic process (GO:0008203)	16	2	.82	+	2.45	1.97E-01
positive regulation of cell growth (GO:0030307)	8	1	.41	+	2.45	3.35E-01
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	8	1	.41	+	2.45	3.35E-01
protein K48-linked deubiquitination (GO:0071108)	8	1	.41	+	2.45	3.35E-01
smooth muscle contraction (GO:0006939)	8	1	.41	+	2.45	3.35E-01
developmental growth involved in morphogenesis (GO:0060560)	32	4	1.63	+	2.45	8.34E-02
positive regulation of proteolysis (GO:0045862)	48	6	2.45	+	2.45	3.86E-02
endosome organization (GO:0007032)	8	1	.41	+	2.45	3.35E-01
histone H3 acetylation (GO:0043966)	16	2	.82	+	2.45	1.97E-01
NIK/NF-kappaB signaling (GO:0038061)	8	1	.41	+	2.45	3.35E-01
protein sumoylation (GO:0016925)	16	2	.82	+	2.45	1.97E-01
alcohol biosynthetic process (GO:0046165)	33	4	1.69	+	2.37	9.08E-02
nucleoside diphosphate phosphorylation (GO:0006165)	25	3	1.28	+	2.35	1.37E-01
nucleotide phosphorylation (GO:0046939)	25	3	1.28	+	2.35	1.37E-01
epithelial cell differentiation (GO:0030855)	25	3	1.28	+	2.35	1.37E-01
regulation of mRNA metabolic process (GO:1903311)	75	9	3.83	+	2.35	1.65E-02
protein folding (GO:0006457)	75	9	3.83	+	2.35	1.65E-02
protein K63-linked ubiquitination (GO:0070534)	17	2	.87	+	2.30	2.16E-01
histone ubiquitination (GO:0016574)	17	2	.87	+	2.30	2.16E-01
tRNA methylation (GO:0030488)	17	2	.87	+	2.30	2.16E-01
glycosaminoglycan metabolic process (GO:0030203)	17	2	.87	+	2.30	2.16E-01
phosphatidylinositol metabolic process (GO:0046488)	77	9	3.93	+	2.29	1.92E-02
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	26	3	1.33	+	2.26	1.49E-01
polysaccharide biosynthetic process (GO:0000271)	26	3	1.33	+	2.26	1.49E-01
positive regulation of Wnt signaling pathway (GO:0030177)	26	3	1.33	+	2.26	1.49E-01
regulation of endocytosis (GO:0030100)	26	3	1.33	+	2.26	1.49E-01
axon extension (GO:0048675)	26	3	1.33	+	2.26	1.49E-01
activation of MAPK activity (GO:0000187)	26	3	1.33	+	2.26	1.49E-01
cellular polysaccharide biosynthetic process (GO:0033692)	26	3	1.33	+	2.26	1.49E-01
plasma membrane organization (GO:0007009)	26	3	1.33	+	2.26	1.49E-01
spindle assembly (GO:0051225)	35	4	1.79	+	2.24	1.07E-01
intrinsic apoptotic signaling pathway (GO:0097193)	35	4	1.79	+	2.24	1.07E-01
RNA splicing (GO:0008380)	185	21	9.45	+	2.22	7.44E-04
purine ribonucleoside monophosphate metabolic process (GO:0009167)	9	1	.46	+	2.18	3.69E-01
protein K63-linked deubiquitination (GO:0070536)	9	1	.46	+	2.18	3.69E-01
long-chain fatty acid metabolic process (GO:0001676)	18	2	.92	+	2.18	2.35E-01
positive regulation of angiogenesis (GO:0045766)	9	1	.46	+	2.18	3.69E-01
purine nucleoside monophosphate metabolic process (GO:0009126)	9	1	.46	+	2.18	3.69E-01
urogenital system development (GO:0001655)	9	1	.46	+	2.18	3.69E-01
negative regulation of dephosphorylation (GO:0035305)	9	1	.46	+	2.18	3.69E-01
intra-S DNA damage checkpoint (GO:0031573)	9	1	.46	+	2.18	3.69E-01
dendritic spine organization (GO:0097061)	9	1	.46	+	2.18	3.69E-01
protein-containing complex disassembly (GO:0032984)	63	7	3.22	+	2.18	4.54E-02
positive chemotaxis (GO:0050918)	9	1	.46	+	2.18	3.69E-01
sprouting angiogenesis (GO:0002040)	9	1	.46	+	2.18	3.69E-01
reproductive structure development (GO:0048608)	9	1	.46	+	2.18	3.69E-01
microtubule polymerization (GO:0046785)	18	2	.92	+	2.18	2.35E-01
reproductive system development (GO:0061458)	9	1	.46	+	2.18	3.69E-01
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	9	1	.46	+	2.18	3.69E-01
epidermis development (GO:0008544)	9	1	.46	+	2.18	3.69E-01
cellular response to insulin stimulus (GO:0032869)	27	3	1.38	+	2.18	1.61E-01
cholesterol transport (GO:0030301)	9	1	.46	+	2.18	3.69E-01
regulation of muscle contraction (GO:0006937)	9	1	.46	+	2.18	3.69E-01
cell growth (GO:0016049)	36	4	1.84	+	2.18	1.15E-01
RNA-dependent DNA biosynthetic process (GO:0006278)	18	2	.92	+	2.18	2.35E-01
histone lysine methylation (GO:0034968)	18	2	.92	+	2.18	2.35E-01
negative regulation of cellular catabolic process (GO:0031330)	27	3	1.38	+	2.18	1.61E-01
chondroitin sulfate metabolic process (GO:0030204)	9	1	.46	+	2.18	3.69E-01
phospholipid metabolic process (GO:0006644)	136	15	6.95	+	2.16	5.15E-03
positive regulation of cellular catabolic process (GO:0031331)	55	6	2.81	+	2.14	6.56E-02
cellular response to topologically incorrect protein (GO:0035967)	46	5	2.35	+	2.13	8.94E-02
response to topologically incorrect protein (GO:0035966)	46	5	2.35	+	2.13	8.94E-02
regulation of microtubule cytoskeleton organization (GO:0070507)	37	4	1.89	+	2.12	1.23E-01
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	37	4	1.89	+	2.12	1.23E-01
lipid modification (GO:0030258)	111	12	5.67	+	2.12	1.33E-02
cellular carbohydrate metabolic process (GO:0044262)	65	7	3.32	+	2.11	5.19E-02
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	28	3	1.43	+	2.10	1.74E-01
response to insulin (GO:0032868)	28	3	1.43	+	2.10	1.74E-01
ERAD pathway (GO:0036503)	47	5	2.40	+	2.08	9.57E-02
positive regulation of peptidase activity (GO:0010952)	19	2	.97	+	2.06	2.53E-01
positive regulation of endopeptidase activity (GO:0010950)	19	2	.97	+	2.06	2.53E-01
positive regulation of autophagy (GO:0010508)	19	2	.97	+	2.06	2.53E-01
dendrite morphogenesis (GO:0048813)	19	2	.97	+	2.06	2.53E-01
post-Golgi vesicle-mediated transport (GO:0006892)	38	4	1.94	+	2.06	1.32E-01
glycerophospholipid metabolic process (GO:0006650)	105	11	5.36	+	2.05	2.12E-02
tRNA metabolic process (GO:0006399)	96	10	4.90	+	2.04	2.81E-02
secretion (GO:0046903)	144	15	7.36	+	2.04	8.43E-03
nucleoside diphosphate metabolic process (GO:0009132)	29	3	1.48	+	2.03	1.86E-01
phospholipid dephosphorylation (GO:0046839)	29	3	1.48	+	2.03	1.86E-01
cellular response to starvation (GO:0009267)	39	4	1.99	+	2.01	1.41E-01
negative regulation of cellular component organization (GO:0051129)	98	10	5.01	+	2.00	3.16E-02
protein localization to nucleus (GO:0034504)	49	5	2.50	+	2.00	1.09E-01
anatomical structure homeostasis (GO:0060249)	49	5	2.50	+	2.00	1.09E-01
negative regulation of organelle organization (GO:0010639)	69	7	3.52	+	1.99	6.68E-02
negative regulation of protein catabolic process (GO:0042177)	10	1	.51	+	1.96	4.00E-01
regulation of intracellular pH (GO:0051453)	20	2	1.02	+	1.96	2.72E-01
positive regulation of epithelial cell proliferation (GO:0050679)	10	1	.51	+	1.96	4.00E-01
endothelial cell proliferation (GO:0001935)	10	1	.51	+	1.96	4.00E-01
ubiquitin-dependent ERAD pathway (GO:0030433)	40	4	2.04	+	1.96	1.51E-01
signal transduction by p53 class mediator (GO:0072331)	10	1	.51	+	1.96	4.00E-01
regulation of reproductive process (GO:2000241)	20	2	1.02	+	1.96	2.72E-01
vesicle fusion to plasma membrane (GO:0099500)	100	10	5.11	+	1.96	3.54E-02
exocytic process (GO:0140029)	100	10	5.11	+	1.96	3.54E-02
receptor clustering (GO:0043113)	10	1	.51	+	1.96	4.00E-01
positive regulation of mitotic cell cycle (GO:0045931)	20	2	1.02	+	1.96	2.72E-01
positive regulation of ion transmembrane transport (GO:0034767)	10	1	.51	+	1.96	4.00E-01
cholesterol homeostasis (GO:0042632)	10	1	.51	+	1.96	4.00E-01
mitochondrial cytochrome c oxidase assembly (GO:0033617)	10	1	.51	+	1.96	4.00E-01
defense response to Gram-positive bacterium (GO:0050830)	20	2	1.02	+	1.96	2.72E-01
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	10	1	.51	+	1.96	4.00E-01
centrosome duplication (GO:0051298)	20	2	1.02	+	1.96	2.72E-01
snRNA metabolic process (GO:0016073)	20	2	1.02	+	1.96	2.72E-01
regulation of double-strand break repair (GO:2000779)	10	1	.51	+	1.96	4.00E-01
forebrain development (GO:0030900)	10	1	.51	+	1.96	4.00E-01
sister chromatid cohesion (GO:0007062)	20	2	1.02	+	1.96	2.72E-01
spindle organization (GO:0007051)	50	5	2.55	+	1.96	1.16E-01
lysosome localization (GO:0032418)	10	1	.51	+	1.96	4.00E-01
positive regulation of ion transmembrane transporter activity (GO:0032414)	10	1	.51	+	1.96	4.00E-01
positive regulation of transporter activity (GO:0032411)	10	1	.51	+	1.96	4.00E-01
Golgi to vacuole transport (GO:0006896)	10	1	.51	+	1.96	4.00E-01
exocytosis (GO:0006887)	100	10	5.11	+	1.96	3.54E-02
regulation of establishment of protein localization (GO:0070201)	30	3	1.53	+	1.96	1.99E-01
secretion by cell (GO:0032940)	140	14	7.15	+	1.96	1.47E-02
cytoplasmic microtubule organization (GO:0031122)	30	3	1.53	+	1.96	1.99E-01
protein localization to cell junction (GO:1902414)	30	3	1.53	+	1.96	1.99E-01
ncRNA metabolic process (GO:0034660)	220	22	11.24	+	1.96	2.70E-03
regulation of cellular catabolic process (GO:0031329)	120	12	6.13	+	1.96	2.27E-02
cellular response to hormone stimulus (GO:0032870)	91	9	4.65	+	1.94	4.70E-02
vesicle fusion (GO:0006906)	132	13	6.74	+	1.93	2.03E-02
macroautophagy (GO:0016236)	61	6	3.12	+	1.93	9.56E-02
histone modification (GO:0016570)	112	11	5.72	+	1.92	3.16E-02
regulation of autophagy (GO:0010506)	51	5	2.60	+	1.92	1.23E-01
organelle membrane fusion (GO:0090174)	133	13	6.79	+	1.91	2.15E-02
autophagosome assembly (GO:0000045)	41	4	2.09	+	1.91	1.60E-01
autophagosome organization (GO:1905037)	41	4	2.09	+	1.91	1.60E-01
covalent chromatin modification (GO:0016569)	113	11	5.77	+	1.91	3.34E-02
organic hydroxy compound metabolic process (GO:1901615)	113	11	5.77	+	1.91	3.34E-02
RNA processing (GO:0006396)	403	39	20.58	+	1.89	1.55E-04
polysaccharide metabolic process (GO:0005976)	31	3	1.58	+	1.89	2.12E-01
cellular response to transforming growth factor beta stimulus (GO:0071560)	31	3	1.58	+	1.89	2.12E-01
cellular polysaccharide metabolic process (GO:0044264)	31	3	1.58	+	1.89	2.12E-01
response to transforming growth factor beta (GO:0071559)	31	3	1.58	+	1.89	2.12E-01
regulation of cell growth (GO:0001558)	31	3	1.58	+	1.89	2.12E-01
transforming growth factor beta receptor signaling pathway (GO:0007179)	31	3	1.58	+	1.89	2.12E-01
cellular carbohydrate biosynthetic process (GO:0034637)	31	3	1.58	+	1.89	2.12E-01
nuclear-transcribed mRNA catabolic process (GO:0000956)	52	5	2.66	+	1.88	1.30E-01
regulation of canonical Wnt signaling pathway (GO:0060828)	52	5	2.66	+	1.88	1.30E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	21	2	1.07	+	1.86	2.91E-01
maturation of LSU-rRNA (GO:0000470)	21	2	1.07	+	1.86	2.91E-01
negative regulation of response to external stimulus (GO:0032102)	42	4	2.15	+	1.86	1.70E-01
regulation of inflammatory response (GO:0050727)	21	2	1.07	+	1.86	2.91E-01
secondary alcohol metabolic process (GO:1902652)	21	2	1.07	+	1.86	2.91E-01
cellular response to nutrient levels (GO:0031669)	42	4	2.15	+	1.86	1.70E-01
cellular response to extracellular stimulus (GO:0031668)	42	4	2.15	+	1.86	1.70E-01
mRNA splicing, via spliceosome (GO:0000398)	148	14	7.56	+	1.85	2.23E-02
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	148	14	7.56	+	1.85	2.23E-02
RNA splicing, via transesterification reactions (GO:0000375)	148	14	7.56	+	1.85	2.23E-02
epithelium development (GO:0060429)	53	5	2.71	+	1.85	1.38E-01
response to hormone (GO:0009725)	106	10	5.41	+	1.85	4.89E-02
mRNA processing (GO:0006397)	191	18	9.76	+	1.85	1.10E-02
regulation of protein catabolic process (GO:0042176)	64	6	3.27	+	1.84	1.13E-01
chromatin organization (GO:0006325)	203	19	10.37	+	1.83	9.77E-03
regulation of actin filament organization (GO:0110053)	75	7	3.83	+	1.83	9.33E-02
developmental growth (GO:0048589)	43	4	2.20	+	1.82	1.80E-01
canonical Wnt signaling pathway (GO:0060070)	97	9	4.95	+	1.82	6.46E-02
double-strand break repair via homologous recombination (GO:0000724)	55	5	2.81	+	1.78	1.53E-01
import into nucleus (GO:0051170)	44	4	2.25	+	1.78	1.90E-01
positive regulation of ion transport (GO:0043270)	11	1	.56	+	1.78	4.30E-01
ribonucleoside monophosphate metabolic process (GO:0009161)	11	1	.56	+	1.78	4.30E-01
histone methylation (GO:0016571)	22	2	1.12	+	1.78	3.10E-01
heart looping (GO:0001947)	11	1	.56	+	1.78	4.30E-01
apoptotic mitochondrial changes (GO:0008637)	11	1	.56	+	1.78	4.30E-01
positive regulation of innate immune response (GO:0045089)	11	1	.56	+	1.78	4.30E-01
translational initiation (GO:0006413)	33	3	1.69	+	1.78	2.39E-01
glycerophospholipid catabolic process (GO:0046475)	11	1	.56	+	1.78	4.30E-01
cellular response to amino acid starvation (GO:0034198)	11	1	.56	+	1.78	4.30E-01
positive regulation of leukocyte chemotaxis (GO:0002690)	11	1	.56	+	1.78	4.30E-01
response to ionizing radiation (GO:0010212)	11	1	.56	+	1.78	4.30E-01
peptidyl-lysine methylation (GO:0018022)	22	2	1.12	+	1.78	3.10E-01
negative regulation of neuron differentiation (GO:0045665)	22	2	1.12	+	1.78	3.10E-01
regulation of dendritic spine development (GO:0060998)	11	1	.56	+	1.78	4.30E-01
positive regulation of transmembrane transport (GO:0034764)	11	1	.56	+	1.78	4.30E-01
L-alpha-amino acid transmembrane transport (GO:1902475)	11	1	.56	+	1.78	4.30E-01
double-strand break repair via break-induced replication (GO:0000727)	11	1	.56	+	1.78	4.30E-01
organelle fusion (GO:0048284)	143	13	7.30	+	1.78	3.52E-02
resolution of meiotic recombination intermediates (GO:0000712)	11	1	.56	+	1.78	4.30E-01
cellular response to external stimulus (GO:0071496)	44	4	2.25	+	1.78	1.90E-01
regulation of cellular pH (GO:0030641)	22	2	1.12	+	1.78	3.10E-01
protein import into nucleus (GO:0006606)	44	4	2.25	+	1.78	1.90E-01
sterol transport (GO:0015918)	11	1	.56	+	1.78	4.30E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	11	1	.56	+	1.78	4.30E-01
lysosome organization (GO:0007040)	11	1	.56	+	1.78	4.30E-01
positive regulation of mitotic nuclear division (GO:0045840)	11	1	.56	+	1.78	4.30E-01
DNA strand elongation involved in DNA replication (GO:0006271)	11	1	.56	+	1.78	4.30E-01
intra-Golgi vesicle-mediated transport (GO:0006891)	22	2	1.12	+	1.78	3.10E-01
regulation of pH (GO:0006885)	22	2	1.12	+	1.78	3.10E-01
homologous chromosome segregation (GO:0045143)	11	1	.56	+	1.78	4.30E-01
regulation of catabolic process (GO:0009894)	144	13	7.36	+	1.77	3.69E-02
membrane fusion (GO:0061025)	156	14	7.97	+	1.76	3.25E-02
positive regulation of nucleic acid-templated transcription (GO:1903508)	268	24	13.69	+	1.75	6.79E-03
positive regulation of transcription, DNA-templated (GO:0045893)	268	24	13.69	+	1.75	6.79E-03
positive regulation of RNA biosynthetic process (GO:1902680)	268	24	13.69	+	1.75	6.79E-03
regulation of chromosome organization (GO:0033044)	56	5	2.86	+	1.75	1.62E-01
recombinational repair (GO:0000725)	56	5	2.86	+	1.75	1.62E-01
export from cell (GO:0140352)	157	14	8.02	+	1.75	3.40E-02
cellular component disassembly (GO:0022411)	101	9	5.16	+	1.74	7.83E-02
regulation of microtubule-based process (GO:0032886)	45	4	2.30	+	1.74	2.00E-01
response to starvation (GO:0042594)	45	4	2.30	+	1.74	2.00E-01
mRNA metabolic process (GO:0016071)	259	23	13.23	+	1.74	8.70E-03
peptidyl-serine phosphorylation (GO:0018105)	102	9	5.21	+	1.73	8.20E-02
actin filament bundle assembly (GO:0051017)	34	3	1.74	+	1.73	2.52E-01
positive regulation of MAP kinase activity (GO:0043406)	34	3	1.74	+	1.73	2.52E-01
RNA catabolic process (GO:0006401)	91	8	4.65	+	1.72	9.87E-02
alcohol metabolic process (GO:0006066)	80	7	4.09	+	1.71	1.19E-01
positive regulation of RNA metabolic process (GO:0051254)	286	25	14.61	+	1.71	7.74E-03
morphogenesis of an epithelium (GO:0002009)	23	2	1.17	+	1.70	3.28E-01
regulation of mRNA stability (GO:0043488)	23	2	1.17	+	1.70	3.28E-01
protein targeting to vacuole (GO:0006623)	23	2	1.17	+	1.70	3.28E-01
lysosomal transport (GO:0007041)	23	2	1.17	+	1.70	3.28E-01
cellular protein complex disassembly (GO:0043624)	46	4	2.35	+	1.70	2.11E-01
regulation of synaptic plasticity (GO:0048167)	23	2	1.17	+	1.70	3.28E-01
actin filament bundle organization (GO:0061572)	35	3	1.79	+	1.68	2.66E-01
ncRNA processing (GO:0034470)	175	15	8.94	+	1.68	3.87E-02
negative regulation of cellular component movement (GO:0051271)	35	3	1.79	+	1.68	2.66E-01
negative regulation of locomotion (GO:0040013)	35	3	1.79	+	1.68	2.66E-01
regulation of defense response (GO:0031347)	35	3	1.79	+	1.68	2.66E-01
chromosome organization (GO:0051276)	327	28	16.70	+	1.68	6.56E-03
cell-cell signaling by wnt (GO:0198738)	117	10	5.98	+	1.67	8.15E-02
positive regulation of transcription by RNA polymerase II (GO:0045944)	211	18	10.78	+	1.67	2.64E-02
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	305	26	15.58	+	1.67	9.05E-03
regulation of axonogenesis (GO:0050770)	47	4	2.40	+	1.67	2.21E-01
cellular response to stress (GO:0033554)	447	38	22.83	+	1.66	1.96E-03
regulation of cell development (GO:0060284)	106	9	5.41	+	1.66	9.78E-02
peptidyl-serine modification (GO:0018209)	106	9	5.41	+	1.66	9.78E-02
regulation of cell morphogenesis involved in differentiation (GO:0010769)	59	5	3.01	+	1.66	1.87E-01
meiotic cell cycle process (GO:1903046)	71	6	3.63	+	1.65	1.59E-01
meiotic nuclear division (GO:0140013)	71	6	3.63	+	1.65	1.59E-01
meiotic cell cycle (GO:0051321)	71	6	3.63	+	1.65	1.59E-01
positive regulation of protein catabolic process (GO:0045732)	48	4	2.45	+	1.63	2.32E-01
regulation of phosphatase activity (GO:0010921)	12	1	.61	+	1.63	4.58E-01
phospholipid translocation (GO:0045332)	24	2	1.23	+	1.63	3.47E-01
late endosome to vacuole transport (GO:0045324)	24	2	1.23	+	1.63	3.47E-01
regulation of RNA stability (GO:0043487)	24	2	1.23	+	1.63	3.47E-01
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	24	2	1.23	+	1.63	3.47E-01
neuron projection development (GO:0031175)	204	17	10.42	+	1.63	3.64E-02
glycosaminoglycan biosynthetic process (GO:0006024)	12	1	.61	+	1.63	4.58E-01
glucose metabolic process (GO:0006006)	24	2	1.23	+	1.63	3.47E-01
autophagy of nucleus (GO:0044804)	12	1	.61	+	1.63	4.58E-01
determination of heart left/right asymmetry (GO:0061371)	12	1	.61	+	1.63	4.58E-01
rRNA metabolic process (GO:0016072)	108	9	5.52	+	1.63	1.06E-01
protein polymerization (GO:0051258)	96	8	4.90	+	1.63	1.23E-01
cell cycle arrest (GO:0007050)	12	1	.61	+	1.63	4.58E-01
activation of protein kinase activity (GO:0032147)	48	4	2.45	+	1.63	2.32E-01
regulation of histone modification (GO:0031056)	12	1	.61	+	1.63	4.58E-01
DNA replication initiation (GO:0006270)	12	1	.61	+	1.63	4.58E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209)	12	1	.61	+	1.63	4.58E-01
regulation of protein secretion (GO:0050708)	12	1	.61	+	1.63	4.58E-01
cytoplasmic translational initiation (GO:0002183)	12	1	.61	+	1.63	4.58E-01
amino acid transport (GO:0006865)	48	4	2.45	+	1.63	2.32E-01
receptor localization to synapse (GO:0097120)	24	2	1.23	+	1.63	3.47E-01
neutral amino acid transport (GO:0015804)	24	2	1.23	+	1.63	3.47E-01
embryonic heart tube development (GO:0035050)	12	1	.61	+	1.63	4.58E-01
regulation of chemotaxis (GO:0050920)	36	3	1.84	+	1.63	2.80E-01
amino acid transmembrane transport (GO:0003333)	36	3	1.84	+	1.63	2.80E-01
protein depolymerization (GO:0051261)	36	3	1.84	+	1.63	2.80E-01
vacuole organization (GO:0007033)	60	5	3.06	+	1.63	1.95E-01
regulation of supramolecular fiber organization (GO:1902903)	85	7	4.34	+	1.61	1.49E-01
cell part morphogenesis (GO:0032990)	170	14	8.68	+	1.61	5.80E-02
regulation of neurogenesis (GO:0050767)	98	8	5.01	+	1.60	1.33E-01
RNA methylation (GO:0001510)	37	3	1.89	+	1.59	2.94E-01
response to endoplasmic reticulum stress (GO:0034976)	74	6	3.78	+	1.59	1.81E-01
axon development (GO:0061564)	136	11	6.95	+	1.58	9.39E-02
regulation of cytoskeleton organization (GO:0051493)	136	11	6.95	+	1.58	9.39E-02
chromosome segregation (GO:0007059)	99	8	5.06	+	1.58	1.39E-01
peptidyl-lysine modification (GO:0018205)	99	8	5.06	+	1.58	1.39E-01
DNA recombination (GO:0006310)	87	7	4.44	+	1.58	1.61E-01
neural crest cell differentiation (GO:0014033)	25	2	1.28	+	1.57	3.65E-01
neural crest cell development (GO:0014032)	25	2	1.28	+	1.57	3.65E-01
axon guidance (GO:0007411)	100	8	5.11	+	1.57	1.44E-01
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	25	2	1.28	+	1.57	3.65E-01
stem cell differentiation (GO:0048863)	25	2	1.28	+	1.57	3.65E-01
neuron projection guidance (GO:0097485)	100	8	5.11	+	1.57	1.44E-01
regulation of cellular component biogenesis (GO:0044087)	150	12	7.66	+	1.57	8.81E-02
double-strand break repair (GO:0006302)	88	7	4.49	+	1.56	1.68E-01
regulation of organelle organization (GO:0033043)	239	19	12.21	+	1.56	4.18E-02
positive regulation of macromolecule biosynthetic process (GO:0010557)	302	24	15.43	+	1.56	2.46E-02
lipid metabolic process (GO:0006629)	378	30	19.31	+	1.55	1.34E-02
positive regulation of protein serine/threonine kinase activity (GO:0071902)	38	3	1.94	+	1.55	3.07E-01
mRNA catabolic process (GO:0006402)	76	6	3.88	+	1.55	1.96E-01
positive regulation of catabolic process (GO:0009896)	76	6	3.88	+	1.55	1.96E-01
apoptotic signaling pathway (GO:0097190)	76	6	3.88	+	1.55	1.96E-01
organophosphate metabolic process (GO:0019637)	333	26	17.01	+	1.53	2.41E-02
glycerolipid metabolic process (GO:0046486)	141	11	7.20	+	1.53	1.13E-01
neuron projection morphogenesis (GO:0048812)	167	13	8.53	+	1.52	9.16E-02
protein-containing complex localization (GO:0031503)	180	14	9.19	+	1.52	8.29E-02
positive regulation of cellular biosynthetic process (GO:0031328)	309	24	15.78	+	1.52	3.09E-02
Wnt signaling pathway (GO:0016055)	116	9	5.92	+	1.52	1.44E-01
cell projection morphogenesis (GO:0048858)	168	13	8.58	+	1.51	9.48E-02
plasma membrane bounded cell projection morphogenesis (GO:0120039)	168	13	8.58	+	1.51	9.48E-02
neuron development (GO:0048666)	220	17	11.24	+	1.51	6.38E-02
meiosis I cell cycle process (GO:0061982)	39	3	1.99	+	1.51	3.21E-01
positive regulation of biosynthetic process (GO:0009891)	312	24	15.94	+	1.51	3.39E-02
regulation of growth (GO:0040008)	39	3	1.99	+	1.51	3.21E-01
regulation of actin filament polymerization (GO:0030833)	65	5	3.32	+	1.51	2.41E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	26	2	1.33	+	1.51	3.83E-01
endothelial cell migration (GO:0043542)	13	1	.66	+	1.51	4.85E-01
specification of symmetry (GO:0009799)	13	1	.66	+	1.51	4.85E-01
regulation of innate immune response (GO:0045088)	13	1	.66	+	1.51	4.85E-01
positive regulation of chemotaxis (GO:0050921)	13	1	.66	+	1.51	4.85E-01
protein palmitoylation (GO:0018345)	26	2	1.33	+	1.51	3.83E-01
rRNA methylation (GO:0031167)	13	1	.66	+	1.51	4.85E-01
positive regulation of growth (GO:0045927)	13	1	.66	+	1.51	4.85E-01
transcription elongation from RNA polymerase II promoter (GO:0006368)	13	1	.66	+	1.51	4.85E-01
negative regulation of chromosome organization (GO:2001251)	26	2	1.33	+	1.51	3.83E-01
regulation of mRNA catabolic process (GO:0061013)	26	2	1.33	+	1.51	3.83E-01
regulation of dendrite morphogenesis (GO:0048814)	13	1	.66	+	1.51	4.85E-01
protein localization to synapse (GO:0035418)	26	2	1.33	+	1.51	3.83E-01
positive regulation of response to biotic stimulus (GO:0002833)	13	1	.66	+	1.51	4.85E-01
determination of left/right symmetry (GO:0007368)	13	1	.66	+	1.51	4.85E-01
growth (GO:0040007)	52	4	2.66	+	1.51	2.76E-01
determination of bilateral symmetry (GO:0009855)	13	1	.66	+	1.51	4.85E-01
cellular response to steroid hormone stimulus (GO:0071383)	13	1	.66	+	1.51	4.85E-01
mesenchymal cell differentiation (GO:0048762)	26	2	1.33	+	1.51	3.83E-01
regulation of response to external stimulus (GO:0032101)	79	6	4.04	+	1.49	2.20E-01
macromolecule methylation (GO:0043414)	66	5	3.37	+	1.48	2.50E-01
methylation (GO:0032259)	66	5	3.37	+	1.48	2.50E-01
vacuolar transport (GO:0007034)	66	5	3.37	+	1.48	2.50E-01
response to peptide hormone (GO:0043434)	53	4	2.71	+	1.48	2.87E-01
mitotic sister chromatid segregation (GO:0000070)	53	4	2.71	+	1.48	2.87E-01
regulation of exocytosis (GO:0017157)	53	4	2.71	+	1.48	2.87E-01
axonogenesis (GO:0007409)	133	10	6.79	+	1.47	1.48E-01
regulation of neuron differentiation (GO:0045664)	80	6	4.09	+	1.47	2.28E-01
regulation of actin filament length (GO:0030832)	67	5	3.42	+	1.46	2.60E-01
regulation of actin polymerization or depolymerization (GO:0008064)	67	5	3.42	+	1.46	2.60E-01
sister chromatid segregation (GO:0000819)	67	5	3.42	+	1.46	2.60E-01
regulation of Wnt signaling pathway (GO:0030111)	67	5	3.42	+	1.46	2.60E-01
endosomal transport (GO:0016197)	94	7	4.80	+	1.46	2.09E-01
RNA metabolic process (GO:0016070)	2297	171	117.32	+	1.46	2.46E-07
mesenchyme development (GO:0060485)	27	2	1.38	+	1.45	4.01E-01
regulation of lipid metabolic process (GO:0019216)	27	2	1.38	+	1.45	4.01E-01
lipid translocation (GO:0034204)	27	2	1.38	+	1.45	4.01E-01
regulation of nervous system development (GO:0051960)	108	8	5.52	+	1.45	1.92E-01
response to peptide (GO:1901652)	54	4	2.76	+	1.45	2.99E-01
acyl-CoA metabolic process (GO:0006637)	27	2	1.38	+	1.45	4.01E-01
nucleotide-excision repair (GO:0006289)	27	2	1.38	+	1.45	4.01E-01
nucleic acid metabolic process (GO:0090304)	2513	186	128.36	+	1.45	9.07E-08
cell morphogenesis involved in neuron differentiation (GO:0048667)	149	11	7.61	+	1.45	1.46E-01
lipid biosynthetic process (GO:0008610)	163	12	8.33	+	1.44	1.36E-01
carbohydrate metabolic process (GO:0005975)	123	9	6.28	+	1.43	1.83E-01
regulation of DNA metabolic process (GO:0051052)	41	3	2.09	+	1.43	3.49E-01
carbohydrate biosynthetic process (GO:0016051)	41	3	2.09	+	1.43	3.49E-01
regulation of actin cytoskeleton organization (GO:0032956)	96	7	4.90	+	1.43	2.23E-01
phospholipid biosynthetic process (GO:0008654)	55	4	2.81	+	1.42	3.10E-01
cell morphogenesis involved in differentiation (GO:0000904)	165	12	8.43	+	1.42	1.44E-01
regulation of RNA metabolic process (GO:0051252)	1829	133	93.42	+	1.42	2.22E-05
response to organonitrogen compound (GO:0010243)	124	9	6.33	+	1.42	1.88E-01
cellular component morphogenesis (GO:0032989)	193	14	9.86	+	1.42	1.24E-01
nucleobase-containing compound metabolic process (GO:0006139)	2706	196	138.21	+	1.42	1.72E-07
transcription by RNA polymerase II (GO:0006366)	1437	104	73.40	+	1.42	2.31E-04
regulation of nucleobase-containing compound metabolic process (GO:0019219)	1867	135	95.36	+	1.42	2.49E-05
RNA biosynthetic process (GO:0032774)	1785	129	91.17	+	1.41	3.99E-05
organic cyclic compound metabolic process (GO:1901360)	2812	203	143.63	+	1.41	1.21E-07
posttranscriptional regulation of gene expression (GO:0010608)	97	7	4.95	+	1.41	2.31E-01
regulation of actin filament-based process (GO:0032970)	97	7	4.95	+	1.41	2.31E-01
nucleic acid-templated transcription (GO:0097659)	1778	128	90.81	+	1.41	5.08E-05
transcription, DNA-templated (GO:0006351)	1778	128	90.81	+	1.41	5.08E-05
regulation of transcription by RNA polymerase II (GO:0006357)	1407	101	71.87	+	1.41	3.79E-04
heterocycle metabolic process (GO:0046483)	2752	197	140.56	+	1.40	3.64E-07
regulation of blood vessel diameter (GO:0097746)	14	1	.72	+	1.40	5.11E-01
nucleoside monophosphate metabolic process (GO:0009123)	14	1	.72	+	1.40	5.11E-01
cytochrome complex assembly (GO:0017004)	14	1	.72	+	1.40	5.11E-01
regulation of neuron projection development (GO:0010975)	70	5	3.58	+	1.40	2.89E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	28	2	1.43	+	1.40	4.19E-01
negative regulation of TOR signaling (GO:0032007)	14	1	.72	+	1.40	5.11E-01
smoothened signaling pathway (GO:0007224)	14	1	.72	+	1.40	5.11E-01
protein methylation (GO:0006479)	28	2	1.43	+	1.40	4.19E-01
folic acid-containing compound metabolic process (GO:0006760)	14	1	.72	+	1.40	5.11E-01
mitochondrial gene expression (GO:0140053)	28	2	1.43	+	1.40	4.19E-01
protein alkylation (GO:0008213)	28	2	1.43	+	1.40	4.19E-01
actin filament polymerization (GO:0030041)	70	5	3.58	+	1.40	2.89E-01
nucleosome assembly (GO:0006334)	14	1	.72	+	1.40	5.11E-01
regulation of systemic arterial blood pressure (GO:0003073)	14	1	.72	+	1.40	5.11E-01
negative regulation of cell migration (GO:0030336)	14	1	.72	+	1.40	5.11E-01
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	14	1	.72	+	1.40	5.11E-01
gene silencing by miRNA (GO:0035195)	14	1	.72	+	1.40	5.11E-01
regulation of cysteine-type endopeptidase activity (GO:2000116)	28	2	1.43	+	1.40	4.19E-01
endoplasmic reticulum unfolded protein response (GO:0030968)	28	2	1.43	+	1.40	4.19E-01
cell cycle DNA replication (GO:0044786)	14	1	.72	+	1.40	5.11E-01
nuclear DNA replication (GO:0033260)	14	1	.72	+	1.40	5.11E-01
regulation of plasma membrane bounded cell projection organization (GO:0120035)	84	6	4.29	+	1.40	2.61E-01
positive regulation of defense response (GO:0031349)	14	1	.72	+	1.40	5.11E-01
protein-DNA complex assembly (GO:0065004)	56	4	2.86	+	1.40	3.21E-01
COPII-coated vesicle budding (GO:0090114)	14	1	.72	+	1.40	5.11E-01
cortical actin cytoskeleton organization (GO:0030866)	14	1	.72	+	1.40	5.11E-01
regulation of vesicle-mediated transport (GO:0060627)	98	7	5.01	+	1.40	2.38E-01
cellular aromatic compound metabolic process (GO:0006725)	2766	197	141.28	+	1.39	5.18E-07
regulation of transcription, DNA-templated (GO:0006355)	1731	123	88.41	+	1.39	1.25E-04
regulation of nucleic acid-templated transcription (GO:1903506)	1731	123	88.41	+	1.39	1.25E-04
regulation of RNA biosynthetic process (GO:2001141)	1731	123	88.41	+	1.39	1.25E-04
cellular lipid metabolic process (GO:0044255)	325	23	16.60	+	1.39	7.69E-02
positive regulation of gene expression (GO:0010628)	368	26	18.80	+	1.38	6.43E-02
nuclear chromosome segregation (GO:0098813)	85	6	4.34	+	1.38	2.70E-01
regulation of gene expression (GO:0010468)	2086	147	106.55	+	1.38	3.63E-05
regulation of translation (GO:0006417)	71	5	3.63	+	1.38	2.98E-01
dephosphorylation (GO:0016311)	128	9	6.54	+	1.38	2.12E-01
regulation of cellular macromolecule biosynthetic process (GO:2000112)	1836	129	93.78	+	1.38	1.35E-04
neuron differentiation (GO:0030182)	299	21	15.27	+	1.38	9.29E-02
regulation of anatomical structure size (GO:0090066)	114	8	5.82	+	1.37	2.31E-01
response to extracellular stimulus (GO:0009991)	57	4	2.91	+	1.37	3.33E-01
regulation of protein localization (GO:0032880)	57	4	2.91	+	1.37	3.33E-01
response to nutrient levels (GO:0031667)	57	4	2.91	+	1.37	3.33E-01
actin filament organization (GO:0007015)	171	12	8.73	+	1.37	1.71E-01
gene expression (GO:0010467)	2640	185	134.84	+	1.37	3.67E-06
regulation of cellular component size (GO:0032535)	100	7	5.11	+	1.37	2.53E-01
regulation of macromolecule biosynthetic process (GO:0010556)	1843	129	94.13	+	1.37	1.58E-04
mitochondrial transmembrane transport (GO:1990542)	43	3	2.20	+	1.37	3.76E-01
cellular response to peptide (GO:1901653)	43	3	2.20	+	1.37	3.76E-01
regulation of cell projection organization (GO:0031344)	86	6	4.39	+	1.37	2.79E-01
cellular response to peptide hormone stimulus (GO:0071375)	43	3	2.20	+	1.37	3.76E-01
regulation of cellular biosynthetic process (GO:0031326)	1854	129	94.70	+	1.36	2.02E-04
endomembrane system organization (GO:0010256)	115	8	5.87	+	1.36	2.38E-01
cellular nitrogen compound metabolic process (GO:0034641)	2992	208	152.82	+	1.36	1.23E-06
regulation of protein polymerization (GO:0032271)	72	5	3.68	+	1.36	3.08E-01
regulation of biosynthetic process (GO:0009889)	1860	129	95.00	+	1.36	2.31E-04
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	130	9	6.64	+	1.36	2.25E-01
regulation of membrane lipid distribution (GO:0097035)	29	2	1.48	+	1.35	4.36E-01
negative regulation of phosphorus metabolic process (GO:0010563)	58	4	2.96	+	1.35	3.44E-01
regulation of cellular localization (GO:0060341)	87	6	4.44	+	1.35	2.87E-01
negative regulation of phosphate metabolic process (GO:0045936)	58	4	2.96	+	1.35	3.44E-01
mRNA 3'-end processing (GO:0031124)	29	2	1.48	+	1.35	4.36E-01
ceramide metabolic process (GO:0006672)	29	2	1.48	+	1.35	4.36E-01
regulation of protein transport (GO:0051223)	29	2	1.48	+	1.35	4.36E-01
DNA repair (GO:0006281)	174	12	8.89	+	1.35	1.85E-01
positive regulation of response to external stimulus (GO:0032103)	29	2	1.48	+	1.35	4.36E-01
organic cyclic compound biosynthetic process (GO:1901362)	2039	140	104.15	+	1.34	1.85E-04
rRNA processing (GO:0006364)	102	7	5.21	+	1.34	2.69E-01
nucleobase-containing compound biosynthetic process (GO:0034654)	1988	136	101.54	+	1.34	2.71E-04
generation of neurons (GO:0048699)	322	22	16.45	+	1.34	1.07E-01
organophosphate catabolic process (GO:0046434)	44	3	2.25	+	1.33	3.90E-01
carbohydrate catabolic process (GO:0016052)	44	3	2.25	+	1.33	3.90E-01
mitotic cell cycle (GO:0000278)	236	16	12.05	+	1.33	1.58E-01
mitotic cell cycle process (GO:1903047)	236	16	12.05	+	1.33	1.58E-01
mitotic nuclear division (GO:0140014)	236	16	12.05	+	1.33	1.58E-01
ribose phosphate metabolic process (GO:0019693)	133	9	6.79	+	1.32	2.44E-01
heterocycle biosynthetic process (GO:0018130)	2012	136	102.77	+	1.32	4.44E-04
aromatic compound biosynthetic process (GO:0019438)	2013	136	102.82	+	1.32	4.53E-04
negative regulation of nucleic acid-templated transcription (GO:1903507)	282	19	14.40	+	1.32	1.39E-01
negative regulation of transcription, DNA-templated (GO:0045892)	282	19	14.40	+	1.32	1.39E-01
negative regulation of RNA biosynthetic process (GO:1902679)	282	19	14.40	+	1.32	1.39E-01
supramolecular fiber organization (GO:0097435)	253	17	12.92	+	1.32	1.57E-01
protein localization (GO:0008104)	716	48	36.57	+	1.31	3.64E-02
cellular nitrogen compound biosynthetic process (GO:0044271)	2247	150	114.77	+	1.31	3.72E-04
organic acid transmembrane transport (GO:1903825)	45	3	2.30	+	1.31	4.04E-01
carboxylic acid transmembrane transport (GO:1905039)	45	3	2.30	+	1.31	4.04E-01
ribosomal small subunit biogenesis (GO:0042274)	45	3	2.30	+	1.31	4.04E-01
regulation of gene expression, epigenetic (GO:0040029)	45	3	2.30	+	1.31	4.04E-01
purine ribonucleotide metabolic process (GO:0009150)	120	8	6.13	+	1.31	2.74E-01
positive regulation of cell adhesion (GO:0045785)	30	2	1.53	+	1.31	4.53E-01
protein import (GO:0017038)	75	5	3.83	+	1.31	3.38E-01
purine nucleotide metabolic process (GO:0006163)	135	9	6.90	+	1.31	2.57E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	15	1	.77	+	1.31	5.35E-01
regulation of proteolysis (GO:0030162)	120	8	6.13	+	1.31	2.74E-01
lens development in camera-type eye (GO:0002088)	15	1	.77	+	1.31	5.35E-01
negative regulation of DNA metabolic process (GO:0051053)	15	1	.77	+	1.31	5.35E-01
phospholipid catabolic process (GO:0009395)	15	1	.77	+	1.31	5.35E-01
protein-DNA complex subunit organization (GO:0071824)	75	5	3.83	+	1.31	3.38E-01
substrate adhesion-dependent cell spreading (GO:0034446)	15	1	.77	+	1.31	5.35E-01
ossification (GO:0001503)	15	1	.77	+	1.31	5.35E-01
meiotic chromosome separation (GO:0051307)	15	1	.77	+	1.31	5.35E-01
aminoglycan metabolic process (GO:0006022)	30	2	1.53	+	1.31	4.53E-01
regulation of potassium ion transmembrane transport (GO:1901379)	15	1	.77	+	1.31	5.35E-01
postreplication repair (GO:0006301)	15	1	.77	+	1.31	5.35E-01
negative regulation of cell motility (GO:2000146)	15	1	.77	+	1.31	5.35E-01
autophagy (GO:0006914)	105	7	5.36	+	1.31	2.92E-01
centriole replication (GO:0007099)	15	1	.77	+	1.31	5.35E-01
regulation of mitotic nuclear division (GO:0007088)	30	2	1.53	+	1.31	4.53E-01
negative regulation of translation (GO:0017148)	30	2	1.53	+	1.31	4.53E-01
negative regulation of multicellular organismal process (GO:0051241)	60	4	3.06	+	1.31	3.67E-01
hexose metabolic process (GO:0019318)	30	2	1.53	+	1.31	4.53E-01
regulation of neurotransmitter secretion (GO:0046928)	15	1	.77	+	1.31	5.35E-01
process utilizing autophagic mechanism (GO:0061919)	105	7	5.36	+	1.31	2.92E-01
meiotic chromosome segregation (GO:0045132)	30	2	1.53	+	1.31	4.53E-01
macromolecule localization (GO:0033036)	813	54	41.53	+	1.30	3.20E-02
vesicle organization (GO:0016050)	317	21	16.19	+	1.30	1.41E-01
regulation of cell differentiation (GO:0045595)	151	10	7.71	+	1.30	2.48E-01
cellular macromolecule biosynthetic process (GO:0034645)	2251	149	114.97	+	1.30	5.61E-04
regulation of primary metabolic process (GO:0080090)	2389	158	122.02	+	1.29	3.83E-04
macromolecule biosynthetic process (GO:0009059)	2260	149	115.43	+	1.29	6.63E-04
regulation of nitrogen compound metabolic process (GO:0051171)	2367	156	120.90	+	1.29	4.91E-04
regulation of macromolecule metabolic process (GO:0060255)	2551	168	130.30	+	1.29	2.93E-04
regulation of cellular amide metabolic process (GO:0034248)	76	5	3.88	+	1.29	3.48E-01
actin polymerization or depolymerization (GO:0008154)	76	5	3.88	+	1.29	3.48E-01
negative regulation of transcription by RNA polymerase II (GO:0000122)	198	13	10.11	+	1.29	2.18E-01
generation of precursor metabolites and energy (GO:0006091)	107	7	5.47	+	1.28	3.08E-01
organic substance biosynthetic process (GO:1901576)	2617	171	133.67	+	1.28	3.72E-04
biosynthetic process (GO:0009058)	2623	171	133.97	+	1.28	4.14E-04
cellular macromolecule catabolic process (GO:0044265)	399	26	20.38	+	1.28	1.27E-01
regulation of cellular metabolic process (GO:0031323)	2472	161	126.26	+	1.28	6.64E-04
regulation of cellular component organization (GO:0051128)	369	24	18.85	+	1.27	1.40E-01
neurogenesis (GO:0022008)	339	22	17.32	+	1.27	1.54E-01
positive regulation of nitrogen compound metabolic process (GO:0051173)	632	41	32.28	+	1.27	7.38E-02
regulation of multicellular organismal development (GO:2000026)	170	11	8.68	+	1.27	2.56E-01
peptidyl-amino acid modification (GO:0018193)	340	22	17.37	+	1.27	1.58E-01
microtubule cytoskeleton organization (GO:0000226)	294	19	15.02	+	1.27	1.80E-01
response to external stimulus (GO:0009605)	434	28	22.17	+	1.26	1.27E-01
cellular response to organic cyclic compound (GO:0071407)	31	2	1.58	+	1.26	4.70E-01
nucleobase-containing compound catabolic process (GO:0034655)	124	8	6.33	+	1.26	3.03E-01
regulation of metabolic process (GO:0019222)	2701	174	137.96	+	1.26	6.38E-04
negative regulation of RNA metabolic process (GO:0051253)	295	19	15.07	+	1.26	1.83E-01
cellular biosynthetic process (GO:0044249)	2581	166	131.83	+	1.26	9.40E-04
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	327	21	16.70	+	1.26	1.72E-01
plasma membrane bounded cell projection organization (GO:0120036)	343	22	17.52	+	1.26	1.67E-01
intracellular transport (GO:0046907)	655	42	33.46	+	1.26	8.13E-02
ribosome biogenesis (GO:0042254)	156	10	7.97	+	1.26	2.79E-01
regulation of cell morphogenesis (GO:0022604)	78	5	3.98	+	1.26	3.68E-01
positive regulation of cellular metabolic process (GO:0031325)	687	44	35.09	+	1.25	7.70E-02
negative regulation of gene expression (GO:0010629)	406	26	20.74	+	1.25	1.45E-01
negative regulation of macromolecule biosynthetic process (GO:0010558)	328	21	16.75	+	1.25	1.76E-01
ribonucleotide metabolic process (GO:0009259)	125	8	6.38	+	1.25	3.10E-01
establishment of protein localization (GO:0045184)	549	35	28.04	+	1.25	1.10E-01
modification-dependent protein catabolic process (GO:0019941)	267	17	13.64	+	1.25	2.12E-01
nucleotide metabolic process (GO:0009117)	158	10	8.07	+	1.24	2.92E-01
primary metabolic process (GO:0044238)	4791	303	244.71	+	1.24	7.94E-06
macromolecule metabolic process (GO:0043170)	4320	273	220.65	+	1.24	3.31E-05
regulation of mitotic cell cycle (GO:0007346)	95	6	4.85	+	1.24	3.58E-01
protein transport (GO:0015031)	539	34	27.53	+	1.23	1.25E-01
cell projection organization (GO:0030030)	349	22	17.83	+	1.23	1.87E-01
organic substance metabolic process (GO:0071704)	5064	319	258.65	+	1.23	5.23E-06
DNA metabolic process (GO:0006259)	271	17	13.84	+	1.23	2.29E-01
positive regulation of macromolecule metabolic process (GO:0010604)	670	42	34.22	+	1.23	1.04E-01
negative regulation of biosynthetic process (GO:0009890)	335	21	17.11	+	1.23	2.00E-01
negative regulation of cellular biosynthetic process (GO:0031327)	335	21	17.11	+	1.23	2.00E-01
regulation of potassium ion transport (GO:0043266)	16	1	.82	+	1.22	5.59E-01
regulation of peptide secretion (GO:0002791)	16	1	.82	+	1.22	5.59E-01
positive regulation of cell cycle process (GO:0090068)	32	2	1.63	+	1.22	4.86E-01
maturation of SSU-rRNA (GO:0030490)	32	2	1.63	+	1.22	4.86E-01
chromosome organization involved in meiotic cell cycle (GO:0070192)	16	1	.82	+	1.22	5.59E-01
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	32	2	1.63	+	1.22	4.86E-01
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	16	1	.82	+	1.22	5.59E-01
skeletal system development (GO:0001501)	32	2	1.63	+	1.22	4.86E-01
taxis (GO:0042330)	160	10	8.17	+	1.22	3.04E-01
negative regulation of phosphorylation (GO:0042326)	48	3	2.45	+	1.22	4.44E-01
nucleosome organization (GO:0034728)	32	2	1.63	+	1.22	4.86E-01
establishment of cell polarity (GO:0030010)	16	1	.82	+	1.22	5.59E-01
DNA duplex unwinding (GO:0032508)	16	1	.82	+	1.22	5.59E-01
energy derivation by oxidation of organic compounds (GO:0015980)	64	4	3.27	+	1.22	4.13E-01
regulation of synapse organization (GO:0050807)	16	1	.82	+	1.22	5.59E-01
response to steroid hormone (GO:0048545)	16	1	.82	+	1.22	5.59E-01
heart morphogenesis (GO:0003007)	16	1	.82	+	1.22	5.59E-01
chemotaxis (GO:0006935)	160	10	8.17	+	1.22	3.04E-01
spliceosomal snRNP assembly (GO:0000387)	16	1	.82	+	1.22	5.59E-01
dendrite development (GO:0016358)	32	2	1.63	+	1.22	4.86E-01
modification-dependent macromolecule catabolic process (GO:0043632)	272	17	13.89	+	1.22	2.33E-01
intracellular protein transport (GO:0006886)	464	29	23.70	+	1.22	1.58E-01
peptide transport (GO:0015833)	544	34	27.79	+	1.22	1.36E-01
nuclear division (GO:0000280)	273	17	13.94	+	1.22	2.38E-01
peptide biosynthetic process (GO:0043043)	209	13	10.68	+	1.22	2.75E-01
cellular macromolecule metabolic process (GO:0044260)	3698	230	188.88	+	1.22	4.96E-04
response to nitrogen compound (GO:1901698)	145	9	7.41	+	1.22	3.25E-01
cellular metabolic process (GO:0044237)	4947	307	252.68	+	1.21	3.26E-05
cell development (GO:0048468)	339	21	17.32	+	1.21	2.15E-01
macromolecule catabolic process (GO:0009057)	436	27	22.27	+	1.21	1.80E-01
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	307	19	15.68	+	1.21	2.30E-01
organelle organization (GO:0006996)	1617	100	82.59	+	1.21	2.74E-02
protein localization to cell periphery (GO:1990778)	81	5	4.14	+	1.21	3.98E-01
organelle localization (GO:0051640)	243	15	12.41	+	1.21	2.65E-01
establishment of localization in cell (GO:0051649)	778	48	39.74	+	1.21	1.06E-01
cell morphogenesis (GO:0000902)	227	14	11.59	+	1.21	2.75E-01
purine-containing compound metabolic process (GO:0072521)	146	9	7.46	+	1.21	3.32E-01
nitrogen compound metabolic process (GO:0006807)	4562	281	233.01	+	1.21	1.56E-04
protein modification by small protein removal (GO:0070646)	65	4	3.32	+	1.20	4.24E-01
pattern specification process (GO:0007389)	65	4	3.32	+	1.20	4.24E-01
ubiquitin-dependent protein catabolic process (GO:0006511)	260	16	13.28	+	1.20	2.60E-01
organelle fission (GO:0048285)	293	18	14.97	+	1.20	2.47E-01
cellular response to DNA damage stimulus (GO:0006974)	228	14	11.65	+	1.20	2.81E-01
cellular localization (GO:0051641)	963	59	49.19	+	1.20	8.81E-02
amide transport (GO:0042886)	555	34	28.35	+	1.20	1.62E-01
Golgi organization (GO:0007030)	49	3	2.50	+	1.20	4.57E-01
metabolic process (GO:0008152)	5300	324	270.71	+	1.20	5.78E-05
cellular protein localization (GO:0034613)	638	39	32.59	+	1.20	1.46E-01
proteolysis involved in cellular protein catabolic process (GO:0051603)	295	18	15.07	+	1.19	2.55E-01
nucleoside phosphate metabolic process (GO:0006753)	164	10	8.38	+	1.19	3.31E-01
cellular macromolecule localization (GO:0070727)	640	39	32.69	+	1.19	1.50E-01
cell cycle (GO:0007049)	378	23	19.31	+	1.19	2.26E-01
cellular protein catabolic process (GO:0044257)	296	18	15.12	+	1.19	2.60E-01
cell cycle process (GO:0022402)	346	21	17.67	+	1.19	2.42E-01
cytoskeleton organization (GO:0007010)	561	34	28.65	+	1.19	1.77E-01
tissue morphogenesis (GO:0048729)	33	2	1.69	+	1.19	5.02E-01
cell recognition (GO:0008037)	33	2	1.69	+	1.19	5.02E-01
regulation of peptide transport (GO:0090087)	33	2	1.69	+	1.19	5.02E-01
regulation of nuclear division (GO:0051783)	33	2	1.69	+	1.19	5.02E-01
cellular amino acid biosynthetic process (GO:0008652)	33	2	1.69	+	1.19	5.02E-01
chromatin organization involved in regulation of transcription (GO:0034401)	33	2	1.69	+	1.19	5.02E-01
cellular monovalent inorganic cation homeostasis (GO:0030004)	33	2	1.69	+	1.19	5.02E-01
phospholipid transport (GO:0015914)	33	2	1.69	+	1.19	5.02E-01
centrosome cycle (GO:0007098)	33	2	1.69	+	1.19	5.02E-01
regulation of response to stress (GO:0080134)	116	7	5.92	+	1.18	3.82E-01
negative regulation of metabolic process (GO:0009892)	566	34	28.91	+	1.18	1.90E-01
positive regulation of metabolic process (GO:0009893)	750	45	38.31	+	1.17	1.53E-01
monocarboxylic acid metabolic process (GO:0032787)	150	9	7.66	+	1.17	3.60E-01
organelle assembly (GO:0070925)	268	16	13.69	+	1.17	2.99E-01
response to stress (GO:0006950)	772	46	39.43	+	1.17	1.61E-01
response to endogenous stimulus (GO:0009719)	235	14	12.00	+	1.17	3.18E-01
apoptotic process (GO:0006915)	185	11	9.45	+	1.16	3.48E-01
cellular response to endogenous stimulus (GO:0071495)	220	13	11.24	+	1.16	3.37E-01
small molecule metabolic process (GO:0044281)	576	34	29.42	+	1.16	2.18E-01
sulfur compound metabolic process (GO:0006790)	102	6	5.21	+	1.15	4.21E-01
RNA 3'-end processing (GO:0031123)	51	3	2.60	+	1.15	4.83E-01
M phase (GO:0000279)	34	2	1.74	+	1.15	5.18E-01
mitochondrial fission (GO:0000266)	17	1	.87	+	1.15	5.81E-01
positive regulation of cell cycle (GO:0045787)	34	2	1.74	+	1.15	5.18E-01
retrograde transport, endosome to Golgi (GO:0042147)	34	2	1.74	+	1.15	5.18E-01
regulation of dephosphorylation (GO:0035303)	17	1	.87	+	1.15	5.81E-01
DNA geometric change (GO:0032392)	17	1	.87	+	1.15	5.81E-01
protein catabolic process (GO:0030163)	323	19	16.50	+	1.15	2.99E-01
regulation of sodium ion transport (GO:0002028)	17	1	.87	+	1.15	5.81E-01
negative regulation of transport (GO:0051051)	34	2	1.74	+	1.15	5.18E-01
meiosis I cell cycle phase (GO:0098764)	34	2	1.74	+	1.15	5.18E-01
meiotic cell cycle phase (GO:0098762)	34	2	1.74	+	1.15	5.18E-01
positive regulation of leukocyte migration (GO:0002687)	17	1	.87	+	1.15	5.81E-01
snRNA processing (GO:0016180)	17	1	.87	+	1.15	5.81E-01
snRNA 3'-end processing (GO:0034472)	17	1	.87	+	1.15	5.81E-01
telophase (GO:0051326)	34	2	1.74	+	1.15	5.18E-01
meiotic telophase I (GO:0007134)	34	2	1.74	+	1.15	5.18E-01
biological phase (GO:0044848)	34	2	1.74	+	1.15	5.18E-01
meiosis I (GO:0007127)	34	2	1.74	+	1.15	5.18E-01
posttranscriptional gene silencing (GO:0016441)	17	1	.87	+	1.15	5.81E-01
cell cycle phase (GO:0022403)	34	2	1.74	+	1.15	5.18E-01
post-transcriptional gene silencing by RNA (GO:0035194)	17	1	.87	+	1.15	5.81E-01
positive regulation of protein kinase activity (GO:0045860)	68	4	3.47	+	1.15	4.58E-01
mitotic DNA damage checkpoint (GO:0044773)	17	1	.87	+	1.15	5.81E-01
nitrogen compound transport (GO:0071705)	663	39	33.86	+	1.15	2.05E-01
regulation of response to biotic stimulus (GO:0002831)	17	1	.87	+	1.15	5.81E-01
gene silencing by RNA (GO:0031047)	17	1	.87	+	1.15	5.81E-01
pteridine-containing compound metabolic process (GO:0042558)	17	1	.87	+	1.15	5.81E-01
histone H4 acetylation (GO:0043967)	17	1	.87	+	1.15	5.81E-01
organophosphate biosynthetic process (GO:0090407)	170	10	8.68	+	1.15	3.71E-01
L-amino acid transport (GO:0015807)	17	1	.87	+	1.15	5.81E-01
protein modification by small protein conjugation or removal (GO:0070647)	324	19	16.55	+	1.15	3.03E-01
amide biosynthetic process (GO:0043604)	239	14	12.21	+	1.15	3.40E-01
carboxylic acid metabolic process (GO:0019752)	308	18	15.73	+	1.14	3.15E-01
cellular component organization or biogenesis (GO:0071840)	2295	134	117.22	+	1.14	5.43E-02
translational elongation (GO:0006414)	206	12	10.52	+	1.14	3.63E-01
translation (GO:0006412)	206	12	10.52	+	1.14	3.63E-01
membrane organization (GO:0061024)	431	25	22.01	+	1.14	2.87E-01
vesicle-mediated transport (GO:0016192)	621	36	31.72	+	1.13	2.42E-01
programmed cell death (GO:0012501)	190	11	9.70	+	1.13	3.80E-01
negative regulation of macromolecule metabolic process (GO:0010605)	537	31	27.43	+	1.13	2.69E-01
establishment or maintenance of cell polarity (GO:0007163)	52	3	2.66	+	1.13	4.96E-01
cellular response to lipid (GO:0071396)	52	3	2.66	+	1.13	4.96E-01
ribonucleoprotein complex biogenesis (GO:0022613)	208	12	10.62	+	1.13	3.76E-01
protein modification by small protein conjugation (GO:0032446)	261	15	13.33	+	1.13	3.58E-01
cellular component organization (GO:0016043)	2181	125	111.40	+	1.12	9.26E-02
TOR signaling (GO:0031929)	35	2	1.79	+	1.12	5.34E-01
monosaccharide metabolic process (GO:0005996)	35	2	1.79	+	1.12	5.34E-01
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	70	4	3.58	+	1.12	4.80E-01
establishment of protein localization to vacuole (GO:0072666)	35	2	1.79	+	1.12	5.34E-01
actin cytoskeleton organization (GO:0030036)	245	14	12.51	+	1.12	3.73E-01
cellular response to organic substance (GO:0071310)	423	24	21.61	+	1.11	3.29E-01
microtubule-based process (GO:0007017)	388	22	19.82	+	1.11	3.40E-01
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	53	3	2.71	+	1.11	5.08E-01
positive regulation of cell migration (GO:0030335)	53	3	2.71	+	1.11	5.08E-01
phosphate-containing compound metabolic process (GO:0006796)	972	55	49.65	+	1.11	2.35E-01
negative regulation of nitrogen compound metabolic process (GO:0051172)	462	26	23.60	+	1.10	3.35E-01
regulation of protein-containing complex assembly (GO:0043254)	89	5	4.55	+	1.10	4.77E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	89	5	4.55	+	1.10	4.77E-01
response to organic substance (GO:0010033)	499	28	25.49	+	1.10	3.33E-01
regulation of anatomical structure morphogenesis (GO:0022603)	107	6	5.47	+	1.10	4.65E-01
phosphorus metabolic process (GO:0006793)	984	55	50.26	+	1.09	2.64E-01
organic acid metabolic process (GO:0006082)	340	19	17.37	+	1.09	3.78E-01
regulation of cell cycle (GO:0051726)	179	10	9.14	+	1.09	4.31E-01
establishment of organelle localization (GO:0051656)	197	11	10.06	+	1.09	4.25E-01
negative regulation of cellular metabolic process (GO:0031324)	485	27	24.77	+	1.09	3.52E-01
organic substance transport (GO:0071702)	773	43	39.48	+	1.09	3.05E-01
regulation of cellular process (GO:0050794)	4301	239	219.68	+	1.09	7.03E-02
regulation of cell projection assembly (GO:0060491)	18	1	.92	+	1.09	6.01E-01
organelle disassembly (GO:1903008)	36	2	1.84	+	1.09	5.49E-01
protein localization to vacuole (GO:0072665)	36	2	1.84	+	1.09	5.49E-01
regulation of Notch signaling pathway (GO:0008593)	18	1	.92	+	1.09	6.01E-01
membrane protein proteolysis (GO:0033619)	18	1	.92	+	1.09	6.01E-01
regulation of cellular response to stress (GO:0080135)	72	4	3.68	+	1.09	5.01E-01
ATP metabolic process (GO:0046034)	54	3	2.76	+	1.09	5.21E-01
cilium movement (GO:0003341)	36	2	1.84	+	1.09	5.49E-01
cytoskeleton-dependent cytokinesis (GO:0061640)	18	1	.92	+	1.09	6.01E-01
actomyosin structure organization (GO:0031032)	36	2	1.84	+	1.09	5.49E-01
cell fate commitment (GO:0045165)	54	3	2.76	+	1.09	5.21E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	18	1	.92	+	1.09	6.01E-01
phosphorylation (GO:0016310)	650	36	33.20	+	1.08	3.34E-01
regulation of biological process (GO:0050789)	4501	249	229.90	+	1.08	7.54E-02
oxoacid metabolic process (GO:0043436)	326	18	16.65	+	1.08	4.02E-01
cellular nitrogen compound catabolic process (GO:0044270)	145	8	7.41	+	1.08	4.62E-01
small molecule catabolic process (GO:0044282)	127	7	6.49	+	1.08	4.72E-01
actin filament-based process (GO:0030029)	254	14	12.97	+	1.08	4.24E-01
cellular amino acid metabolic process (GO:0006520)	127	7	6.49	+	1.08	4.72E-01
regulation of developmental process (GO:0050793)	219	12	11.19	+	1.07	4.43E-01
cellular process (GO:0009987)	8508	466	434.56	+	1.07	1.57E-02
cellular amide metabolic process (GO:0043603)	347	19	17.72	+	1.07	4.12E-01
cellular component biogenesis (GO:0044085)	859	47	43.88	+	1.07	3.35E-01
negative regulation of biological process (GO:0048519)	1006	55	51.38	+	1.07	3.21E-01
organic substance catabolic process (GO:1901575)	677	37	34.58	+	1.07	3.60E-01
biological regulation (GO:0065007)	4924	269	251.50	+	1.07	1.00E-01
protein ubiquitination (GO:0016567)	238	13	12.16	+	1.07	4.42E-01
cellular protein metabolic process (GO:0044267)	1686	92	86.12	+	1.07	2.67E-01
regulation of MAP kinase activity (GO:0043405)	55	3	2.81	+	1.07	5.33E-01
ribosomal large subunit biogenesis (GO:0042273)	55	3	2.81	+	1.07	5.33E-01
catabolic process (GO:0009056)	826	45	42.19	+	1.07	3.50E-01
oxidation-reduction process (GO:0055114)	202	11	10.32	+	1.07	4.57E-01
aromatic compound catabolic process (GO:0019439)	147	8	7.51	+	1.07	4.77E-01
heterocycle catabolic process (GO:0046700)	147	8	7.51	+	1.07	4.77E-01
tissue development (GO:0009888)	147	8	7.51	+	1.07	4.77E-01
mitotic cell cycle checkpoint (GO:0007093)	37	2	1.89	+	1.06	5.64E-01
response to chemical (GO:0042221)	743	40	37.95	+	1.05	3.89E-01
nucleotide biosynthetic process (GO:0009165)	93	5	4.75	+	1.05	5.15E-01
biological_process (GO:0008150)	9146	491	467.15	+	1.05	5.08E-02
small molecule biosynthetic process (GO:0044283)	168	9	8.58	+	1.05	4.88E-01
positive regulation of cellular process (GO:0048522)	1084	58	55.37	+	1.05	3.76E-01
cellular catabolic process (GO:0044248)	730	39	37.29	+	1.05	4.10E-01
cell death (GO:0008219)	206	11	10.52	+	1.05	4.82E-01
positive regulation of organelle organization (GO:0010638)	75	4	3.83	+	1.04	5.33E-01
purine nucleotide biosynthetic process (GO:0006164)	75	4	3.83	+	1.04	5.33E-01
regulation of secretion by cell (GO:1903530)	75	4	3.83	+	1.04	5.33E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	75	4	3.83	+	1.04	5.33E-01
negative regulation of protein modification process (GO:0031400)	57	3	2.91	+	1.03	5.57E-01
positive regulation of cell motility (GO:2000147)	57	3	2.91	+	1.03	5.57E-01
positive regulation of cellular component movement (GO:0051272)	57	3	2.91	+	1.03	5.57E-01
peptide metabolic process (GO:0006518)	266	14	13.59	+	1.03	4.92E-01
regulation of angiogenesis (GO:0045765)	19	1	.97	+	1.03	6.21E-01
negative regulation of Wnt signaling pathway (GO:0030178)	38	2	1.94	+	1.03	5.78E-01
rRNA modification (GO:0000154)	19	1	.97	+	1.03	6.21E-01
regulation of mitotic sister chromatid segregation (GO:0033047)	19	1	.97	+	1.03	6.21E-01
maturation of 5.8S rRNA (GO:0000460)	19	1	.97	+	1.03	6.21E-01
regulation of blood pressure (GO:0008217)	19	1	.97	+	1.03	6.21E-01
mRNA polyadenylation (GO:0006378)	19	1	.97	+	1.03	6.21E-01
regulation of vasculature development (GO:1901342)	19	1	.97	+	1.03	6.21E-01
regulation of cell cycle G2/M phase transition (GO:1902749)	19	1	.97	+	1.03	6.21E-01
proteasomal protein catabolic process (GO:0010498)	190	10	9.70	+	1.03	5.05E-01
regulation of DNA repair (GO:0006282)	19	1	.97	+	1.03	6.21E-01
nucleoside phosphate biosynthetic process (GO:1901293)	95	5	4.85	+	1.03	5.34E-01
Golgi vesicle budding (GO:0048194)	19	1	.97	+	1.03	6.21E-01
regulation of dendrite development (GO:0050773)	19	1	.97	+	1.03	6.21E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	19	1	.97	+	1.03	6.21E-01
cellular protein modification process (GO:0006464)	1212	63	61.91	+	1.02	4.61E-01
protein modification process (GO:0036211)	1212	63	61.91	+	1.02	4.61E-01
regulation of secretion (GO:0051046)	77	4	3.93	+	1.02	5.54E-01
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	58	3	2.96	+	1.01	5.69E-01
protein deubiquitination (GO:0016579)	58	3	2.96	+	1.01	5.69E-01
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	58	3	2.96	+	1.01	5.69E-01
positive regulation of locomotion (GO:0040017)	58	3	2.96	+	1.01	5.69E-01
protein metabolic process (GO:0019538)	1895	98	96.79	+	1.01	4.64E-01
macromolecule modification (GO:0043412)	1296	67	66.20	+	1.01	4.77E-01
organophosphate ester transport (GO:0015748)	39	2	1.99	+	1.00	5.92E-01
tRNA modification (GO:0006400)	39	2	1.99	+	1.00	5.92E-01
negative regulation of kinase activity (GO:0033673)	39	2	1.99	+	1.00	5.92E-01
microtubule polymerization or depolymerization (GO:0031109)	39	2	1.99	+	1.00	5.92E-01
sensory organ development (GO:0007423)	39	2	1.99	+	1.00	5.92E-01
ribose phosphate biosynthetic process (GO:0046390)	78	4	3.98	+	1.00	5.64E-01
purine-containing compound biosynthetic process (GO:0072522)	78	4	3.98	+	1.00	5.64E-01
microtubule organizing center organization (GO:0031023)	39	2	1.99	+	1.00	5.92E-01
membrane fission (GO:0090148)	39	2	1.99	+	1.00	5.92E-01
homeostatic process (GO:0042592)	332	17	16.96	+	1.00	5.29E-01
proteolysis (GO:0006508)	586	30	29.93	+	1.00	5.21E-01
organonitrogen compound metabolic process (GO:1901564)	2288	117	116.86	+	1.00	5.10E-01
nucleobase-containing small molecule metabolic process (GO:0055086)	196	10	10.01	-	1.00	5.82E-01
cellular protein-containing complex assembly (GO:0034622)	334	17	17.06	-	1.00	5.58E-01
cellular response to chemical stimulus (GO:0070887)	531	27	27.12	-	1.00	5.41E-01
protein acylation (GO:0043543)	79	4	4.04	-	.99	6.22E-01
establishment of protein localization to organelle (GO:0072594)	158	8	8.07	-	.99	5.83E-01
negative regulation of response to stimulus (GO:0048585)	237	12	12.11	-	.99	5.64E-01
regulation of multicellular organismal process (GO:0051239)	297	15	15.17	-	.99	5.51E-01
negative regulation of cellular process (GO:0048523)	893	45	45.61	-	.99	5.02E-01
enzyme linked receptor protein signaling pathway (GO:0007167)	298	15	15.22	-	.99	5.45E-01
cellular response to stimulus (GO:0051716)	2107	106	107.62	-	.98	4.59E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	179	9	9.14	-	.98	5.69E-01
establishment of localization (GO:0051234)	1654	83	84.48	-	.98	4.61E-01
nervous system development (GO:0007399)	439	22	22.42	-	.98	5.20E-01
localization (GO:0051179)	2058	103	105.12	-	.98	4.38E-01
ceramide biosynthetic process (GO:0046513)	20	1	1.02	-	.98	7.28E-01
peptidyl-threonine phosphorylation (GO:0018107)	20	1	1.02	-	.98	7.28E-01
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	20	1	1.02	-	.98	7.28E-01
integrin-mediated signaling pathway (GO:0007229)	20	1	1.02	-	.98	7.28E-01
Notch signaling pathway (GO:0007219)	40	2	2.04	-	.98	6.65E-01
regulation of leukocyte migration (GO:0002685)	20	1	1.02	-	.98	7.28E-01
negative regulation of transferase activity (GO:0051348)	40	2	2.04	-	.98	6.65E-01
epidermal growth factor receptor signaling pathway (GO:0007173)	20	1	1.02	-	.98	7.28E-01
cytosolic transport (GO:0016482)	40	2	2.04	-	.98	6.65E-01
aminoglycan biosynthetic process (GO:0006023)	20	1	1.02	-	.98	7.28E-01
DNA-templated transcription, elongation (GO:0006354)	20	1	1.02	-	.98	7.28E-01
positive regulation of T cell activation (GO:0050870)	20	1	1.02	-	.98	7.28E-01
anterior/posterior pattern specification (GO:0009952)	40	2	2.04	-	.98	6.65E-01
G2/M transition of mitotic cell cycle (GO:0000086)	20	1	1.02	-	.98	7.28E-01
positive regulation of axonogenesis (GO:0050772)	20	1	1.02	-	.98	7.28E-01
lipid transport (GO:0006869)	80	4	4.09	-	.98	6.12E-01
positive regulation of Ras protein signal transduction (GO:0046579)	20	1	1.02	-	.98	7.28E-01
reproductive process (GO:0022414)	140	7	7.15	-	.98	5.76E-01
reproduction (GO:0000003)	140	7	7.15	-	.98	5.76E-01
cellular component assembly (GO:0022607)	741	37	37.85	-	.98	4.87E-01
positive regulation of biological process (GO:0048518)	1227	61	62.67	-	.97	4.46E-01
intracellular signal transduction (GO:0035556)	705	35	36.01	-	.97	4.76E-01
protein-containing complex subunit organization (GO:0043933)	425	21	21.71	-	.97	4.96E-01
embryo development (GO:0009790)	81	4	4.14	-	.97	6.02E-01
positive regulation of DNA-binding transcription factor activity (GO:0051091)	81	4	4.14	-	.97	6.02E-01
organic cyclic compound catabolic process (GO:1901361)	163	8	8.33	-	.96	5.47E-01
positive regulation of supramolecular fiber organization (GO:1902905)	41	2	2.09	-	.96	6.51E-01
histone acetylation (GO:0016573)	41	2	2.09	-	.96	6.51E-01
internal protein amino acid acetylation (GO:0006475)	41	2	2.09	-	.96	6.51E-01
peptidyl-lysine acetylation (GO:0018394)	41	2	2.09	-	.96	6.51E-01
internal peptidyl-lysine acetylation (GO:0018393)	41	2	2.09	-	.96	6.51E-01
regulation of cellular response to growth factor stimulus (GO:0090287)	41	2	2.09	-	.96	6.51E-01
positive regulation of cellular protein metabolic process (GO:0032270)	308	15	15.73	-	.95	4.93E-01
response to stimulus (GO:0050896)	2444	119	124.83	-	.95	3.05E-01
transport (GO:0006810)	1627	79	83.10	-	.95	3.43E-01
organonitrogen compound catabolic process (GO:1901565)	433	21	22.12	-	.95	4.61E-01
RNA modification (GO:0009451)	83	4	4.24	-	.94	5.82E-01
protein maturation (GO:0051604)	83	4	4.24	-	.94	5.82E-01
Unclassified (UNCLASSIFIED)	7104	339	362.85	-	.93	5.08E-02
protein phosphorylation (GO:0006468)	503	24	25.69	-	.93	4.17E-01
cell communication (GO:0007154)	1867	89	95.36	-	.93	2.64E-01
negative regulation of intracellular signal transduction (GO:1902532)	84	4	4.29	-	.93	5.72E-01
protein localization to plasma membrane (GO:0072659)	63	3	3.22	-	.93	5.98E-01
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	42	2	2.15	-	.93	6.37E-01
reciprocal meiotic recombination (GO:0007131)	21	1	1.07	-	.93	7.09E-01
cell cycle G2/M phase transition (GO:0044839)	21	1	1.07	-	.93	7.09E-01
homologous recombination (GO:0035825)	21	1	1.07	-	.93	7.09E-01
monovalent inorganic cation homeostasis (GO:0055067)	42	2	2.15	-	.93	6.37E-01
mitotic DNA integrity checkpoint (GO:0044774)	21	1	1.07	-	.93	7.09E-01
carboxylic acid transport (GO:0046942)	84	4	4.29	-	.93	5.72E-01
negative regulation of cAMP-mediated signaling (GO:0043951)	21	1	1.07	-	.93	7.09E-01
extrinsic apoptotic signaling pathway (GO:0097191)	42	2	2.15	-	.93	6.37E-01
organic acid transport (GO:0015849)	84	4	4.29	-	.93	5.72E-01
protein-containing complex assembly (GO:0065003)	358	17	18.29	-	.93	4.41E-01
signal transduction (GO:0007165)	1710	81	87.34	-	.93	2.57E-01
protein localization to organelle (GO:0033365)	317	15	16.19	-	.93	4.47E-01
cellular developmental process (GO:0048869)	723	34	36.93	-	.92	3.49E-01
regulation of cellular protein metabolic process (GO:0032268)	511	24	26.10	-	.92	3.86E-01
response to lipid (GO:0033993)	64	3	3.27	-	.92	5.87E-01
signaling (GO:0023052)	1856	87	94.80	-	.92	2.14E-01
regulation of biological quality (GO:0065008)	811	38	41.42	-	.92	3.27E-01
protein polyubiquitination (GO:0000209)	107	5	5.47	-	.91	5.35E-01
RNA phosphodiester bond hydrolysis (GO:0090501)	43	2	2.20	-	.91	6.24E-01
alpha-amino acid metabolic process (GO:1901605)	86	4	4.39	-	.91	5.52E-01
positive regulation of cell development (GO:0010720)	43	2	2.20	-	.91	6.24E-01
cell surface receptor signaling pathway (GO:0007166)	796	37	40.66	-	.91	3.12E-01
cell differentiation (GO:0030154)	719	33	36.72	-	.90	2.99E-01
regulation of protein metabolic process (GO:0051246)	548	25	27.99	-	.89	3.24E-01
Golgi vesicle transport (GO:0048193)	242	11	12.36	-	.89	4.20E-01
glycerolipid catabolic process (GO:0046503)	22	1	1.12	-	.89	6.90E-01
signal release (GO:0023061)	66	3	3.37	-	.89	5.65E-01
neurotransmitter secretion (GO:0007269)	44	2	2.25	-	.89	6.10E-01
regulation of DNA-binding transcription factor activity (GO:0051090)	88	4	4.49	-	.89	5.33E-01
DNA biosynthetic process (GO:0071897)	88	4	4.49	-	.89	5.33E-01
regulation of sister chromatid segregation (GO:0033045)	22	1	1.12	-	.89	6.90E-01
activation of adenylate cyclase activity (GO:0007190)	88	4	4.49	-	.89	5.33E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	88	4	4.49	-	.89	5.33E-01
calcium-mediated signaling (GO:0019722)	22	1	1.12	-	.89	6.90E-01
regulation of body fluid levels (GO:0050878)	22	1	1.12	-	.89	6.90E-01
fatty acid beta-oxidation (GO:0006635)	22	1	1.12	-	.89	6.90E-01
ERBB signaling pathway (GO:0038127)	22	1	1.12	-	.89	6.90E-01
cellular response to organonitrogen compound (GO:0071417)	66	3	3.37	-	.89	5.65E-01
signal release from synapse (GO:0099643)	44	2	2.25	-	.89	6.10E-01
regulation of transport (GO:0051049)	222	10	11.34	-	.88	4.19E-01
carboxylic acid biosynthetic process (GO:0046394)	89	4	4.55	-	.88	5.23E-01
organic acid biosynthetic process (GO:0016053)	89	4	4.55	-	.88	5.23E-01
positive regulation of protein metabolic process (GO:0051247)	334	15	17.06	-	.88	3.64E-01
regulation of localization (GO:0032879)	381	17	19.46	-	.87	3.37E-01
negative regulation of protein metabolic process (GO:0051248)	157	7	8.02	-	.87	4.50E-01
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	202	9	10.32	-	.87	4.18E-01
positive regulation of cytoskeleton organization (GO:0051495)	45	2	2.30	-	.87	5.96E-01
cell projection assembly (GO:0030031)	135	6	6.90	-	.87	4.65E-01
purine ribonucleotide biosynthetic process (GO:0009152)	68	3	3.47	-	.86	5.42E-01
lipid localization (GO:0010876)	91	4	4.65	-	.86	5.04E-01
negative regulation of catalytic activity (GO:0043086)	137	6	7.00	-	.86	4.49E-01
organonitrogen compound biosynthetic process (GO:1901566)	575	25	29.37	-	.85	2.38E-01
histone deacetylation (GO:0016575)	23	1	1.17	-	.85	6.72E-01
negative regulation of protein phosphorylation (GO:0001933)	46	2	2.35	-	.85	5.83E-01
glutathione metabolic process (GO:0006749)	23	1	1.17	-	.85	6.72E-01
cellular amino acid catabolic process (GO:0009063)	46	2	2.35	-	.85	5.83E-01
regulation of chromosome segregation (GO:0051983)	23	1	1.17	-	.85	6.72E-01
endosome transport via multivesicular body sorting pathway (GO:0032509)	23	1	1.17	-	.85	6.72E-01
positive regulation of cell-cell adhesion (GO:0022409)	23	1	1.17	-	.85	6.72E-01
negative regulation of apoptotic signaling pathway (GO:2001234)	23	1	1.17	-	.85	6.72E-01
cell fate specification (GO:0001708)	23	1	1.17	-	.85	6.72E-01
cytoplasmic translation (GO:0002181)	46	2	2.35	-	.85	5.83E-01
negative regulation of signal transduction (GO:0009968)	186	8	9.50	-	.84	3.91E-01
anion transmembrane transport (GO:0098656)	93	4	4.75	-	.84	4.85E-01
response to cytokine (GO:0034097)	140	6	7.15	-	.84	4.27E-01
mitochondrial transport (GO:0006839)	70	3	3.58	-	.84	5.20E-01
response to organic cyclic compound (GO:0014070)	47	2	2.40	-	.83	5.69E-01
positive regulation of transport (GO:0051050)	47	2	2.40	-	.83	5.69E-01
regulation of cell cycle process (GO:0010564)	94	4	4.80	-	.83	4.76E-01
sphingolipid metabolic process (GO:0006665)	47	2	2.40	-	.83	5.69E-01
locomotion (GO:0040011)	355	15	18.13	-	.83	2.74E-01
chemical homeostasis (GO:0048878)	263	11	13.43	-	.82	3.09E-01
negative regulation of cell communication (GO:0010648)	192	8	9.81	-	.82	3.54E-01
negative regulation of signaling (GO:0023057)	192	8	9.81	-	.82	3.54E-01
mitochondrial respiratory chain complex assembly (GO:0033108)	24	1	1.23	-	.82	6.53E-01
cellular homeostasis (GO:0019725)	216	9	11.03	-	.82	3.36E-01
regulation of synapse structure or activity (GO:0050803)	24	1	1.23	-	.82	6.53E-01
camera-type eye development (GO:0043010)	24	1	1.23	-	.82	6.53E-01
Ras protein signal transduction (GO:0007265)	72	3	3.68	-	.82	4.99E-01
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	72	3	3.68	-	.82	4.99E-01
ribonucleotide biosynthetic process (GO:0009260)	72	3	3.68	-	.82	4.99E-01
positive regulation of kinase activity (GO:0033674)	121	5	6.18	-	.81	4.16E-01
regulation of cytokine production (GO:0001817)	73	3	3.73	-	.80	4.88E-01
interspecies interaction between organisms (GO:0044419)	219	9	11.19	-	.80	3.19E-01
vasculature development (GO:0001944)	49	2	2.50	-	.80	5.43E-01
cell cycle checkpoint (GO:0000075)	49	2	2.50	-	.80	5.43E-01
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	123	5	6.28	-	.80	4.01E-01
organic anion transport (GO:0015711)	149	6	7.61	-	.79	3.62E-01
protein deacetylation (GO:0006476)	25	1	1.28	-	.78	6.35E-01
protein acetylation (GO:0006473)	50	2	2.55	-	.78	5.30E-01
cellular respiration (GO:0045333)	50	2	2.55	-	.78	5.30E-01
chromatin assembly (GO:0031497)	25	1	1.28	-	.78	6.35E-01
positive regulation of synaptic transmission (GO:0050806)	25	1	1.28	-	.78	6.35E-01
fatty acid derivative metabolic process (GO:1901568)	25	1	1.28	-	.78	6.35E-01
cortical cytoskeleton organization (GO:0030865)	25	1	1.28	-	.78	6.35E-01
response to growth factor (GO:0070848)	125	5	6.38	-	.78	3.85E-01
protein dephosphorylation (GO:0006470)	75	3	3.83	-	.78	4.67E-01
cellular response to nitrogen compound (GO:1901699)	75	3	3.83	-	.78	4.67E-01
vesicle budding from membrane (GO:0006900)	175	7	8.94	-	.78	3.30E-01
endocytosis (GO:0006897)	150	6	7.66	-	.78	3.55E-01
positive regulation of molecular function (GO:0044093)	375	15	19.15	-	.78	2.02E-01
cellular response to growth factor stimulus (GO:0071363)	125	5	6.38	-	.78	3.85E-01
anatomical structure morphogenesis (GO:0009653)	452	18	23.09	-	.78	1.67E-01
multicellular organism development (GO:0007275)	830	33	42.39	-	.78	7.66E-02
negative regulation of cellular protein metabolic process (GO:0032269)	151	6	7.71	-	.78	3.49E-01
regulation of adenylate cyclase activity (GO:0045761)	126	5	6.44	-	.78	3.78E-01
membrane invagination (GO:0010324)	152	6	7.76	-	.77	3.42E-01
cellular lipid catabolic process (GO:0044242)	76	3	3.88	-	.77	4.56E-01
regulation of trans-synaptic signaling (GO:0099177)	76	3	3.88	-	.77	4.56E-01
modulation of chemical synaptic transmission (GO:0050804)	76	3	3.88	-	.77	4.56E-01
system development (GO:0048731)	735	29	37.54	-	.77	8.58E-02
cytokine-mediated signaling pathway (GO:0019221)	127	5	6.49	-	.77	3.70E-01
defense response to bacterium (GO:0042742)	51	2	2.60	-	.77	5.17E-01
inorganic anion transport (GO:0015698)	51	2	2.60	-	.77	5.17E-01
fatty acid metabolic process (GO:0006631)	102	4	5.21	-	.77	4.04E-01
regulation of response to stimulus (GO:0048583)	818	32	41.78	-	.77	6.61E-02
positive regulation of immune system process (GO:0002684)	128	5	6.54	-	.76	3.63E-01
regulation of cyclase activity (GO:0031279)	129	5	6.59	-	.76	3.55E-01
positive regulation of transferase activity (GO:0051347)	129	5	6.59	-	.76	3.55E-01
regulation of lyase activity (GO:0051339)	129	5	6.59	-	.76	3.55E-01
plasma membrane bounded cell projection assembly (GO:0120031)	129	5	6.59	-	.76	3.55E-01
movement of cell or subcellular component (GO:0006928)	542	21	27.68	-	.76	1.13E-01
regulation of endopeptidase activity (GO:0052548)	78	3	3.98	-	.75	4.36E-01
respiratory electron transport chain (GO:0022904)	26	1	1.33	-	.75	6.17E-01
electron transport chain (GO:0022900)	26	1	1.33	-	.75	6.17E-01
positive regulation of cellular component organization (GO:0051130)	130	5	6.64	-	.75	3.48E-01
regulated exocytosis (GO:0045055)	52	2	2.66	-	.75	5.04E-01
regulation of neurotransmitter levels (GO:0001505)	52	2	2.66	-	.75	5.04E-01
negative regulation of mitotic cell cycle (GO:0045930)	52	2	2.66	-	.75	5.04E-01
regulation of cell migration (GO:0030334)	104	4	5.31	-	.75	3.87E-01
DNA damage checkpoint (GO:0000077)	26	1	1.33	-	.75	6.17E-01
calcium-ion regulated exocytosis (GO:0017156)	26	1	1.33	-	.75	6.17E-01
regulation of cAMP-mediated signaling (GO:0043949)	130	5	6.64	-	.75	3.48E-01
cell-cell signaling (GO:0007267)	391	15	19.97	-	.75	1.55E-01
regulation of immune system process (GO:0002682)	183	7	9.35	-	.75	2.83E-01
positive regulation of cell communication (GO:0010647)	289	11	14.76	-	.75	1.99E-01
positive regulation of signaling (GO:0023056)	289	11	14.76	-	.75	1.99E-01
positive regulation of signal transduction (GO:0009967)	263	10	13.43	-	.74	2.14E-01
positive regulation of GTPase activity (GO:0043547)	79	3	4.04	-	.74	4.26E-01
positive regulation of response to stimulus (GO:0048584)	369	14	18.85	-	.74	1.55E-01
negative regulation of molecular function (GO:0044092)	159	6	8.12	-	.74	2.98E-01
defense response to other organism (GO:0098542)	159	6	8.12	-	.74	2.98E-01
neurotransmitter transport (GO:0006836)	53	2	2.71	-	.74	4.92E-01
regulation of peptidase activity (GO:0052547)	80	3	4.09	-	.73	4.16E-01
cytokine production (GO:0001816)	80	3	4.09	-	.73	4.16E-01
positive regulation of protein modification process (GO:0031401)	240	9	12.26	-	.73	2.19E-01
regulation of protein kinase activity (GO:0045859)	134	5	6.84	-	.73	3.20E-01
cAMP-mediated signaling (GO:0019933)	134	5	6.84	-	.73	3.20E-01
cellular response to cytokine stimulus (GO:0071345)	134	5	6.84	-	.73	3.20E-01
negative regulation of cell cycle (GO:0045786)	81	3	4.14	-	.73	4.07E-01
cell-cell adhesion (GO:0098609)	162	6	8.27	-	.73	2.80E-01
sodium ion transport (GO:0006814)	81	3	4.14	-	.73	4.07E-01
lipoprotein biosynthetic process (GO:0042158)	54	2	2.76	-	.73	4.79E-01
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	27	1	1.38	-	.73	5.99E-01
regulation of TOR signaling (GO:0032006)	27	1	1.38	-	.73	5.99E-01
protein lipidation (GO:0006497)	54	2	2.76	-	.73	4.79E-01
regulation of leukocyte activation (GO:0002694)	54	2	2.76	-	.73	4.79E-01
autophagy of mitochondrion (GO:0000422)	27	1	1.38	-	.73	5.99E-01
embryonic organ morphogenesis (GO:0048562)	27	1	1.38	-	.73	5.99E-01
cellular modified amino acid metabolic process (GO:0006575)	54	2	2.76	-	.73	4.79E-01
multicellular organismal process (GO:0032501)	1220	45	62.31	-	.72	1.08E-02
regulation of cell communication (GO:0010646)	734	27	37.49	-	.72	4.25E-02
regulation of signaling (GO:0023051)	734	27	37.49	-	.72	4.25E-02
regulation of signal transduction (GO:0009966)	654	24	33.40	-	.72	5.26E-02
cellular chemical homeostasis (GO:0055082)	192	7	9.81	-	.71	2.37E-01
positive regulation of intracellular signal transduction (GO:1902533)	165	6	8.43	-	.71	2.63E-01
innate immune response (GO:0045087)	110	4	5.62	-	.71	3.39E-01
tube morphogenesis (GO:0035239)	55	2	2.81	-	.71	4.67E-01
regulation of cell activation (GO:0050865)	55	2	2.81	-	.71	4.67E-01
DNA conformation change (GO:0071103)	55	2	2.81	-	.71	4.67E-01
regulation of kinase activity (GO:0043549)	193	7	9.86	-	.71	2.32E-01
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	138	5	7.05	-	.71	2.93E-01
regulation of protein serine/threonine kinase activity (GO:0071900)	83	3	4.24	-	.71	3.88E-01
regulation of cell motility (GO:2000145)	111	4	5.67	-	.71	3.31E-01
developmental process (GO:0032502)	1142	41	58.33	-	.70	8.63E-03
multivesicular body sorting pathway (GO:0071985)	28	1	1.43	-	.70	5.81E-01
germ cell development (GO:0007281)	28	1	1.43	-	.70	5.81E-01
regulation of leukocyte mediated immunity (GO:0002703)	28	1	1.43	-	.70	5.81E-01
small GTPase mediated signal transduction (GO:0007264)	84	3	4.29	-	.70	3.78E-01
leukocyte activation involved in immune response (GO:0002366)	28	1	1.43	-	.70	5.81E-01
vesicle cytoskeletal trafficking (GO:0099518)	28	1	1.43	-	.70	5.81E-01
positive regulation of apoptotic process (GO:0043065)	56	2	2.86	-	.70	4.55E-01
protein localization to endoplasmic reticulum (GO:0070972)	28	1	1.43	-	.70	5.81E-01
protein transmembrane import into intracellular organelle (GO:0044743)	28	1	1.43	-	.70	5.81E-01
anatomical structure development (GO:0048856)	1016	36	51.89	-	.69	1.07E-02
positive regulation of developmental process (GO:0051094)	85	3	4.34	-	.69	3.69E-01
positive regulation of catalytic activity (GO:0043085)	284	10	14.51	-	.69	1.42E-01
positive regulation of programmed cell death (GO:0043068)	57	2	2.91	-	.69	4.43E-01
regulation of protein modification process (GO:0031399)	342	12	17.47	-	.69	1.10E-01
mitochondrion organization (GO:0007005)	143	5	7.30	-	.68	2.62E-01
carbohydrate derivative metabolic process (GO:1901135)	373	13	19.05	-	.68	9.39E-02
anion transport (GO:0006820)	201	7	10.27	-	.68	1.95E-01
regulation of cellular component movement (GO:0051270)	115	4	5.87	-	.68	3.01E-01
regulation of locomotion (GO:0040012)	115	4	5.87	-	.68	3.01E-01
regulation of transferase activity (GO:0051338)	202	7	10.32	-	.68	1.91E-01
positive regulation of neuron projection development (GO:0010976)	29	1	1.48	-	.68	5.64E-01
regulation of response to DNA damage stimulus (GO:2001020)	29	1	1.48	-	.68	5.64E-01
negative regulation of cell population proliferation (GO:0008285)	29	1	1.48	-	.68	5.64E-01
lipid oxidation (GO:0034440)	29	1	1.48	-	.68	5.64E-01
protein processing (GO:0016485)	58	2	2.96	-	.68	4.31E-01
positive regulation of cytokine production (GO:0001819)	29	1	1.48	-	.68	5.64E-01
T cell receptor signaling pathway (GO:0050852)	29	1	1.48	-	.68	5.64E-01
cell activation involved in immune response (GO:0002263)	29	1	1.48	-	.68	5.64E-01
positive regulation of hydrolase activity (GO:0051345)	146	5	7.46	-	.67	2.45E-01
lipid catabolic process (GO:0016042)	88	3	4.49	-	.67	3.42E-01
positive regulation of cell death (GO:0010942)	59	2	3.01	-	.66	4.20E-01
synapse organization (GO:0050808)	59	2	3.01	-	.66	4.20E-01
response to external biotic stimulus (GO:0043207)	208	7	10.62	-	.66	1.67E-01
response to other organism (GO:0051707)	208	7	10.62	-	.66	1.67E-01
response to biotic stimulus (GO:0009607)	209	7	10.68	-	.66	1.64E-01
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	60	2	3.06	-	.65	4.08E-01
immune response-regulating signaling pathway (GO:0002764)	60	2	3.06	-	.65	4.08E-01
regulation of cell adhesion (GO:0030155)	60	2	3.06	-	.65	4.08E-01
tube development (GO:0035295)	60	2	3.06	-	.65	4.08E-01
G1/S transition of mitotic cell cycle (GO:0000082)	30	1	1.53	-	.65	5.47E-01
regulation of intracellular signal transduction (GO:1902531)	392	13	20.02	-	.65	6.32E-02
response to oxygen-containing compound (GO:1901700)	152	5	7.76	-	.64	2.13E-01
protein localization to membrane (GO:0072657)	153	5	7.81	-	.64	2.07E-01
ion homeostasis (GO:0050801)	216	7	11.03	-	.63	1.39E-01
carboxylic acid catabolic process (GO:0046395)	93	3	4.75	-	.63	3.01E-01
organic acid catabolic process (GO:0016054)	93	3	4.75	-	.63	3.01E-01
regulation of leukocyte cell-cell adhesion (GO:1903037)	31	1	1.58	-	.63	5.30E-01
protein deacylation (GO:0035601)	31	1	1.58	-	.63	5.30E-01
protein N-linked glycosylation (GO:0006487)	31	1	1.58	-	.63	5.30E-01
positive regulation of immune effector process (GO:0002699)	31	1	1.58	-	.63	5.30E-01
macromolecule deacylation (GO:0098732)	31	1	1.58	-	.63	5.30E-01
positive regulation of lymphocyte activation (GO:0051251)	31	1	1.58	-	.63	5.30E-01
endoplasmic reticulum organization (GO:0007029)	31	1	1.58	-	.63	5.30E-01
cytokinesis (GO:0000910)	31	1	1.58	-	.63	5.30E-01
cyclic-nucleotide-mediated signaling (GO:0019935)	156	5	7.97	-	.63	1.93E-01
regulation of molecular function (GO:0065009)	719	23	36.72	-	.63	9.22E-03
positive regulation of MAPK cascade (GO:0043410)	94	3	4.80	-	.62	2.93E-01
positive regulation of protein phosphorylation (GO:0001934)	220	7	11.24	-	.62	1.27E-01
positive regulation of cell differentiation (GO:0045597)	63	2	3.22	-	.62	3.76E-01
positive regulation of cellular component biogenesis (GO:0044089)	63	2	3.22	-	.62	3.76E-01
regulation of phosphorus metabolic process (GO:0051174)	380	12	19.41	-	.62	4.88E-02
regulation of phosphate metabolic process (GO:0019220)	380	12	19.41	-	.62	4.88E-02
regulation of GTPase activity (GO:0043087)	95	3	4.85	-	.62	2.86E-01
regulation of catalytic activity (GO:0050790)	575	18	29.37	-	.61	1.56E-02
lipoprotein metabolic process (GO:0042157)	64	2	3.27	-	.61	3.65E-01
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	96	3	4.90	-	.61	2.78E-01
DNA integrity checkpoint (GO:0031570)	32	1	1.63	-	.61	5.14E-01
cellular response to oxygen-containing compound (GO:1901701)	128	4	6.54	-	.61	2.18E-01
cytoskeleton-dependent intracellular transport (GO:0030705)	160	5	8.17	-	.61	1.75E-01
negative regulation of immune system process (GO:0002683)	32	1	1.63	-	.61	5.14E-01
positive regulation of neuron differentiation (GO:0045666)	32	1	1.63	-	.61	5.14E-01
protein transmembrane transport (GO:0071806)	32	1	1.63	-	.61	5.14E-01
cell cycle G1/S phase transition (GO:0044843)	32	1	1.63	-	.61	5.14E-01
chloride transmembrane transport (GO:1902476)	32	1	1.63	-	.61	5.14E-01
activation of immune response (GO:0002253)	64	2	3.27	-	.61	3.65E-01
cilium assembly (GO:0060271)	96	3	4.90	-	.61	2.78E-01
synaptic vesicle exocytosis (GO:0016079)	32	1	1.63	-	.61	5.14E-01
ciliary transition zone assembly (GO:1905349)	96	3	4.90	-	.61	2.78E-01
intraciliary transport involved in cilium assembly (GO:0035735)	96	3	4.90	-	.61	2.78E-01
intracellular protein transmembrane transport (GO:0065002)	32	1	1.63	-	.61	5.14E-01
axoneme assembly (GO:0035082)	96	3	4.90	-	.61	2.78E-01
defense response (GO:0006952)	258	8	13.18	-	.61	9.01E-02
cell adhesion (GO:0007155)	325	10	16.60	-	.60	5.73E-02
biological adhesion (GO:0022610)	325	10	16.60	-	.60	5.73E-02
regulation of phosphorylation (GO:0042325)	360	11	18.39	-	.60	4.44E-02
microtubule-based movement (GO:0007018)	197	6	10.06	-	.60	1.25E-01
circulatory system development (GO:0072359)	99	3	5.06	-	.59	2.56E-01
sphingolipid biosynthetic process (GO:0030148)	33	1	1.69	-	.59	4.98E-01
lipid homeostasis (GO:0055088)	33	1	1.69	-	.59	4.98E-01
regulation of T cell activation (GO:0050863)	33	1	1.69	-	.59	4.98E-01
protein targeting to mitochondrion (GO:0006626)	33	1	1.69	-	.59	4.98E-01
regulation of apoptotic signaling pathway (GO:2001233)	33	1	1.69	-	.59	4.98E-01
DNA replication (GO:0006260)	66	2	3.37	-	.59	3.45E-01
regulation of protein phosphorylation (GO:0001932)	300	9	15.32	-	.59	5.84E-02
cation homeostasis (GO:0055080)	201	6	10.27	-	.58	1.13E-01
membrane lipid metabolic process (GO:0006643)	67	2	3.42	-	.58	3.35E-01
sodium ion transmembrane transport (GO:0035725)	67	2	3.42	-	.58	3.35E-01
positive regulation of phosphorylation (GO:0042327)	269	8	13.74	-	.58	6.88E-02
inorganic ion homeostasis (GO:0098771)	203	6	10.37	-	.58	1.07E-01
regulation of immune response (GO:0050776)	102	3	5.21	-	.58	2.36E-01
leukocyte mediated immunity (GO:0002443)	34	1	1.74	-	.58	4.82E-01
receptor signaling pathway via JAK-STAT (GO:0007259)	34	1	1.74	-	.58	4.82E-01
receptor signaling pathway via STAT (GO:0097696)	34	1	1.74	-	.58	4.82E-01
proteoglycan metabolic process (GO:0006029)	34	1	1.74	-	.58	4.82E-01
response to wounding (GO:0009611)	34	1	1.74	-	.58	4.82E-01
response to tumor necrosis factor (GO:0034612)	34	1	1.74	-	.58	4.82E-01
cellular response to tumor necrosis factor (GO:0071356)	34	1	1.74	-	.58	4.82E-01
positive regulation of phosphorus metabolic process (GO:0010562)	274	8	14.00	-	.57	6.07E-02
positive regulation of phosphate metabolic process (GO:0045937)	274	8	14.00	-	.57	6.07E-02
microtubule bundle formation (GO:0001578)	103	3	5.26	-	.57	2.29E-01
second-messenger-mediated signaling (GO:0019932)	206	6	10.52	-	.57	9.91E-02
divalent inorganic cation homeostasis (GO:0072507)	138	4	7.05	-	.57	1.67E-01
carbohydrate derivative biosynthetic process (GO:1901137)	243	7	12.41	-	.56	7.15E-02
cell migration (GO:0016477)	243	7	12.41	-	.56	7.15E-02
eye development (GO:0001654)	35	1	1.79	-	.56	4.66E-01
regulation of immune effector process (GO:0002697)	35	1	1.79	-	.56	4.66E-01
positive regulation of leukocyte activation (GO:0002696)	35	1	1.79	-	.56	4.66E-01
synaptic transmission, glutamatergic (GO:0035249)	35	1	1.79	-	.56	4.66E-01
leukocyte cell-cell adhesion (GO:0007159)	35	1	1.79	-	.56	4.66E-01
localization of cell (GO:0051674)	280	8	14.30	-	.56	5.20E-02
chromosome separation (GO:0051304)	35	1	1.79	-	.56	4.66E-01
positive regulation of cell activation (GO:0050867)	35	1	1.79	-	.56	4.66E-01
DNA packaging (GO:0006323)	35	1	1.79	-	.56	4.66E-01
visual system development (GO:0150063)	35	1	1.79	-	.56	4.66E-01
sensory system development (GO:0048880)	35	1	1.79	-	.56	4.66E-01
cell motility (GO:0048870)	280	8	14.30	-	.56	5.20E-02
signal transduction by protein phosphorylation (GO:0023014)	141	4	7.20	-	.56	1.54E-01
protein localization to cilium (GO:0061512)	106	3	5.41	-	.55	2.11E-01
intraciliary transport (GO:0042073)	106	3	5.41	-	.55	2.11E-01
vesicle targeting, to, from or within Golgi (GO:0048199)	106	3	5.41	-	.55	2.11E-01
cellular cation homeostasis (GO:0030003)	179	5	9.14	-	.55	1.06E-01
protein localization to mitochondrion (GO:0070585)	36	1	1.84	-	.54	4.51E-01
establishment of protein localization to mitochondrion (GO:0072655)	36	1	1.84	-	.54	4.51E-01
positive regulation of cell projection organization (GO:0031346)	36	1	1.84	-	.54	4.51E-01
chloride transport (GO:0006821)	36	1	1.84	-	.54	4.51E-01
protein transport along microtubule (GO:0098840)	109	3	5.57	-	.54	1.93E-01
microtubule-based protein transport (GO:0099118)	109	3	5.57	-	.54	1.93E-01
vesicle targeting (GO:0006903)	109	3	5.57	-	.54	1.93E-01
cellular calcium ion homeostasis (GO:0006874)	109	3	5.57	-	.54	1.93E-01
cellular ion homeostasis (GO:0006873)	182	5	9.30	-	.54	9.76E-02
calcium ion homeostasis (GO:0055074)	110	3	5.62	-	.53	1.88E-01
phagocytosis (GO:0006909)	37	1	1.89	-	.53	4.36E-01
positive regulation of multicellular organismal process (GO:0051240)	111	3	5.67	-	.53	1.82E-01
regulation of cell population proliferation (GO:0042127)	150	4	7.66	-	.52	1.20E-01
negative regulation of hydrolase activity (GO:0051346)	75	2	3.83	-	.52	2.63E-01
cilium organization (GO:0044782)	113	3	5.77	-	.52	1.72E-01
establishment of vesicle localization (GO:0051650)	151	4	7.71	-	.52	1.16E-01
vesicle localization (GO:0051648)	151	4	7.71	-	.52	1.16E-01
negative regulation of protein kinase activity (GO:0006469)	38	1	1.94	-	.52	4.22E-01
glycerophospholipid biosynthetic process (GO:0046474)	38	1	1.94	-	.52	4.22E-01
fatty acid catabolic process (GO:0009062)	38	1	1.94	-	.52	4.22E-01
cell division (GO:0051301)	38	1	1.94	-	.52	4.22E-01
gene silencing (GO:0016458)	38	1	1.94	-	.52	4.22E-01
embryonic organ development (GO:0048568)	38	1	1.94	-	.52	4.22E-01
positive regulation of neurogenesis (GO:0050769)	38	1	1.94	-	.52	4.22E-01
inflammatory response (GO:0006954)	115	3	5.87	-	.51	1.62E-01
animal organ development (GO:0048513)	350	9	17.88	-	.50	1.56E-02
angiogenesis (GO:0001525)	39	1	1.99	-	.50	4.08E-01
fatty acid biosynthetic process (GO:0006633)	39	1	1.99	-	.50	4.08E-01
regulation of cell-cell adhesion (GO:0022407)	39	1	1.99	-	.50	4.08E-01
protein targeting (GO:0006605)	117	3	5.98	-	.50	1.52E-01
mitotic cell cycle phase transition (GO:0044772)	78	2	3.98	-	.50	2.40E-01
protein autophosphorylation (GO:0046777)	40	1	2.04	-	.49	3.94E-01
maintenance of location in cell (GO:0051651)	40	1	2.04	-	.49	3.94E-01
inorganic anion transmembrane transport (GO:0098661)	40	1	2.04	-	.49	3.94E-01
organic hydroxy compound transport (GO:0015850)	40	1	2.04	-	.49	3.94E-01
regulation of hydrolase activity (GO:0051336)	243	6	12.41	-	.48	3.54E-02
regulation of MAPK cascade (GO:0043408)	123	3	6.28	-	.48	1.27E-01
cell junction organization (GO:0034330)	123	3	6.28	-	.48	1.27E-01
cell-substrate adhesion (GO:0031589)	42	1	2.15	-	.47	3.68E-01
immune system process (GO:0002376)	420	10	21.45	-	.47	4.45E-03
head development (GO:0060322)	42	1	2.15	-	.47	3.68E-01
antimicrobial humoral response (GO:0019730)	42	1	2.15	-	.47	3.68E-01
positive regulation of nervous system development (GO:0051962)	42	1	2.15	-	.47	3.68E-01
brain development (GO:0007420)	42	1	2.15	-	.47	3.68E-01
embryonic morphogenesis (GO:0048598)	42	1	2.15	-	.47	3.68E-01
cell cycle phase transition (GO:0044770)	84	2	4.29	-	.47	1.98E-01
calcium ion transport (GO:0006816)	84	2	4.29	-	.47	1.98E-01
cell population proliferation (GO:0008283)	169	4	8.63	-	.46	6.77E-02
regulation of apoptotic process (GO:0042981)	128	3	6.54	-	.46	1.08E-01
monocarboxylic acid catabolic process (GO:0072329)	43	1	2.20	-	.46	3.55E-01
leukocyte activation (GO:0045321)	86	2	4.39	-	.46	1.85E-01
positive regulation of cell population proliferation (GO:0008284)	86	2	4.39	-	.46	1.85E-01
muscle structure development (GO:0061061)	43	1	2.20	-	.46	3.55E-01
muscle contraction (GO:0006936)	43	1	2.20	-	.46	3.55E-01
regulation of system process (GO:0044057)	43	1	2.20	-	.46	3.55E-01
blood circulation (GO:0008015)	44	1	2.25	-	.44	3.43E-01
muscle system process (GO:0003012)	44	1	2.25	-	.44	3.43E-01
blood vessel morphogenesis (GO:0048514)	44	1	2.25	-	.44	3.43E-01
regulation of programmed cell death (GO:0043067)	132	3	6.74	-	.44	9.53E-02
response to bacterium (GO:0009617)	89	2	4.55	-	.44	1.68E-01
positive regulation of immune response (GO:0050778)	89	2	4.55	-	.44	1.68E-01
transport along microtubule (GO:0010970)	134	3	6.84	-	.44	8.93E-02
microtubule-based transport (GO:0099111)	134	3	6.84	-	.44	8.93E-02
cellular divalent inorganic cation homeostasis (GO:0072503)	134	3	6.84	-	.44	8.93E-02
regulation of transmembrane transporter activity (GO:0022898)	45	1	2.30	-	.44	3.31E-01
monocarboxylic acid biosynthetic process (GO:0072330)	45	1	2.30	-	.44	3.31E-01
circulatory system process (GO:0003013)	45	1	2.30	-	.44	3.31E-01
cellular process involved in reproduction in multicellular organism (GO:0022412)	45	1	2.30	-	.44	3.31E-01
regulation of ion transmembrane transporter activity (GO:0032412)	45	1	2.30	-	.44	3.31E-01
regulation of transporter activity (GO:0032409)	45	1	2.30	-	.44	3.31E-01
ribonucleoprotein complex assembly (GO:0022618)	90	2	4.60	-	.44	1.62E-01
MAPK cascade (GO:0000165)	135	3	6.90	-	.44	8.65E-02
ion transport (GO:0006811)	591	13	30.19	-	.43	3.02E-04
ribonucleoprotein complex subunit organization (GO:0071826)	91	2	4.65	-	.43	1.57E-01
blood vessel development (GO:0001568)	46	1	2.35	-	.43	3.19E-01
antigen receptor-mediated signaling pathway (GO:0050851)	46	1	2.35	-	.43	3.19E-01
regulation of lymphocyte activation (GO:0051249)	46	1	2.35	-	.43	3.19E-01
regulation of Ras protein signal transduction (GO:0046578)	46	1	2.35	-	.43	3.19E-01
BMP signaling pathway (GO:0030509)	47	1	2.40	-	.42	3.08E-01
immune response (GO:0006955)	284	6	14.51	-	.41	9.93E-03
cell activation (GO:0001775)	95	2	4.85	-	.41	1.37E-01
chemical synaptic transmission (GO:0007268)	238	5	12.16	-	.41	1.78E-02
anterograde trans-synaptic signaling (GO:0098916)	238	5	12.16	-	.41	1.78E-02
peptidyl-tyrosine phosphorylation (GO:0018108)	48	1	2.45	-	.41	2.97E-01
cellular response to BMP stimulus (GO:0071773)	48	1	2.45	-	.41	2.97E-01
response to BMP (GO:0071772)	48	1	2.45	-	.41	2.97E-01
trans-synaptic signaling (GO:0099537)	240	5	12.26	-	.41	1.67E-02
transmembrane transport (GO:0055085)	486	10	24.82	-	.40	5.69E-04
gamete generation (GO:0007276)	49	1	2.50	-	.40	2.86E-01
stress-activated protein kinase signaling cascade (GO:0031098)	49	1	2.50	-	.40	2.86E-01
metal ion transport (GO:0030001)	296	6	15.12	-	.40	6.71E-03
synaptic signaling (GO:0099536)	247	5	12.62	-	.40	1.33E-02
regulation of cell death (GO:0010941)	149	3	7.61	-	.39	5.42E-02
ion transmembrane transport (GO:0034220)	400	8	20.43	-	.39	1.44E-03
regulation of metal ion transport (GO:0010959)	50	1	2.55	-	.39	2.76E-01
regulation of small GTPase mediated signal transduction (GO:0051056)	50	1	2.55	-	.39	2.76E-01
regulation of mitotic cell cycle phase transition (GO:1901990)	50	1	2.55	-	.39	2.76E-01
peptidyl-tyrosine modification (GO:0018212)	50	1	2.55	-	.39	2.76E-01
leukocyte chemotaxis (GO:0030595)	51	1	2.60	-	.38	2.66E-01
T cell activation (GO:0042110)	52	1	2.66	-	.38	2.56E-01
membrane lipid biosynthetic process (GO:0046467)	52	1	2.66	-	.38	2.56E-01
glycerolipid biosynthetic process (GO:0045017)	52	1	2.66	-	.38	2.56E-01
regulation of cation transmembrane transport (GO:1904062)	52	1	2.66	-	.38	2.56E-01
DNA-dependent DNA replication (GO:0006261)	52	1	2.66	-	.38	2.56E-01
cellular metal ion homeostasis (GO:0006875)	157	3	8.02	-	.37	4.12E-02
multicellular organismal reproductive process (GO:0048609)	53	1	2.71	-	.37	2.47E-01
cell chemotaxis (GO:0060326)	53	1	2.71	-	.37	2.47E-01
developmental process involved in reproduction (GO:0003006)	53	1	2.71	-	.37	2.47E-01
calcium ion transmembrane transport (GO:0070588)	54	1	2.76	-	.36	2.38E-01
myeloid leukocyte migration (GO:0097529)	54	1	2.76	-	.36	2.38E-01
extracellular matrix organization (GO:0030198)	110	2	5.62	-	.36	8.06E-02
heart development (GO:0007507)	55	1	2.81	-	.36	2.29E-01
maintenance of location (GO:0051235)	55	1	2.81	-	.36	2.29E-01
divalent metal ion transport (GO:0070838)	111	2	5.67	-	.35	7.78E-02
extracellular structure organization (GO:0043062)	111	2	5.67	-	.35	7.78E-02
divalent inorganic cation transport (GO:0072511)	111	2	5.67	-	.35	7.78E-02
immune response-activating cell surface receptor signaling pathway (GO:0002429)	56	1	2.86	-	.35	2.20E-01
immune response-activating signal transduction (GO:0002757)	56	1	2.86	-	.35	2.20E-01
regulation of cell cycle phase transition (GO:1901987)	56	1	2.86	-	.35	2.20E-01
negative regulation of apoptotic process (GO:0043066)	56	1	2.86	-	.35	2.20E-01
cation transport (GO:0006812)	396	7	20.23	-	.35	5.98E-04
chromatin remodeling (GO:0006338)	57	1	2.91	-	.34	2.12E-01
negative regulation of programmed cell death (GO:0043069)	57	1	2.91	-	.34	2.12E-01
cell-cell junction organization (GO:0045216)	58	1	2.96	-	.34	2.04E-01
negative regulation of endopeptidase activity (GO:0010951)	59	1	3.01	-	.33	1.97E-01
metal ion homeostasis (GO:0055065)	177	3	9.04	-	.33	2.01E-02
cation transmembrane transport (GO:0098655)	299	5	15.27	-	.33	2.16E-03
multicellular organism reproduction (GO:0032504)	61	1	3.12	-	.32	1.82E-01
negative regulation of peptidase activity (GO:0010466)	61	1	3.12	-	.32	1.82E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204)	63	1	3.22	-	.31	1.68E-01
humoral immune response (GO:0006959)	63	1	3.22	-	.31	1.68E-01
leukocyte migration (GO:0050900)	64	1	3.27	-	.31	1.62E-01
synaptic vesicle cycle (GO:0099504)	64	1	3.27	-	.31	1.62E-01
vesicle-mediated transport in synapse (GO:0099003)	64	1	3.27	-	.31	1.62E-01
negative regulation of proteolysis (GO:0045861)	65	1	3.32	-	.30	1.56E-01
sexual reproduction (GO:0019953)	65	1	3.32	-	.30	1.56E-01
multi-organism process (GO:0051704)	66	1	3.37	-	.30	1.50E-01
multi-organism reproductive process (GO:0044703)	66	1	3.37	-	.30	1.50E-01
glycoprotein metabolic process (GO:0009100)	135	2	6.90	-	.29	3.16E-02
regulation of ion transmembrane transport (GO:0034765)	69	1	3.52	-	.28	1.33E-01
negative regulation of cell death (GO:0060548)	69	1	3.52	-	.28	1.33E-01
central nervous system development (GO:0007417)	70	1	3.58	-	.28	1.28E-01
monovalent inorganic cation transport (GO:0015672)	211	3	10.78	-	.28	5.59E-03
G protein-coupled receptor signaling pathway (GO:0007186)	353	5	18.03	-	.28	2.85E-04
regulation of transmembrane transport (GO:0034762)	71	1	3.63	-	.28	1.23E-01
establishment of protein localization to membrane (GO:0090150)	72	1	3.68	-	.27	1.18E-01
lymphocyte activation (GO:0046649)	74	1	3.78	-	.26	1.09E-01
inorganic ion transmembrane transport (GO:0098660)	301	4	15.37	-	.26	5.95E-04
regulation of cytosolic calcium ion concentration (GO:0051480)	78	1	3.98	-	.25	9.22E-02
protein glycosylation (GO:0006486)	80	1	4.09	-	.24	8.49E-02
macromolecule glycosylation (GO:0043413)	80	1	4.09	-	.24	8.49E-02
immune effector process (GO:0002252)	85	1	4.34	-	.23	6.90E-02
anatomical structure formation involved in morphogenesis (GO:0048646)	87	1	4.44	-	.23	6.35E-02
inorganic cation transmembrane transport (GO:0098662)	270	3	13.79	-	.22	5.21E-04
glycosylation (GO:0070085)	92	1	4.70	-	.21	5.14E-02
regulation of ion transport (GO:0043269)	97	1	4.95	-	.20	4.16E-02
potassium ion transmembrane transport (GO:0071805)	106	1	5.41	-	.18	2.82E-02
potassium ion transport (GO:0006813)	107	1	5.47	-	.18	2.70E-02
animal organ morphogenesis (GO:0009887)	113	1	5.77	-	.17	2.08E-02
glycoprotein biosynthetic process (GO:0009101)	115	1	5.87	-	.17	1.90E-02
regulation of membrane potential (GO:0042391)	119	1	6.08	-	.16	1.60E-02
system process (GO:0003008)	236	1	12.05	-	.08	7.05E-05
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	27	0	1.38	-	 < 0.01	2.52E-01
ribonucleoside triphosphate metabolic process (GO:0009199)	35	0	1.79	-	 < 0.01	1.67E-01
intermediate filament cytoskeleton organization (GO:0045104)	13	0	.66	-	 < 0.01	5.15E-01
cellular component macromolecule biosynthetic process (GO:0070589)	1	0	.05	-	 < 0.01	9.50E-01
mitotic cytokinesis (GO:0000281)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of actin filament polymerization (GO:0030838)	25	0	1.28	-	 < 0.01	2.79E-01
sperm-egg recognition (GO:0035036)	13	0	.66	-	 < 0.01	5.15E-01
T cell mediated immunity (GO:0002456)	15	0	.77	-	 < 0.01	4.65E-01
bone resorption (GO:0045453)	6	0	.31	-	 < 0.01	7.36E-01
lymphocyte mediated immunity (GO:0002449)	27	0	1.38	-	 < 0.01	2.52E-01
regulation of Rho protein signal transduction (GO:0035023)	33	0	1.69	-	 < 0.01	1.85E-01
apoptotic cell clearance (GO:0043277)	12	0	.61	-	 < 0.01	5.42E-01
regulation of neurotransmitter receptor activity (GO:0099601)	19	0	.97	-	 < 0.01	3.79E-01
production of molecular mediator of immune response (GO:0002440)	13	0	.66	-	 < 0.01	5.15E-01
oligodendrocyte differentiation (GO:0048709)	5	0	.26	-	 < 0.01	7.75E-01
regulation of lipid biosynthetic process (GO:0046890)	14	0	.72	-	 < 0.01	4.89E-01
endothelial cell differentiation (GO:0045446)	8	0	.41	-	 < 0.01	6.65E-01
neutrophil migration (GO:1990266)	43	0	2.20	-	 < 0.01	1.11E-01
fat cell differentiation (GO:0045444)	4	0	.20	-	 < 0.01	8.15E-01
axo-dendritic transport (GO:0008088)	14	0	.72	-	 < 0.01	4.89E-01
sensory perception of pain (GO:0019233)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of hormone secretion (GO:0046887)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of peptide secretion (GO:0002793)	5	0	.26	-	 < 0.01	7.75E-01
regulation of hormone secretion (GO:0046883)	13	0	.66	-	 < 0.01	5.15E-01
nucleotide catabolic process (GO:0009166)	14	0	.72	-	 < 0.01	4.89E-01
response to interleukin-1 (GO:0070555)	29	0	1.48	-	 < 0.01	2.27E-01
regulation of AMPA receptor activity (GO:2000311)	14	0	.72	-	 < 0.01	4.89E-01
hormone secretion (GO:0046879)	14	0	.72	-	 < 0.01	4.89E-01
striated muscle cell differentiation (GO:0051146)	26	0	1.33	-	 < 0.01	2.65E-01
purine ribonucleotide catabolic process (GO:0009154)	8	0	.41	-	 < 0.01	6.65E-01
heme metabolic process (GO:0042168)	12	0	.61	-	 < 0.01	5.42E-01
spliceosomal complex assembly (GO:0000245)	18	0	.92	-	 < 0.01	3.99E-01
purine nucleoside triphosphate biosynthetic process (GO:0009145)	34	0	1.74	-	 < 0.01	1.76E-01
purine nucleoside triphosphate metabolic process (GO:0009144)	35	0	1.79	-	 < 0.01	1.67E-01
granulocyte chemotaxis (GO:0071621)	43	0	2.20	-	 < 0.01	1.11E-01
nucleoside triphosphate catabolic process (GO:0009143)	5	0	.26	-	 < 0.01	7.75E-01
nucleoside triphosphate biosynthetic process (GO:0009142)	38	0	1.94	-	 < 0.01	1.43E-01
nucleoside triphosphate metabolic process (GO:0009141)	43	0	2.20	-	 < 0.01	1.11E-01
positive regulation of blood pressure (GO:0045777)	3	0	.15	-	 < 0.01	8.58E-01
transcription preinitiation complex assembly (GO:0070897)	14	0	.72	-	 < 0.01	4.89E-01
mitochondrial fusion (GO:0008053)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	5	0	.26	-	 < 0.01	7.75E-01
regulation of bone remodeling (GO:0046850)	5	0	.26	-	 < 0.01	7.75E-01
RNA polymerase II preinitiation complex assembly (GO:0051123)	13	0	.66	-	 < 0.01	5.15E-01
platelet aggregation (GO:0070527)	7	0	.36	-	 < 0.01	6.99E-01
vacuole fusion, non-autophagic (GO:0042144)	4	0	.20	-	 < 0.01	8.15E-01
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of cellular amide metabolic process (GO:0034250)	24	0	1.23	-	 < 0.01	2.93E-01
motor neuron axon guidance (GO:0008045)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	4	0	.20	-	 < 0.01	8.15E-01
bone remodeling (GO:0046849)	6	0	.31	-	 < 0.01	7.36E-01
peptidyl-tyrosine dephosphorylation (GO:0035335)	14	0	.72	-	 < 0.01	4.89E-01
skin development (GO:0043588)	5	0	.26	-	 < 0.01	7.75E-01
meiotic DNA double-strand break formation (GO:0042138)	1	0	.05	-	 < 0.01	9.50E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of T cell proliferation (GO:0042130)	11	0	.56	-	 < 0.01	5.70E-01
V(D)J recombination (GO:0033151)	1	0	.05	-	 < 0.01	9.50E-01
hippo signaling (GO:0035329)	15	0	.77	-	 < 0.01	4.65E-01
peroxisomal transport (GO:0043574)	17	0	.87	-	 < 0.01	4.19E-01
cellular response to oxidative stress (GO:0034599)	18	0	.92	-	 < 0.01	3.99E-01
purine nucleobase biosynthetic process (GO:0009113)	8	0	.41	-	 < 0.01	6.65E-01
regulation of T cell proliferation (GO:0042129)	20	0	1.02	-	 < 0.01	3.60E-01
nucleobase metabolic process (GO:0009112)	22	0	1.12	-	 < 0.01	3.25E-01
calcium ion import (GO:0070509)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of Notch signaling pathway (GO:0045746)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of DNA replication (GO:0045740)	4	0	.20	-	 < 0.01	8.15E-01
regulation of response to wounding (GO:1903034)	10	0	.51	-	 < 0.01	6.00E-01
sperm motility (GO:0097722)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of DNA repair (GO:0045739)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of DNA repair (GO:0045738)	6	0	.31	-	 < 0.01	7.36E-01
B cell activation (GO:0042113)	32	0	1.63	-	 < 0.01	1.95E-01
odontogenesis of dentin-containing tooth (GO:0042475)	4	0	.20	-	 < 0.01	8.15E-01
regulation of heart contraction (GO:0008016)	12	0	.61	-	 < 0.01	5.42E-01
antigen processing and presentation (GO:0019882)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of protein dephosphorylation (GO:0035308)	3	0	.15	-	 < 0.01	8.58E-01
cardiolipin biosynthetic process (GO:0032049)	1	0	.05	-	 < 0.01	9.50E-01
spermatid development (GO:0007286)	18	0	.92	-	 < 0.01	3.99E-01
regulation of protein dephosphorylation (GO:0035304)	10	0	.51	-	 < 0.01	6.00E-01
spermatogenesis (GO:0007283)	33	0	1.69	-	 < 0.01	1.85E-01
carbohydrate transmembrane transport (GO:0034219)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	13	0	.66	-	 < 0.01	5.15E-01
positive regulation of translation (GO:0045727)	23	0	1.17	-	 < 0.01	3.09E-01
positive regulation of T cell proliferation (GO:0042102)	12	0	.61	-	 < 0.01	5.42E-01
B cell proliferation (GO:0042100)	19	0	.97	-	 < 0.01	3.79E-01
regulation of cell shape (GO:0008360)	27	0	1.38	-	 < 0.01	2.52E-01
regulation of cytokine production involved in immune response (GO:0002718)	7	0	.36	-	 < 0.01	6.99E-01
neuromuscular synaptic transmission (GO:0007274)	6	0	.31	-	 < 0.01	7.36E-01
synaptic transmission, cholinergic (GO:0007271)	6	0	.31	-	 < 0.01	7.36E-01
regulation of mitotic sister chromatid separation (GO:0010965)	17	0	.87	-	 < 0.01	4.19E-01
RNA interference (GO:0016246)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of cellular protein catabolic process (GO:1903363)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of lymphocyte mediated immunity (GO:0002708)	19	0	.97	-	 < 0.01	3.79E-01
regulation of lymphocyte mediated immunity (GO:0002706)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of leukocyte mediated immunity (GO:0002705)	22	0	1.12	-	 < 0.01	3.25E-01
Rho protein signal transduction (GO:0007266)	45	0	2.30	-	 < 0.01	1.00E-01
regulation of production of molecular mediator of immune response (GO:0002700)	10	0	.51	-	 < 0.01	6.00E-01
tyrosine phosphorylation of STAT protein (GO:0007260)	11	0	.56	-	 < 0.01	5.70E-01
calcium ion transport into cytosol (GO:0060402)	22	0	1.12	-	 < 0.01	3.25E-01
cytosolic calcium ion transport (GO:0060401)	25	0	1.28	-	 < 0.01	2.79E-01
C-terminal protein amino acid modification (GO:0018410)	5	0	.26	-	 < 0.01	7.75E-01
negative regulation of nuclear division (GO:0051784)	15	0	.77	-	 < 0.01	4.65E-01
replication fork processing (GO:0031297)	6	0	.31	-	 < 0.01	7.36E-01
embryo development ending in birth or egg hatching (GO:0009792)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	9	0	.46	-	 < 0.01	6.31E-01
heterochromatin organization (GO:0070828)	8	0	.41	-	 < 0.01	6.65E-01
mitochondrial respiratory chain complex II assembly (GO:0034553)	2	0	.10	-	 < 0.01	9.03E-01
hormone biosynthetic process (GO:0042446)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of cell division (GO:0051781)	4	0	.20	-	 < 0.01	8.15E-01
post-embryonic development (GO:0009791)	1	0	.05	-	 < 0.01	9.50E-01
phosphatidylinositol 3-kinase signaling (GO:0014065)	16	0	.82	-	 < 0.01	4.41E-01
mitochondrial respiratory chain complex III assembly (GO:0034551)	3	0	.15	-	 < 0.01	8.58E-01
pigment metabolic process (GO:0042440)	23	0	1.17	-	 < 0.01	3.09E-01
JNK cascade (GO:0007254)	30	0	1.53	-	 < 0.01	2.16E-01
negative regulation of cell cycle process (GO:0010948)	34	0	1.74	-	 < 0.01	1.76E-01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	8	0	.41	-	 < 0.01	6.65E-01
iron-sulfur cluster assembly (GO:0016226)	12	0	.61	-	 < 0.01	5.42E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of blood coagulation (GO:0030195)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of TOR signaling (GO:0032008)	9	0	.46	-	 < 0.01	6.31E-01
non-motile cilium assembly (GO:1905515)	13	0	.66	-	 < 0.01	5.15E-01
intracellular sterol transport (GO:0032366)	2	0	.10	-	 < 0.01	9.03E-01
stress-activated MAPK cascade (GO:0051403)	35	0	1.79	-	 < 0.01	1.67E-01
neuron apoptotic process (GO:0051402)	11	0	.56	-	 < 0.01	5.70E-01
response to UV (GO:0009411)	7	0	.36	-	 < 0.01	6.99E-01
regulation of lymphocyte proliferation (GO:0050670)	25	0	1.28	-	 < 0.01	2.79E-01
B cell differentiation (GO:0030183)	16	0	.82	-	 < 0.01	4.41E-01
hemostasis (GO:0007599)	17	0	.87	-	 < 0.01	4.19E-01
blood coagulation (GO:0007596)	17	0	.87	-	 < 0.01	4.19E-01
cellular component assembly involved in morphogenesis (GO:0010927)	23	0	1.17	-	 < 0.01	3.09E-01
response to estradiol (GO:0032355)	4	0	.20	-	 < 0.01	8.15E-01
developmental pigmentation (GO:0048066)	4	0	.20	-	 < 0.01	8.15E-01
response to cold (GO:0009409)	5	0	.26	-	 < 0.01	7.75E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	21	0	1.07	-	 < 0.01	3.42E-01
ATP synthesis coupled electron transport (GO:0042773)	21	0	1.07	-	 < 0.01	3.42E-01
signal transduction in response to DNA damage (GO:0042770)	7	0	.36	-	 < 0.01	6.99E-01
digestion (GO:0007586)	6	0	.31	-	 < 0.01	7.36E-01
response to nutrient (GO:0007584)	4	0	.20	-	 < 0.01	8.15E-01
cristae formation (GO:0042407)	7	0	.36	-	 < 0.01	6.99E-01
protein O-linked glycosylation (GO:0006493)	14	0	.72	-	 < 0.01	4.89E-01
platelet activation (GO:0030168)	10	0	.51	-	 < 0.01	6.00E-01
protein import into peroxisome matrix (GO:0016558)	10	0	.51	-	 < 0.01	6.00E-01
proteoglycan biosynthetic process (GO:0030166)	28	0	1.43	-	 < 0.01	2.39E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	12	0	.61	-	 < 0.01	5.42E-01
neuropeptide signaling pathway (GO:0007218)	41	0	2.09	-	 < 0.01	1.23E-01
glutamate receptor signaling pathway (GO:0007215)	27	0	1.38	-	 < 0.01	2.52E-01
dopamine receptor signaling pathway (GO:0007212)	9	0	.46	-	 < 0.01	6.31E-01
carbohydrate derivative catabolic process (GO:1901136)	43	0	2.20	-	 < 0.01	1.11E-01
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	8	0	.41	-	 < 0.01	6.65E-01
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	5	0	.26	-	 < 0.01	7.75E-01
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	4	0	.20	-	 < 0.01	8.15E-01
protein localization to kinetochore (GO:0034501)	6	0	.31	-	 < 0.01	7.36E-01
protein import into mitochondrial matrix (GO:0030150)	16	0	.82	-	 < 0.01	4.41E-01
alanine transport (GO:0032328)	6	0	.31	-	 < 0.01	7.36E-01
activation of phospholipase C activity (GO:0007202)	37	0	1.89	-	 < 0.01	1.51E-01
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	36	0	1.84	-	 < 0.01	1.59E-01
oxidative phosphorylation (GO:0006119)	29	0	1.48	-	 < 0.01	2.27E-01
N-terminal protein amino acid acetylation (GO:0006474)	7	0	.36	-	 < 0.01	6.99E-01
basic amino acid transmembrane transport (GO:1990822)	2	0	.10	-	 < 0.01	9.03E-01
sphingolipid catabolic process (GO:0030149)	10	0	.51	-	 < 0.01	6.00E-01
carbohydrate transport (GO:0008643)	1	0	.05	-	 < 0.01	9.50E-01
detection of mechanical stimulus (GO:0050982)	13	0	.66	-	 < 0.01	5.15E-01
negative regulation of chromosome separation (GO:1905819)	13	0	.66	-	 < 0.01	5.15E-01
sex differentiation (GO:0007548)	11	0	.56	-	 < 0.01	5.70E-01
regulation of chromosome separation (GO:1905818)	19	0	.97	-	 < 0.01	3.79E-01
inositol lipid-mediated signaling (GO:0048017)	33	0	1.69	-	 < 0.01	1.85E-01
inositol phosphate-mediated signaling (GO:0048016)	46	0	2.35	-	 < 0.01	9.51E-02
phosphatidylinositol-mediated signaling (GO:0048015)	33	0	1.69	-	 < 0.01	1.85E-01
biomineral tissue development (GO:0031214)	9	0	.46	-	 < 0.01	6.31E-01
G2 DNA damage checkpoint (GO:0031572)	6	0	.31	-	 < 0.01	7.36E-01
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	15	0	.77	-	 < 0.01	4.65E-01
biomineralization (GO:0110148)	9	0	.46	-	 < 0.01	6.31E-01
nucleotide-sugar transmembrane transport (GO:0015780)	2	0	.10	-	 < 0.01	9.03E-01
tRNA wobble uridine modification (GO:0002098)	7	0	.36	-	 < 0.01	6.99E-01
neuromuscular junction development (GO:0007528)	15	0	.77	-	 < 0.01	4.65E-01
tumor necrosis factor production (GO:0032640)	7	0	.36	-	 < 0.01	6.99E-01
organelle transport along microtubule (GO:0072384)	18	0	.92	-	 < 0.01	3.99E-01
skeletal muscle tissue development (GO:0007519)	3	0	.15	-	 < 0.01	8.58E-01
negative regulation of proteasomal protein catabolic process (GO:1901799)	4	0	.20	-	 < 0.01	8.15E-01
heme biosynthetic process (GO:0006783)	9	0	.46	-	 < 0.01	6.31E-01
protein activation cascade (GO:0072376)	11	0	.56	-	 < 0.01	5.70E-01
mitochondrial respiratory chain complex I assembly (GO:0032981)	9	0	.46	-	 < 0.01	6.31E-01
mesoderm morphogenesis (GO:0048332)	10	0	.51	-	 < 0.01	6.00E-01
porphyrin-containing compound metabolic process (GO:0006778)	13	0	.66	-	 < 0.01	5.15E-01
actin cytoskeleton reorganization (GO:0031532)	17	0	.87	-	 < 0.01	4.19E-01
regulation of complement activation (GO:0030449)	1	0	.05	-	 < 0.01	9.50E-01
chondrocyte differentiation (GO:0002062)	7	0	.36	-	 < 0.01	6.99E-01
citrate transport (GO:0015746)	3	0	.15	-	 < 0.01	8.58E-01
pigment biosynthetic process (GO:0046148)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of wound healing (GO:0090303)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of response to DNA damage stimulus (GO:2001022)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of response to DNA damage stimulus (GO:2001021)	7	0	.36	-	 < 0.01	6.99E-01
ATP biosynthetic process (GO:0006754)	32	0	1.63	-	 < 0.01	1.95E-01
chemical synaptic transmission, postsynaptic (GO:0099565)	14	0	.72	-	 < 0.01	4.89E-01
synaptic membrane adhesion (GO:0099560)	3	0	.15	-	 < 0.01	8.58E-01
protein targeting to ER (GO:0045047)	16	0	.82	-	 < 0.01	4.41E-01
bile acid and bile salt transport (GO:0015721)	8	0	.41	-	 < 0.01	6.65E-01
heterochromatin assembly (GO:0031507)	7	0	.36	-	 < 0.01	6.99E-01
monocarboxylic acid transport (GO:0015718)	31	0	1.58	-	 < 0.01	2.05E-01
protein insertion into mitochondrial inner membrane (GO:0045039)	5	0	.26	-	 < 0.01	7.75E-01
regulation of mononuclear cell proliferation (GO:0032944)	25	0	1.28	-	 < 0.01	2.79E-01
mononuclear cell proliferation (GO:0032943)	38	0	1.94	-	 < 0.01	1.43E-01
NADP metabolic process (GO:0006739)	10	0	.51	-	 < 0.01	6.00E-01
phosphatidylglycerol metabolic process (GO:0046471)	2	0	.10	-	 < 0.01	9.03E-01
plasma membrane fusion (GO:0045026)	12	0	.61	-	 < 0.01	5.42E-01
lymphocyte migration (GO:0072676)	30	0	1.53	-	 < 0.01	2.16E-01
immunoglobulin production (GO:0002377)	6	0	.31	-	 < 0.01	7.36E-01
acylglycerol catabolic process (GO:0046464)	13	0	.66	-	 < 0.01	5.15E-01
cellular response to lipopolysaccharide (GO:0071222)	34	0	1.74	-	 < 0.01	1.76E-01
neutral lipid catabolic process (GO:0046461)	13	0	.66	-	 < 0.01	5.15E-01
activin receptor signaling pathway (GO:0032924)	11	0	.56	-	 < 0.01	5.70E-01
establishment of protein localization to peroxisome (GO:0072663)	13	0	.66	-	 < 0.01	5.15E-01
protein localization to peroxisome (GO:0072662)	13	0	.66	-	 < 0.01	5.15E-01
TORC1 signaling (GO:0038202)	13	0	.66	-	 < 0.01	5.15E-01
cellular response to misfolded protein (GO:0071218)	10	0	.51	-	 < 0.01	6.00E-01
icosanoid biosynthetic process (GO:0046456)	8	0	.41	-	 < 0.01	6.65E-01
cellular response to biotic stimulus (GO:0071216)	38	0	1.94	-	 < 0.01	1.43E-01
cellular response to abiotic stimulus (GO:0071214)	21	0	1.07	-	 < 0.01	3.42E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808)	8	0	.41	-	 < 0.01	6.65E-01
regulation of cell cycle G1/S phase transition (GO:1902806)	16	0	.82	-	 < 0.01	4.41E-01
steroid catabolic process (GO:0006706)	5	0	.26	-	 < 0.01	7.75E-01
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	14	0	.72	-	 < 0.01	4.89E-01
cellular carbohydrate catabolic process (GO:0044275)	12	0	.61	-	 < 0.01	5.42E-01
branched-chain amino acid biosynthetic process (GO:0009082)	3	0	.15	-	 < 0.01	8.58E-01
T cell proliferation (GO:0042098)	20	0	1.02	-	 < 0.01	3.60E-01
type 2 immune response (GO:0042092)	3	0	.15	-	 < 0.01	8.58E-01
cardiac muscle contraction (GO:0060048)	12	0	.61	-	 < 0.01	5.42E-01
heart contraction (GO:0060047)	19	0	.97	-	 < 0.01	3.79E-01
retina development in camera-type eye (GO:0060041)	8	0	.41	-	 < 0.01	6.65E-01
cell wall organization or biogenesis (GO:0071554)	1	0	.05	-	 < 0.01	9.50E-01
aromatic amino acid family catabolic process (GO:0009074)	13	0	.66	-	 < 0.01	5.15E-01
aromatic amino acid family metabolic process (GO:0009072)	15	0	.77	-	 < 0.01	4.65E-01
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of leukocyte activation (GO:0002695)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	27	0	1.38	-	 < 0.01	2.52E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058)	10	0	.51	-	 < 0.01	6.00E-01
aspartate family amino acid biosynthetic process (GO:0009067)	9	0	.46	-	 < 0.01	6.31E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	11	0	.56	-	 < 0.01	5.70E-01
aerobic respiration (GO:0009060)	33	0	1.69	-	 < 0.01	1.85E-01
protein mannosylation (GO:0035268)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of secretion (GO:0051047)	17	0	.87	-	 < 0.01	4.19E-01
gliogenesis (GO:0042063)	10	0	.51	-	 < 0.01	6.00E-01
wound healing (GO:0042060)	32	0	1.63	-	 < 0.01	1.95E-01
protein localization to lysosome (GO:0061462)	14	0	.72	-	 < 0.01	4.89E-01
regulation of double-strand break repair via homologous recombination (GO:0010569)	5	0	.26	-	 < 0.01	7.75E-01
B cell activation involved in immune response (GO:0002312)	4	0	.20	-	 < 0.01	8.15E-01
peptidyl-lysine trimethylation (GO:0018023)	4	0	.20	-	 < 0.01	8.15E-01
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	16	0	.82	-	 < 0.01	4.41E-01
establishment of mitotic spindle orientation (GO:0000132)	5	0	.26	-	 < 0.01	7.75E-01
folic acid-containing compound biosynthetic process (GO:0009396)	5	0	.26	-	 < 0.01	7.75E-01
protein kinase B signaling (GO:0043491)	11	0	.56	-	 < 0.01	5.70E-01
connective tissue development (GO:0061448)	9	0	.46	-	 < 0.01	6.31E-01
ionotropic glutamate receptor signaling pathway (GO:0035235)	16	0	.82	-	 < 0.01	4.41E-01
histone exchange (GO:0043486)	8	0	.41	-	 < 0.01	6.65E-01
toll-like receptor 4 signaling pathway (GO:0034142)	4	0	.20	-	 < 0.01	8.15E-01
regulation of cytokine biosynthetic process (GO:0042035)	5	0	.26	-	 < 0.01	7.75E-01
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	10	0	.51	-	 < 0.01	6.00E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	10	0	.51	-	 < 0.01	6.00E-01
regulation of protein localization to membrane (GO:1905475)	12	0	.61	-	 < 0.01	5.42E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029)	23	0	1.17	-	 < 0.01	3.09E-01
pigmentation (GO:0043473)	11	0	.56	-	 < 0.01	5.70E-01
cleavage involved in rRNA processing (GO:0000469)	16	0	.82	-	 < 0.01	4.41E-01
negative regulation of mitotic sister chromatid segregation (GO:0033048)	12	0	.61	-	 < 0.01	5.42E-01
negative regulation of sister chromatid segregation (GO:0033046)	12	0	.61	-	 < 0.01	5.42E-01
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	11	0	.56	-	 < 0.01	5.70E-01
triglyceride biosynthetic process (GO:0019432)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of immunoglobulin production (GO:0002639)	3	0	.15	-	 < 0.01	8.58E-01
secondary metabolite biosynthetic process (GO:0044550)	2	0	.10	-	 < 0.01	9.03E-01
protein prenylation (GO:0018342)	9	0	.46	-	 < 0.01	6.31E-01
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	12	0	.61	-	 < 0.01	5.42E-01
non-canonical Wnt signaling pathway (GO:0035567)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of phospholipase activity (GO:0010518)	38	0	1.94	-	 < 0.01	1.43E-01
regulation of phospholipase activity (GO:0010517)	40	0	2.04	-	 < 0.01	1.29E-01
cilium or flagellum-dependent cell motility (GO:0001539)	22	0	1.12	-	 < 0.01	3.25E-01
tricarboxylic acid cycle (GO:0006099)	17	0	.87	-	 < 0.01	4.19E-01
tissue homeostasis (GO:0001894)	13	0	.66	-	 < 0.01	5.15E-01
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	5	0	.26	-	 < 0.01	7.75E-01
homotypic cell-cell adhesion (GO:0034109)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of phospholipase C activity (GO:0010863)	37	0	1.89	-	 < 0.01	1.51E-01
liver development (GO:0001889)	3	0	.15	-	 < 0.01	8.58E-01
regulation of tissue remodeling (GO:0034103)	5	0	.26	-	 < 0.01	7.75E-01
pseudouridine synthesis (GO:0001522)	12	0	.61	-	 < 0.01	5.42E-01
tetrapyrrole metabolic process (GO:0033013)	14	0	.72	-	 < 0.01	4.89E-01
negative regulation of cell adhesion (GO:0007162)	27	0	1.38	-	 < 0.01	2.52E-01
cell-matrix adhesion (GO:0007160)	24	0	1.23	-	 < 0.01	2.93E-01
negative regulation of DNA-binding transcription factor activity (GO:0043433)	9	0	.46	-	 < 0.01	6.31E-01
microtubule anchoring (GO:0034453)	7	0	.36	-	 < 0.01	6.99E-01
regulation of chromatin assembly (GO:0010847)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of protein polymerization (GO:0032273)	32	0	1.63	-	 < 0.01	1.95E-01
action potential (GO:0001508)	30	0	1.53	-	 < 0.01	2.16E-01
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	4	0	.20	-	 < 0.01	8.15E-01
myeloid cell differentiation (GO:0030099)	23	0	1.17	-	 < 0.01	3.09E-01
muscle cell differentiation (GO:0042692)	30	0	1.53	-	 < 0.01	2.16E-01
phytosteroid metabolic process (GO:0016128)	1	0	.05	-	 < 0.01	9.50E-01
secondary metabolic process (GO:0019748)	7	0	.36	-	 < 0.01	6.99E-01
lymphocyte differentiation (GO:0030098)	31	0	1.58	-	 < 0.01	2.05E-01
hemopoiesis (GO:0030097)	66	0	3.37	-	 < 0.01	3.41E-02
male meiotic nuclear division (GO:0007140)	5	0	.26	-	 < 0.01	7.75E-01
mitotic sister chromatid separation (GO:0051306)	18	0	.92	-	 < 0.01	3.99E-01
regulation of cell division (GO:0051302)	16	0	.82	-	 < 0.01	4.41E-01
oligosaccharide biosynthetic process (GO:0009312)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of translational initiation (GO:0045948)	9	0	.46	-	 < 0.01	6.31E-01
syncytium formation by plasma membrane fusion (GO:0000768)	3	0	.15	-	 < 0.01	8.58E-01
carotenoid biosynthetic process (GO:0016117)	1	0	.05	-	 < 0.01	9.50E-01
male gonad development (GO:0008584)	6	0	.31	-	 < 0.01	7.36E-01
antibacterial humoral response (GO:0019731)	18	0	.92	-	 < 0.01	3.99E-01
mesoderm development (GO:0007498)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of MAPK cascade (GO:0043409)	20	0	1.02	-	 < 0.01	3.60E-01
negative regulation of MAP kinase activity (GO:0043407)	17	0	.87	-	 < 0.01	4.19E-01
endoderm development (GO:0007492)	10	0	.51	-	 < 0.01	6.00E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047)	9	0	.46	-	 < 0.01	6.31E-01
regulation of mitochondrion organization (GO:0010821)	12	0	.61	-	 < 0.01	5.42E-01
spindle localization (GO:0051653)	12	0	.61	-	 < 0.01	5.42E-01
amino sugar metabolic process (GO:0006040)	25	0	1.28	-	 < 0.01	2.79E-01
negative regulation of mitotic sister chromatid separation (GO:2000816)	12	0	.61	-	 < 0.01	5.42E-01
insulin secretion (GO:0030073)	6	0	.31	-	 < 0.01	7.36E-01
homologous chromosome pairing at meiosis (GO:0007129)	8	0	.41	-	 < 0.01	6.65E-01
peptide hormone secretion (GO:0030072)	10	0	.51	-	 < 0.01	6.00E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071)	15	0	.77	-	 < 0.01	4.65E-01
regulation of hormone levels (GO:0010817)	38	0	1.94	-	 < 0.01	1.43E-01
nucleus localization (GO:0051647)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of exocytosis (GO:0045921)	9	0	.46	-	 < 0.01	6.31E-01
actomyosin contractile ring organization (GO:0044837)	2	0	.10	-	 < 0.01	9.03E-01
nucleotide-excision repair, DNA incision (GO:0033683)	5	0	.26	-	 < 0.01	7.75E-01
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	27	0	1.38	-	 < 0.01	2.52E-01
nucleobase-containing small molecule biosynthetic process (GO:0034404)	25	0	1.28	-	 < 0.01	2.79E-01
kidney development (GO:0001822)	5	0	.26	-	 < 0.01	7.75E-01
cellular response to environmental stimulus (GO:0104004)	21	0	1.07	-	 < 0.01	3.42E-01
negative regulation of DNA recombination (GO:0045910)	9	0	.46	-	 < 0.01	6.31E-01
DNA catabolic process, endonucleolytic (GO:0000737)	8	0	.41	-	 < 0.01	6.65E-01
mitotic DNA replication checkpoint (GO:0033314)	7	0	.36	-	 < 0.01	6.99E-01
somatic recombination of immunoglobulin gene segments (GO:0016447)	3	0	.15	-	 < 0.01	8.58E-01
DNA synthesis involved in DNA repair (GO:0000731)	10	0	.51	-	 < 0.01	6.00E-01
somatic cell DNA recombination (GO:0016444)	4	0	.20	-	 < 0.01	8.15E-01
regulation of gene silencing (GO:0060968)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288)	28	0	1.43	-	 < 0.01	2.39E-01
response to toxic substance (GO:0009636)	23	0	1.17	-	 < 0.01	3.09E-01
mRNA splice site selection (GO:0006376)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of chromosome segregation (GO:0051985)	13	0	.66	-	 < 0.01	5.15E-01
iron ion transmembrane transport (GO:0034755)	6	0	.31	-	 < 0.01	7.36E-01
DNA double-strand break processing (GO:0000729)	4	0	.20	-	 < 0.01	8.15E-01
non-recombinational repair (GO:0000726)	16	0	.82	-	 < 0.01	4.41E-01
mitotic G2/M transition checkpoint (GO:0044818)	11	0	.56	-	 < 0.01	5.70E-01
fibroblast growth factor receptor signaling pathway (GO:0008543)	32	0	1.63	-	 < 0.01	1.95E-01
cognition (GO:0050890)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of peptide hormone secretion (GO:0090277)	4	0	.20	-	 < 0.01	8.15E-01
regulation of peptide hormone secretion (GO:0090276)	8	0	.41	-	 < 0.01	6.65E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	12	0	.61	-	 < 0.01	5.42E-01
cell-cell recognition (GO:0009988)	13	0	.66	-	 < 0.01	5.15E-01
transcription initiation from RNA polymerase II promoter (GO:0006367)	28	0	1.43	-	 < 0.01	2.39E-01
transcription by RNA polymerase I (GO:0006360)	10	0	.51	-	 < 0.01	6.00E-01
quaternary ammonium group transport (GO:0015697)	3	0	.15	-	 < 0.01	8.58E-01
organic cation transport (GO:0015695)	13	0	.66	-	 < 0.01	5.15E-01
defense response to virus (GO:0051607)	30	0	1.53	-	 < 0.01	2.16E-01
detection of stimulus (GO:0051606)	59	0	3.01	-	 < 0.01	4.88E-02
response to virus (GO:0009615)	33	0	1.69	-	 < 0.01	1.85E-01
regulation of synaptic transmission, glutamatergic (GO:0051966)	19	0	.97	-	 < 0.01	3.79E-01
response to mechanical stimulus (GO:0009612)	14	0	.72	-	 < 0.01	4.89E-01
DNA-templated transcription, initiation (GO:0006352)	40	0	2.04	-	 < 0.01	1.29E-01
regulation of microtubule polymerization or depolymerization (GO:0031110)	20	0	1.02	-	 < 0.01	3.60E-01
nervous system process (GO:0050877)	161	0	8.22	-	 < 0.01	2.58E-04
transition metal ion homeostasis (GO:0055076)	42	0	2.15	-	 < 0.01	1.17E-01
iron ion homeostasis (GO:0055072)	14	0	.72	-	 < 0.01	4.89E-01
regulation of phospholipase C activity (GO:1900274)	37	0	1.89	-	 < 0.01	1.51E-01
positive regulation of secretion by cell (GO:1903532)	16	0	.82	-	 < 0.01	4.41E-01
copper ion homeostasis (GO:0055070)	3	0	.15	-	 < 0.01	8.58E-01
chromatin silencing at telomere (GO:0006348)	5	0	.26	-	 < 0.01	7.75E-01
septin ring organization (GO:0031106)	2	0	.10	-	 < 0.01	9.03E-01
DNA replication-independent nucleosome organization (GO:0034724)	6	0	.31	-	 < 0.01	7.36E-01
chromatin silencing (GO:0006342)	20	0	1.02	-	 < 0.01	3.60E-01
negative regulation of T cell activation (GO:0050868)	17	0	.87	-	 < 0.01	4.19E-01
negative regulation of cell activation (GO:0050866)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of receptor-mediated endocytosis (GO:0048259)	10	0	.51	-	 < 0.01	6.00E-01
peripheral nervous system development (GO:0007422)	3	0	.15	-	 < 0.01	8.58E-01
mitochondrial translation (GO:0032543)	18	0	.92	-	 < 0.01	3.99E-01
prostaglandin metabolic process (GO:0006693)	8	0	.41	-	 < 0.01	6.65E-01
icosanoid metabolic process (GO:0006690)	16	0	.82	-	 < 0.01	4.41E-01
cell adhesion mediated by integrin (GO:0033627)	13	0	.66	-	 < 0.01	5.15E-01
B cell receptor signaling pathway (GO:0050853)	20	0	1.02	-	 < 0.01	3.60E-01
synapse assembly (GO:0007416)	21	0	1.07	-	 < 0.01	3.42E-01
macrophage chemotaxis (GO:0048246)	4	0	.20	-	 < 0.01	8.15E-01
sperm capacitation (GO:0048240)	6	0	.31	-	 < 0.01	7.36E-01
liposaccharide metabolic process (GO:1903509)	38	0	1.94	-	 < 0.01	1.43E-01
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of calcium ion transport (GO:0051928)	8	0	.41	-	 < 0.01	6.65E-01
male gamete generation (GO:0048232)	35	0	1.79	-	 < 0.01	1.67E-01
mitochondrial outer membrane translocase complex assembly (GO:0070096)	2	0	.10	-	 < 0.01	9.03E-01
regulation of calcium ion transport (GO:0051924)	22	0	1.12	-	 < 0.01	3.25E-01
defense response to fungus (GO:0050832)	2	0	.10	-	 < 0.01	9.03E-01
cellular response to chemical stress (GO:0062197)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of stress-activated MAPK cascade (GO:0032874)	23	0	1.17	-	 < 0.01	3.09E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	17	0	.87	-	 < 0.01	4.19E-01
regulation of stress-activated MAPK cascade (GO:0032872)	31	0	1.58	-	 < 0.01	2.05E-01
DNA catabolic process (GO:0006308)	12	0	.61	-	 < 0.01	5.42E-01
nucleotide transmembrane transport (GO:1901679)	2	0	.10	-	 < 0.01	9.03E-01
double-strand break repair via nonhomologous end joining (GO:0006303)	12	0	.61	-	 < 0.01	5.42E-01
glycolipid metabolic process (GO:0006664)	37	0	1.89	-	 < 0.01	1.51E-01
phosphatidylinositol biosynthetic process (GO:0006661)	28	0	1.43	-	 < 0.01	2.39E-01
defense response to Gram-negative bacterium (GO:0050829)	15	0	.77	-	 < 0.01	4.65E-01
vesicle transport along microtubule (GO:0047496)	12	0	.61	-	 < 0.01	5.42E-01
cytokinetic process (GO:0032506)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of cell cycle G2/M phase transition (GO:1902750)	13	0	.66	-	 < 0.01	5.15E-01
hormone transport (GO:0009914)	14	0	.72	-	 < 0.01	4.89E-01
phosphatidylglycerol biosynthetic process (GO:0006655)	1	0	.05	-	 < 0.01	9.50E-01
negative regulation of coagulation (GO:0050819)	5	0	.26	-	 < 0.01	7.75E-01
regulation of coagulation (GO:0050818)	9	0	.46	-	 < 0.01	6.31E-01
coagulation (GO:0050817)	18	0	.92	-	 < 0.01	3.99E-01
cardiac muscle cell development (GO:0055013)	6	0	.31	-	 < 0.01	7.36E-01
regulation of membrane permeability (GO:0090559)	4	0	.20	-	 < 0.01	8.15E-01
ATP synthesis coupled proton transport (GO:0015986)	31	0	1.58	-	 < 0.01	2.05E-01
energy coupled proton transport, down electrochemical gradient (GO:0015985)	31	0	1.58	-	 < 0.01	2.05E-01
triglyceride metabolic process (GO:0006641)	30	0	1.53	-	 < 0.01	2.16E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599)	16	0	.82	-	 < 0.01	4.41E-01
cardiac muscle cell differentiation (GO:0055007)	7	0	.36	-	 < 0.01	6.99E-01
melanocyte differentiation (GO:0030318)	3	0	.15	-	 < 0.01	8.58E-01
flagellated sperm motility (GO:0030317)	10	0	.51	-	 < 0.01	6.00E-01
striated muscle cell development (GO:0055002)	21	0	1.07	-	 < 0.01	3.42E-01
osteoclast differentiation (GO:0030316)	9	0	.46	-	 < 0.01	6.31E-01
muscle cell development (GO:0055001)	23	0	1.17	-	 < 0.01	3.09E-01
acylglycerol metabolic process (GO:0006639)	40	0	2.04	-	 < 0.01	1.29E-01
neutral lipid metabolic process (GO:0006638)	40	0	2.04	-	 < 0.01	1.29E-01
nuclear envelope organization (GO:0006998)	11	0	.56	-	 < 0.01	5.70E-01
unsaturated fatty acid biosynthetic process (GO:0006636)	6	0	.31	-	 < 0.01	7.36E-01
heart process (GO:0003015)	20	0	1.02	-	 < 0.01	3.60E-01
clathrin-dependent endocytosis (GO:0072583)	19	0	.97	-	 < 0.01	3.79E-01
T cell activation involved in immune response (GO:0002286)	16	0	.82	-	 < 0.01	4.41E-01
lymphocyte activation involved in immune response (GO:0002285)	19	0	.97	-	 < 0.01	3.79E-01
positive regulation of cation channel activity (GO:2001259)	5	0	.26	-	 < 0.01	7.75E-01
regulation of cation channel activity (GO:2001257)	32	0	1.63	-	 < 0.01	1.95E-01
skeletal muscle contraction (GO:0003009)	8	0	.41	-	 < 0.01	6.65E-01
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.26	-	 < 0.01	7.75E-01
protein targeting to peroxisome (GO:0006625)	13	0	.66	-	 < 0.01	5.15E-01
protein targeting to lysosome (GO:0006622)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of cell-cell adhesion (GO:0022408)	18	0	.92	-	 < 0.01	3.99E-01
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of mitotic cell cycle phase transition (GO:1901991)	29	0	1.48	-	 < 0.01	2.27E-01
cellular response to light stimulus (GO:0071482)	12	0	.61	-	 < 0.01	5.42E-01
hematopoietic or lymphoid organ development (GO:0048534)	66	0	3.37	-	 < 0.01	3.41E-02
response to oxidative stress (GO:0006979)	29	0	1.48	-	 < 0.01	2.27E-01
negative regulation of cell cycle phase transition (GO:1901988)	30	0	1.53	-	 < 0.01	2.16E-01
interstrand cross-link repair (GO:0036297)	9	0	.46	-	 < 0.01	6.31E-01
protein targeting to membrane (GO:0006612)	42	0	2.15	-	 < 0.01	1.17E-01
response to osmotic stress (GO:0006970)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	13	0	.66	-	 < 0.01	5.15E-01
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	17	0	.87	-	 < 0.01	4.19E-01
positive regulation of apoptotic signaling pathway (GO:2001235)	10	0	.51	-	 < 0.01	6.00E-01
cellular response to osmotic stress (GO:0071470)	1	0	.05	-	 < 0.01	9.50E-01
positive regulation of DNA-templated transcription, initiation (GO:2000144)	6	0	.31	-	 < 0.01	7.36E-01
regulation of DNA-templated transcription, initiation (GO:2000142)	7	0	.36	-	 < 0.01	6.99E-01
regulation of wound healing (GO:0061041)	10	0	.51	-	 < 0.01	6.00E-01
amino sugar catabolic process (GO:0046348)	8	0	.41	-	 < 0.01	6.65E-01
adaptive immune response (GO:0002250)	45	0	2.30	-	 < 0.01	1.00E-01
spermatid differentiation (GO:0048515)	18	0	.92	-	 < 0.01	3.99E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	23	0	1.17	-	 < 0.01	3.09E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	38	0	1.94	-	 < 0.01	1.43E-01
complement activation (GO:0006956)	8	0	.41	-	 < 0.01	6.65E-01
multicellular organismal homeostasis (GO:0048871)	17	0	.87	-	 < 0.01	4.19E-01
regulation of ERK1 and ERK2 cascade (GO:0070372)	41	0	2.09	-	 < 0.01	1.23E-01
DNA replication checkpoint (GO:0000076)	11	0	.56	-	 < 0.01	5.70E-01
ERK1 and ERK2 cascade (GO:0070371)	41	0	2.09	-	 < 0.01	1.23E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of JNK cascade (GO:0046330)	20	0	1.02	-	 < 0.01	3.60E-01
syncytium formation (GO:0006949)	3	0	.15	-	 < 0.01	8.58E-01
striated muscle contraction (GO:0006941)	19	0	.97	-	 < 0.01	3.79E-01
response to molecule of bacterial origin (GO:0002237)	42	0	2.15	-	 < 0.01	1.17E-01
regulation of JNK cascade (GO:0046328)	26	0	1.33	-	 < 0.01	2.65E-01
response to cadmium ion (GO:0046686)	10	0	.51	-	 < 0.01	6.00E-01
cilium movement involved in cell motility (GO:0060294)	19	0	.97	-	 < 0.01	3.79E-01
pyrimidine-containing compound metabolic process (GO:0072527)	19	0	.97	-	 < 0.01	3.79E-01
toll-like receptor signaling pathway (GO:0002224)	22	0	1.12	-	 < 0.01	3.25E-01
pattern recognition receptor signaling pathway (GO:0002221)	22	0	1.12	-	 < 0.01	3.25E-01
cilium-dependent cell motility (GO:0060285)	22	0	1.12	-	 < 0.01	3.25E-01
long-chain fatty acid transport (GO:0015909)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of T cell differentiation (GO:0045582)	6	0	.31	-	 < 0.01	7.36E-01
transition metal ion transport (GO:0000041)	46	0	2.35	-	 < 0.01	9.51E-02
regulation of signaling receptor activity (GO:0010469)	30	0	1.53	-	 < 0.01	2.16E-01
ATP-dependent chromatin remodeling (GO:0043044)	26	0	1.33	-	 < 0.01	2.65E-01
male sex differentiation (GO:0046661)	6	0	.31	-	 < 0.01	7.36E-01
protein localization to Golgi apparatus (GO:0034067)	11	0	.56	-	 < 0.01	5.70E-01
establishment of spindle orientation (GO:0051294)	7	0	.36	-	 < 0.01	6.99E-01
establishment of spindle localization (GO:0051293)	11	0	.56	-	 < 0.01	5.70E-01
sarcomere organization (GO:0045214)	6	0	.31	-	 < 0.01	7.36E-01
very long-chain fatty acid metabolic process (GO:0000038)	20	0	1.02	-	 < 0.01	3.60E-01
calcium ion transmembrane import into cytosol (GO:0097553)	21	0	1.07	-	 < 0.01	3.42E-01
protein N-linked glycosylation via asparagine (GO:0018279)	8	0	.41	-	 < 0.01	6.65E-01
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	4	0	.20	-	 < 0.01	8.15E-01
somatic diversification of immune receptors (GO:0002200)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	6	0	.31	-	 < 0.01	7.36E-01
lymphocyte proliferation (GO:0046651)	38	0	1.94	-	 < 0.01	1.43E-01
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	7	0	.36	-	 < 0.01	6.99E-01
negative regulation of sequestering of calcium ion (GO:0051283)	11	0	.56	-	 < 0.01	5.70E-01
regulation of sequestering of calcium ion (GO:0051282)	11	0	.56	-	 < 0.01	5.70E-01
triglyceride homeostasis (GO:0070328)	7	0	.36	-	 < 0.01	6.99E-01
ribosomal large subunit assembly (GO:0000027)	20	0	1.02	-	 < 0.01	3.60E-01
chromatin organization involved in negative regulation of transcription (GO:0097549)	27	0	1.38	-	 < 0.01	2.52E-01
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	3	0	.15	-	 < 0.01	8.58E-01
central nervous system neuron differentiation (GO:0021953)	5	0	.26	-	 < 0.01	7.75E-01
regulation of DNA recombination (GO:0000018)	14	0	.72	-	 < 0.01	4.89E-01
cellular alcohol metabolic process (GO:0044107)	1	0	.05	-	 < 0.01	9.50E-01
granulocyte migration (GO:0097530)	49	0	2.50	-	 < 0.01	8.15E-02
alpha-beta T cell differentiation (GO:0046632)	6	0	.31	-	 < 0.01	7.36E-01
protein localization to cell surface (GO:0034394)	7	0	.36	-	 < 0.01	6.99E-01
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	23	0	1.17	-	 < 0.01	3.09E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	31	0	1.58	-	 < 0.01	2.05E-01
regulation of leukocyte proliferation (GO:0070663)	25	0	1.28	-	 < 0.01	2.79E-01
leukocyte proliferation (GO:0070661)	38	0	1.94	-	 < 0.01	1.43E-01
negative regulation of double-strand break repair (GO:2000780)	6	0	.31	-	 < 0.01	7.36E-01
nuclear migration (GO:0007097)	5	0	.26	-	 < 0.01	7.75E-01
chordate embryonic development (GO:0043009)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of exit from mitosis (GO:0007096)	2	0	.10	-	 < 0.01	9.03E-01
mitotic G2 DNA damage checkpoint (GO:0007095)	6	0	.31	-	 < 0.01	7.36E-01
mitotic spindle assembly checkpoint (GO:0007094)	11	0	.56	-	 < 0.01	5.70E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	16	0	.82	-	 < 0.01	4.41E-01
positive regulation of immunoglobulin mediated immune response (GO:0002891)	5	0	.26	-	 < 0.01	7.75E-01
Golgi to plasma membrane protein transport (GO:0043001)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	5	0	.26	-	 < 0.01	7.75E-01
purine nucleoside metabolic process (GO:0042278)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of lymphocyte activation (GO:0051250)	20	0	1.02	-	 < 0.01	3.60E-01
plasma lipoprotein particle clearance (GO:0034381)	3	0	.15	-	 < 0.01	8.58E-01
cell-cell fusion (GO:0140253)	3	0	.15	-	 < 0.01	8.58E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	16	0	.82	-	 < 0.01	4.41E-01
leukocyte differentiation (GO:0002521)	45	0	2.30	-	 < 0.01	1.00E-01
immune system development (GO:0002520)	71	0	3.63	-	 < 0.01	2.64E-02
vitamin transmembrane transport (GO:0035461)	2	0	.10	-	 < 0.01	9.03E-01
mannosylation (GO:0097502)	8	0	.41	-	 < 0.01	6.65E-01
mitotic chromosome condensation (GO:0007076)	8	0	.41	-	 < 0.01	6.65E-01
transposition (GO:0032196)	11	0	.56	-	 < 0.01	5.70E-01
glycolipid biosynthetic process (GO:0009247)	28	0	1.43	-	 < 0.01	2.39E-01
neural tube development (GO:0021915)	2	0	.10	-	 < 0.01	9.03E-01
neuron death (GO:0070997)	18	0	.92	-	 < 0.01	3.99E-01
negative regulation of DNA replication (GO:0008156)	7	0	.36	-	 < 0.01	6.99E-01
metaphase/anaphase transition of cell cycle (GO:0044784)	17	0	.87	-	 < 0.01	4.19E-01
peptidyl-arginine methylation (GO:0018216)	3	0	.15	-	 < 0.01	8.58E-01
septin cytoskeleton organization (GO:0032185)	2	0	.10	-	 < 0.01	9.03E-01
detection of chemical stimulus (GO:0009593)	33	0	1.69	-	 < 0.01	1.85E-01
oxidative demethylation (GO:0070989)	10	0	.51	-	 < 0.01	6.00E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	6	0	.31	-	 < 0.01	7.36E-01
post-translational protein modification (GO:0043687)	8	0	.41	-	 < 0.01	6.65E-01
cartilage development (GO:0051216)	9	0	.46	-	 < 0.01	6.31E-01
nucleotide-sugar metabolic process (GO:0009225)	12	0	.61	-	 < 0.01	5.42E-01
neuron migration (GO:0001764)	11	0	.56	-	 < 0.01	5.70E-01
morphogenesis of a branching structure (GO:0001763)	3	0	.15	-	 < 0.01	8.58E-01
protein K11-linked ubiquitination (GO:0070979)	7	0	.36	-	 < 0.01	6.99E-01
aerobic electron transport chain (GO:0019646)	8	0	.41	-	 < 0.01	6.65E-01
multi-organism cellular process (GO:0044764)	1	0	.05	-	 < 0.01	9.50E-01
cell-substrate junction assembly (GO:0007044)	5	0	.26	-	 < 0.01	7.75E-01
cell-cell junction assembly (GO:0007043)	48	0	2.45	-	 < 0.01	8.58E-02
release of sequestered calcium ion into cytosol (GO:0051209)	10	0	.51	-	 < 0.01	6.00E-01
sequestering of calcium ion (GO:0051208)	11	0	.56	-	 < 0.01	5.70E-01
protein insertion into membrane (GO:0051205)	16	0	.82	-	 < 0.01	4.41E-01
mitochondrial calcium ion homeostasis (GO:0051560)	4	0	.20	-	 < 0.01	8.15E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	11	0	.56	-	 < 0.01	5.70E-01
protein catabolic process in the vacuole (GO:0007039)	11	0	.56	-	 < 0.01	5.70E-01
ectoderm development (GO:0007398)	10	0	.51	-	 < 0.01	6.00E-01
muscle tissue development (GO:0060537)	18	0	.92	-	 < 0.01	3.99E-01
peroxisome organization (GO:0007031)	25	0	1.28	-	 < 0.01	2.79E-01
regulation of phosphoprotein phosphatase activity (GO:0043666)	6	0	.31	-	 < 0.01	7.36E-01
cell junction assembly (GO:0034329)	76	0	3.88	-	 < 0.01	2.04E-02
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	34	0	1.74	-	 < 0.01	1.76E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205)	34	0	1.74	-	 < 0.01	1.76E-01
fertilization (GO:0009566)	22	0	1.12	-	 < 0.01	3.25E-01
negative regulation of mitotic nuclear division (GO:0045839)	12	0	.61	-	 < 0.01	5.42E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201)	35	0	1.79	-	 < 0.01	1.67E-01
translesion synthesis (GO:0019985)	8	0	.41	-	 < 0.01	6.65E-01
cellular transition metal ion homeostasis (GO:0046916)	34	0	1.74	-	 < 0.01	1.76E-01
positive regulation of adaptive immune response (GO:0002821)	19	0	.97	-	 < 0.01	3.79E-01
establishment of planar polarity (GO:0001736)	4	0	.20	-	 < 0.01	8.15E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314)	17	0	.87	-	 < 0.01	4.19E-01
microtubule depolymerization (GO:0007019)	15	0	.77	-	 < 0.01	4.65E-01
regulation of adaptive immune response (GO:0002819)	21	0	1.07	-	 < 0.01	3.42E-01
response to lipopolysaccharide (GO:0032496)	38	0	1.94	-	 < 0.01	1.43E-01
regulation of mitochondrial membrane permeability (GO:0046902)	3	0	.15	-	 < 0.01	8.58E-01
positive regulation of protein kinase B signaling (GO:0051897)	5	0	.26	-	 < 0.01	7.75E-01
regulation of protein kinase B signaling (GO:0051896)	11	0	.56	-	 < 0.01	5.70E-01
base-excision repair (GO:0006284)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of gene expression, epigenetic (GO:0045814)	20	0	1.02	-	 < 0.01	3.60E-01
nucleoside phosphate catabolic process (GO:1901292)	18	0	.92	-	 < 0.01	3.99E-01
protein K48-linked ubiquitination (GO:0070936)	14	0	.72	-	 < 0.01	4.89E-01
myelination (GO:0042552)	13	0	.66	-	 < 0.01	5.15E-01
iron import into cell (GO:0033212)	1	0	.05	-	 < 0.01	9.50E-01
inner mitochondrial membrane organization (GO:0007007)	14	0	.72	-	 < 0.01	4.89E-01
gastrulation (GO:0007369)	10	0	.51	-	 < 0.01	6.00E-01
mitochondrial membrane organization (GO:0007006)	22	0	1.12	-	 < 0.01	3.25E-01
regulation of DNA replication (GO:0006275)	17	0	.87	-	 < 0.01	4.19E-01
cell wall biogenesis (GO:0042546)	1	0	.05	-	 < 0.01	9.50E-01
regulation of insulin secretion (GO:0050796)	4	0	.20	-	 < 0.01	8.15E-01
mesoderm formation (GO:0001707)	10	0	.51	-	 < 0.01	6.00E-01
histone H4-K16 acetylation (GO:0043984)	4	0	.20	-	 < 0.01	8.15E-01
DNA unwinding involved in DNA replication (GO:0006268)	9	0	.46	-	 < 0.01	6.31E-01
establishment of mitotic spindle localization (GO:0040001)	6	0	.31	-	 < 0.01	7.36E-01
endoderm formation (GO:0001706)	10	0	.51	-	 < 0.01	6.00E-01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	6	0	.31	-	 < 0.01	7.36E-01
ectoderm formation (GO:0001705)	10	0	.51	-	 < 0.01	6.00E-01
formation of primary germ layer (GO:0001704)	10	0	.51	-	 < 0.01	6.00E-01
positive regulation of receptor signaling pathway via STAT (GO:1904894)	15	0	.77	-	 < 0.01	4.65E-01
regulation of receptor signaling pathway via STAT (GO:1904892)	27	0	1.38	-	 < 0.01	2.52E-01
unsaturated fatty acid metabolic process (GO:0033559)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	11	0	.56	-	 < 0.01	5.70E-01
positive regulation of cytokinesis (GO:0032467)	4	0	.20	-	 < 0.01	8.15E-01
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	2	0	.10	-	 < 0.01	9.03E-01
regulation of cytokinesis (GO:0032465)	14	0	.72	-	 < 0.01	4.89E-01
intraciliary retrograde transport (GO:0035721)	7	0	.36	-	 < 0.01	6.99E-01
acrosome reaction (GO:0007340)	6	0	.31	-	 < 0.01	7.36E-01
carbohydrate derivative transport (GO:1901264)	12	0	.61	-	 < 0.01	5.42E-01
cGMP-mediated signaling (GO:0019934)	9	0	.46	-	 < 0.01	6.31E-01
binding of sperm to zona pellucida (GO:0007339)	8	0	.41	-	 < 0.01	6.65E-01
bone mineralization (GO:0030282)	7	0	.36	-	 < 0.01	6.99E-01
single fertilization (GO:0007338)	21	0	1.07	-	 < 0.01	3.42E-01
endocytic recycling (GO:0032456)	16	0	.82	-	 < 0.01	4.41E-01
mitochondrial protein processing (GO:0034982)	7	0	.36	-	 < 0.01	6.99E-01
regulation of ossification (GO:0030278)	5	0	.26	-	 < 0.01	7.75E-01
lipid storage (GO:0019915)	12	0	.61	-	 < 0.01	5.42E-01
chromosome condensation (GO:0030261)	13	0	.66	-	 < 0.01	5.15E-01
melanosome organization (GO:0032438)	6	0	.31	-	 < 0.01	7.36E-01
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	4	0	.20	-	 < 0.01	8.15E-01
catecholamine metabolic process (GO:0006584)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine nucleotide biosynthetic process (GO:0006221)	6	0	.31	-	 < 0.01	7.36E-01
pyrimidine nucleotide metabolic process (GO:0006220)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of DNA-templated transcription, elongation (GO:0032786)	9	0	.46	-	 < 0.01	6.31E-01
regulation of DNA-templated transcription, elongation (GO:0032784)	13	0	.66	-	 < 0.01	5.15E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	2	0	.10	-	 < 0.01	9.03E-01
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	4	0	.20	-	 < 0.01	8.15E-01
positive regulation of protein-containing complex assembly (GO:0031334)	37	0	1.89	-	 < 0.01	1.51E-01
regulation of NIK/NF-kappaB signaling (GO:1901222)	5	0	.26	-	 < 0.01	7.75E-01
tyrosine metabolic process (GO:0006570)	5	0	.26	-	 < 0.01	7.75E-01
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	23	0	1.17	-	 < 0.01	3.09E-01
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	28	0	1.43	-	 < 0.01	2.39E-01
synaptic vesicle transport (GO:0048489)	14	0	.72	-	 < 0.01	4.89E-01
synaptic vesicle endocytosis (GO:0048488)	30	0	1.53	-	 < 0.01	2.16E-01
pyrimidine nucleobase catabolic process (GO:0006208)	7	0	.36	-	 < 0.01	6.99E-01
pyrimidine nucleobase metabolic process (GO:0006206)	10	0	.51	-	 < 0.01	6.00E-01
negative regulation of neuron death (GO:1901215)	11	0	.56	-	 < 0.01	5.70E-01
regulation of neuron death (GO:1901214)	14	0	.72	-	 < 0.01	4.89E-01
positive regulation of inflammatory response (GO:0050729)	3	0	.15	-	 < 0.01	8.58E-01
myofibril assembly (GO:0030239)	20	0	1.02	-	 < 0.01	3.60E-01
actomyosin contractile ring assembly (GO:0000915)	2	0	.10	-	 < 0.01	9.03E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	22	0	1.12	-	 < 0.01	3.25E-01
execution phase of apoptosis (GO:0097194)	8	0	.41	-	 < 0.01	6.65E-01
positive regulation of protein secretion (GO:0050714)	2	0	.10	-	 < 0.01	9.03E-01
regulation of multi-organism process (GO:0043900)	6	0	.31	-	 < 0.01	7.36E-01
erythrocyte differentiation (GO:0030218)	7	0	.36	-	 < 0.01	6.99E-01
T cell differentiation (GO:0030217)	14	0	.72	-	 < 0.01	4.89E-01
receptor-mediated endocytosis (GO:0006898)	58	0	2.96	-	 < 0.01	5.14E-02
choline transport (GO:0015871)	4	0	.20	-	 < 0.01	8.15E-01
Golgi to endosome transport (GO:0006895)	2	0	.10	-	 < 0.01	9.03E-01
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	22	0	1.12	-	 < 0.01	3.25E-01
heparan sulfate proteoglycan metabolic process (GO:0030201)	14	0	.72	-	 < 0.01	4.89E-01
behavior (GO:0007610)	14	0	.72	-	 < 0.01	4.89E-01
arginine catabolic process (GO:0006527)	6	0	.31	-	 < 0.01	7.36E-01
cellular zinc ion homeostasis (GO:0006882)	25	0	1.28	-	 < 0.01	2.79E-01
regulation of hemopoiesis (GO:1903706)	19	0	.97	-	 < 0.01	3.79E-01
sensory perception of chemical stimulus (GO:0007606)	37	0	1.89	-	 < 0.01	1.51E-01
sensory perception of sound (GO:0007605)	12	0	.61	-	 < 0.01	5.42E-01
sensory perception (GO:0007600)	74	0	3.78	-	 < 0.01	2.26E-02
cellular iron ion homeostasis (GO:0006879)	8	0	.41	-	 < 0.01	6.65E-01
cellular copper ion homeostasis (GO:0006878)	1	0	.05	-	 < 0.01	9.50E-01
zymogen activation (GO:0031638)	11	0	.56	-	 < 0.01	5.70E-01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	10	0	.51	-	 < 0.01	6.00E-01
regulation of cell junction assembly (GO:1901888)	11	0	.56	-	 < 0.01	5.70E-01
membrane protein ectodomain proteolysis (GO:0006509)	13	0	.66	-	 < 0.01	5.15E-01
proton transmembrane transport (GO:1902600)	41	0	2.09	-	 < 0.01	1.23E-01
axonemal dynein complex assembly (GO:0070286)	10	0	.51	-	 < 0.01	6.00E-01
GPI anchor biosynthetic process (GO:0006506)	17	0	.87	-	 < 0.01	4.19E-01
GPI anchor metabolic process (GO:0006505)	18	0	.92	-	 < 0.01	3.99E-01
receptor internalization (GO:0031623)	21	0	1.07	-	 < 0.01	3.42E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	14	0	.72	-	 < 0.01	4.89E-01
nucleotide transport (GO:0006862)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	4	0	.20	-	 < 0.01	8.15E-01
tissue remodeling (GO:0048771)	9	0	.46	-	 < 0.01	6.31E-01
mitochondrial calcium ion transmembrane transport (GO:0006851)	2	0	.10	-	 < 0.01	9.03E-01
regulation of B cell proliferation (GO:0030888)	7	0	.36	-	 < 0.01	6.99E-01
response to metal ion (GO:0010038)	44	0	2.25	-	 < 0.01	1.05E-01
response to inorganic substance (GO:0010035)	55	0	2.81	-	 < 0.01	6.00E-02
meiotic sister chromatid segregation (GO:0045144)	6	0	.31	-	 < 0.01	7.36E-01
leucine transport (GO:0015820)	2	0	.10	-	 < 0.01	9.03E-01
negative regulation of BMP signaling pathway (GO:0030514)	15	0	.77	-	 < 0.01	4.65E-01
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	6	0	.31	-	 < 0.01	7.36E-01
regulation of BMP signaling pathway (GO:0030510)	20	0	1.02	-	 < 0.01	3.60E-01
positive regulation of lipase activity (GO:0060193)	38	0	1.94	-	 < 0.01	1.43E-01
regulation of lipase activity (GO:0060191)	41	0	2.09	-	 < 0.01	1.23E-01
negative regulation of Ras protein signal transduction (GO:0046580)	9	0	.46	-	 < 0.01	6.31E-01
inner dynein arm assembly (GO:0036159)	3	0	.15	-	 < 0.01	8.58E-01
outer dynein arm assembly (GO:0036158)	6	0	.31	-	 < 0.01	7.36E-01
actin-mediated cell contraction (GO:0070252)	6	0	.31	-	 < 0.01	7.36E-01
regulation of reactive oxygen species metabolic process (GO:2000377)	3	0	.15	-	 < 0.01	8.58E-01
branched-chain amino acid transport (GO:0015803)	2	0	.10	-	 < 0.01	9.03E-01
regulation of bone resorption (GO:0045124)	5	0	.26	-	 < 0.01	7.75E-01
basic amino acid transport (GO:0015802)	5	0	.26	-	 < 0.01	7.75E-01
iron ion transport (GO:0006826)	19	0	.97	-	 < 0.01	3.79E-01
cell wall macromolecule biosynthetic process (GO:0044038)	1	0	.05	-	 < 0.01	9.50E-01
cell wall macromolecule metabolic process (GO:0044036)	1	0	.05	-	 < 0.01	9.50E-01
cardiocyte differentiation (GO:0035051)	7	0	.36	-	 < 0.01	6.99E-01
glial cell differentiation (GO:0010001)	7	0	.36	-	 < 0.01	6.99E-01
cardiac muscle tissue development (GO:0048738)	11	0	.56	-	 < 0.01	5.70E-01
negative regulation of chromatin silencing (GO:0031936)	5	0	.26	-	 < 0.01	7.75E-01
striated muscle tissue development (GO:0014706)	15	0	.77	-	 < 0.01	4.65E-01
regulation of chromatin silencing (GO:0031935)	7	0	.36	-	 < 0.01	6.99E-01
protein localization to cytoskeleton (GO:0044380)	8	0	.41	-	 < 0.01	6.65E-01
